
<html lang="en"     class="pb-page"  data-request-id="b2d27bdd-ad30-4019-b2ce-02db2665adc4"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";issue:issue:10.1021/jmcmar.2014.57.issue-13;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text;article:article:10.1021/jm5006429"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain" /></meta><meta name="dc.Creator" content="Shawn J.  Stachel" /></meta><meta name="dc.Creator" content="John M.  Sanders" /></meta><meta name="dc.Creator" content="Darrell A.  Henze" /></meta><meta name="dc.Creator" content="Mike T.  Rudd" /></meta><meta name="dc.Creator" content="Hua-Poo  Su" /></meta><meta name="dc.Creator" content="Yiwei  Li" /></meta><meta name="dc.Creator" content="Kausik K.  Nanda" /></meta><meta name="dc.Creator" content="Melissa S.  Egbertson" /></meta><meta name="dc.Creator" content="Peter J.  Manley" /></meta><meta name="dc.Creator" content="Kristen L. G.  Jones" /></meta><meta name="dc.Creator" content="Edward J.  Brnardic" /></meta><meta name="dc.Creator" content="Ahren  Green" /></meta><meta name="dc.Creator" content="Jay A.  Grobler" /></meta><meta name="dc.Creator" content="Barbara  Hanney" /></meta><meta name="dc.Creator" content="Michael  Leitl" /></meta><meta name="dc.Creator" content="Ming-Tain  Lai" /></meta><meta name="dc.Creator" content="Vandna  Munshi" /></meta><meta name="dc.Creator" content="Dennis  Murphy" /></meta><meta name="dc.Creator" content="Keith  Rickert" /></meta><meta name="dc.Creator" content="Daniel  Riley" /></meta><meta name="dc.Creator" content="Alicja  Krasowska-Zoladek" /></meta><meta name="dc.Creator" content="Christopher  Daley" /></meta><meta name="dc.Creator" content="Paul  Zuck" /></meta><meta name="dc.Creator" content="Stephanie A.  Kane" /></meta><meta name="dc.Creator" content="Mark T.  Bilodeau" /></meta><meta name="dc.Description" content="We have identified several series of small molecule inhibitors of TrkA with unique binding modes. The starting leads were chosen to maximize the structural and binding mode diversity derived from a..." /></meta><meta name="Description" content="We have identified several series of small molecule inhibitors of TrkA with unique binding modes. The starting leads were chosen to maximize the structural and binding mode diversity derived from a..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="June 19, 2014" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm5006429" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2014 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm5006429" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm5006429" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm5006429" /></link>
        
    
    

<title>Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm5006429" /></meta><meta property="og:title" content="Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0020.jpeg" /></meta><meta property="og:description" content="We have identified several series of small molecule inhibitors of TrkA with unique binding modes. The starting leads were chosen to maximize the structural and binding mode diversity derived from a high throughput screen of our internal compound collection. These leads were optimized for potency and selectivity employing a structure based drug design approach adhering to the principles of ligand efficiency to maximize binding affinity without overly relying on lipophilic interactions. This endeavor resulted in the identification of several small molecule pan-Trk inhibitor series that exhibit high selectivity for TrkA/B/C versus a diverse panel of kinases. We have also demonstrated efficacy in both inflammatory and neuropathic pain models upon oral dosing. Herein we describe the identification process, hit-to-lead progression, and binding profiles of these selective pan-Trk kinase inhibitors." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm5006429"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm5006429">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm5006429&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm5006429&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm5006429&amp;href=/doi/10.1021/jm5006429" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2014</span><span class="cit-fg-volume">, 57</span><span class="cit-fg-issue">, 13</span><span class="cit-fg-pageRange">, 5800-5816</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/57/13" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm5006435" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm500246h" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shawn+J.++Stachel">Shawn J. Stachel</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=John+M.++Sanders">John M. Sanders</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Darrell+A.++Henze">Darrell A. Henze</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mike+T.++Rudd">Mike T. Rudd</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Hua-Poo++Su">Hua-Poo Su</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yiwei++Li">Yiwei Li</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kausik+K.++Nanda">Kausik K. Nanda</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Melissa+S.++Egbertson">Melissa S. Egbertson</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+J.++Manley">Peter J. Manley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristen+L.+G.++Jones">Kristen L. G. Jones</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Edward+J.++Brnardic">Edward J. Brnardic</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ahren++Green">Ahren Green</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jay+A.++Grobler">Jay A. Grobler</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Hanney">Barbara Hanney</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Leitl">Michael Leitl</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ming-Tain++Lai">Ming-Tain Lai</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Vandna++Munshi">Vandna Munshi</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Dennis++Murphy">Dennis Murphy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Keith++Rickert">Keith Rickert</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Riley">Daniel Riley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Alicja++Krasowska-Zoladek">Alicja Krasowska-Zoladek</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher++Daley">Christopher Daley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Zuck">Paul Zuck</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stephanie+A.++Kane">Stephanie A. Kane</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+T.++Bilodeau">Mark T. Bilodeau</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Departments of Medicinal Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div><div class="corresp-info"><strong>*</strong>Phone: 215-652-2273. Fax: 215-652-7310. E-mail: <a href="/cdn-cgi/l/email-protection#4a39222b3d2415393e2b29222f260a272f38292164292527"><span class="__cf_email__" data-cfemail="1d6e757c6a73426e697c7e7578715d70786f7e76337e7270">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm5006429&amp;href=/doi/10.1021%2Fjm5006429" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2014</span></span><span class="cit-volume">, 57</span><span class="cit-issue">, 13</span><span class="cit-pageRange">, 5800–5816</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">June 10, 2014</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>1 May 2014</li><li><span class="item_label"><b>Published</b> online</span>19 June 2014</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 10 July 2014</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm5006429" title="DOI URL">https://doi.org/10.1021/jm5006429</a></div><div class="article_header-article-copyright"><strong>Copyright © 2014 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D5800%26pageCount%3D17%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DShawn%2BJ.%2BStachel%252C%2BJohn%2BM.%2BSanders%252C%2BDarrell%2BA.%2BHenze%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D57%26issueNum%3D13%26contentID%3Djm5006429%26title%3DMaximizing%2BDiversity%2Bfrom%2Ba%2BKinase%2BScreen%253A%2BIdentification%2Bof%2BNovel%2Band%2BSelective%2Bpan-Trk%2BInhibitors%2Bfor%2BChronic%2BPain%26numPages%3D17%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D5816%26publicationDate%3DJuly%2B2014">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm5006429"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3780</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">38</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm5006429" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Maximizing Diversity from a Kinase Screen: Identification of Novel and Selective pan-Trk Inhibitors for Chronic Pain&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Shawn&quot;,&quot;last_name&quot;:&quot;J. Stachel&quot;},{&quot;first_name&quot;:&quot;John&quot;,&quot;last_name&quot;:&quot;M. Sanders&quot;},{&quot;first_name&quot;:&quot;Darrell&quot;,&quot;last_name&quot;:&quot;A. Henze&quot;},{&quot;first_name&quot;:&quot;Mike&quot;,&quot;last_name&quot;:&quot;T. Rudd&quot;},{&quot;first_name&quot;:&quot;Hua-Poo&quot;,&quot;last_name&quot;:&quot;Su&quot;},{&quot;first_name&quot;:&quot;Yiwei&quot;,&quot;last_name&quot;:&quot;Li&quot;},{&quot;first_name&quot;:&quot;Kausik&quot;,&quot;last_name&quot;:&quot;K. Nanda&quot;},{&quot;first_name&quot;:&quot;Melissa&quot;,&quot;last_name&quot;:&quot;S. Egbertson&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;J. Manley&quot;},{&quot;first_name&quot;:&quot;Kristen&quot;,&quot;last_name&quot;:&quot;L. G. Jones&quot;},{&quot;first_name&quot;:&quot;Edward&quot;,&quot;last_name&quot;:&quot;J. Brnardic&quot;},{&quot;first_name&quot;:&quot;Ahren&quot;,&quot;last_name&quot;:&quot;Green&quot;},{&quot;first_name&quot;:&quot;Jay&quot;,&quot;last_name&quot;:&quot;A. Grobler&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Hanney&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Leitl&quot;},{&quot;first_name&quot;:&quot;Ming-Tain&quot;,&quot;last_name&quot;:&quot;Lai&quot;},{&quot;first_name&quot;:&quot;Vandna&quot;,&quot;last_name&quot;:&quot;Munshi&quot;},{&quot;first_name&quot;:&quot;Dennis&quot;,&quot;last_name&quot;:&quot;Murphy&quot;},{&quot;first_name&quot;:&quot;Keith&quot;,&quot;last_name&quot;:&quot;Rickert&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Riley&quot;},{&quot;first_name&quot;:&quot;Alicja&quot;,&quot;last_name&quot;:&quot;Krasowska-Zoladek&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;Daley&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Zuck&quot;},{&quot;first_name&quot;:&quot;Stephanie&quot;,&quot;last_name&quot;:&quot;A. Kane&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;T. Bilodeau&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2014&quot;,&quot;month&quot;:&quot;06&quot;,&quot;day&quot;:&quot;19&quot;,&quot;issue&quot;:&quot;13&quot;,&quot;volume&quot;:&quot;57&quot;,&quot;pages&quot;:&quot;5800-5816&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm5006429&quot;},&quot;abstract&quot;:&quot;We have identified several series of small molecule inhibitors of TrkA with unique binding modes. The starting leads were chosen to maximize the structural and binding mode diversity derived from a high throughput screen of our internal compound collection. These leads were optimized for potency and selectivity employing a structure based drug design approach adhering to the principles of ligand efficiency to maximize binding affinity without overly relying on lipophilic interactions. This endeavor resulted in the identification of several small molecule pan-Trk inhibitor series that exhibit high selectivity for TrkA/B/C versus a diverse panel of kinases. We have also demonstrated efficacy in both inflammatory and neuropathic pain models upon oral dosing. Herein we describe the identification process, hit-to-lead progression, and binding profiles of these selective pan-Trk kinase inhibitors.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5006429&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006429" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5006429&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006429" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm5006429&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006429" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm5006429&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm5006429&amp;href=/doi/10.1021/jm5006429" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm5006429" /></input><a href="/doi/pdf/10.1021/jm5006429" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm5006429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm5006429%26sid%3Dliteratum%253Aachs%26pmid%3D24914455%26genre%3Darticle%26aulast%3DStachel%26date%3D2014%26atitle%3DMaximizing%2BDiversity%2Bfrom%2Ba%2BKinase%2BScreen%253A%2BIdentification%2Bof%2BNovel%2Band%2BSelective%2Bpan-Trk%2BInhibitors%2Bfor%2BChronic%2BPain%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D57%26issue%3D13%26spage%3D5800%26epage%3D5816%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291026" title="Conformation">Conformation</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/57/13" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jmcmar.2014.57.issue-13/production/jmcmar.2014.57.issue-13.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">We have identified several series of small molecule inhibitors of TrkA with unique binding modes. The starting leads were chosen to maximize the structural and binding mode diversity derived from a high throughput screen of our internal compound collection. These leads were optimized for potency and selectivity employing a structure based drug design approach adhering to the principles of ligand efficiency to maximize binding affinity without overly relying on lipophilic interactions. This endeavor resulted in the identification of several small molecule pan-Trk inhibitor series that exhibit high selectivity for TrkA/B/C versus a diverse panel of kinases. We have also demonstrated efficacy in both inflammatory and neuropathic pain models upon oral dosing. Herein we describe the identification process, hit-to-lead progression, and binding profiles of these selective pan-Trk kinase inhibitors.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_78088" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_78088" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Kinases are a class of enzymes whose primary function is to transfer the terminal phosphate group of ATP to an acceptor. For a major subclass of kinases the acceptor is another protein. This phospho-transfer event, termed phosphorylation, induces a conformational change in the receiving protein, resulting in a change in functional activity. This change in function is manifested in a diverse array of signal transduction processes within a cell and influences a wide array of cellular processes. Kinases are grouped into two main classes by cellular location, receptor and intracellular kinases. Receptor kinases propagate transmembrane signaling events, whereas intracellular kinases initiate signal transduction to the nucleus. In fact, kinases are so integral to biological processes that greater than 500 kinases have been identified, representing close to 2% of the human genome.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> In totality, it has been stated that approximately 30% of all human proteins may be modified by kinase activity. Given that kinase signaling plays a ubiquitous role in physiological processes and the fact that ATP is the conserved ligand for all kinases, selectivity becomes paramount for the development of a safe and effective pharmaceutical agent. As such, achieving high selectivity against other kinases is a prerequisite for the development of clinical kinase inhibitor candidates.</div><div class="NLM_p last">Tropomysin receptor kinases (Trks) are cell surface receptor kinases that are highly expressed in neurons and play an important role in cell signaling.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> There are three known members of the Trk family: TrkA, TrkB, and TrkC. All three of the Trks’ polypeptides are composed of three distinct topological domains: an extracellular domain, a transmembrane domain, and a cytoplasmic kinase domain. Activation of the receptor occurs when a complementary neurotrophic partner binds with the extracellular domain of these kinases. Binding results in dimerization and subsequent autophosphorylation, thereby initiating the intracellular signaling pathway. Each of the Trks binds to a specific neurotrophic factor, and the complementary neurotrophin for each of the Trks is NGF for TrkA, BDNF for TrkB, and NT-3 for TrkC. We were particularly interested in the NGF/TrkA pathway because it plays a central role in the biology of chronic pain.<a onclick="showRef(event, 'ref3 ref4'); return false;" href="javascript:void(0);" class="ref ref3 ref4">(3, 4)</a> Activation of the receptor tyrosine kinase TrkA by NGF triggers intracellular signaling cascades and protein expression that increases the sensitivity of nociceptors leading to chronic sensitization and pain. Inhibition of the NGF/TrkA pathway has been validated clinically using NGF-neutralizing monoclonal antibodies that are currently in phase II–III trials for osteoarthritis pain.<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> We were interested in identifying small-molecule inhibitors of TrkA as an alternative intervention modality for the treatment of chronic pain.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">HTS Effort</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88208" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88208" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">As part of our effort to identify selective inhibitors of TrkA, we conducted an HTS campaign with the intent of identifying nontraditional chemotypes as a starting point for discovery efforts to maximize the potential for increased selectivity versus the known kinome. Approximately 30K compounds were identified in the initial HTS campaign that displayed at least 30% activity toward TrkA, the kinase of interest (median <i>Z</i>′ is 0.81; hit rate at 3σ is 0.5%). To narrow the number of active hits derived from the high throughput screen, we employed a number of filters. We removed hits that displayed promiscuous activity, defined as being active in more than five HTS campaigns or more than two kinase HTS campaigns. In addition, compounds were also counterscreened against the receptor tyrosine kinase insulin-like growth factor receptor 1 (IGFR1) serving as a general kinase for initial selectivity assessments. Lastly, activity against TrkA was measured using both low (0.1 mM) and high (2 mM) ATP concentrations to inform on potential ATP competitive binders. We succeeded in identifying a number of potentially interesting candidates to investigate further. Four particularly noteworthy compounds that showed modest activity against TrkA and at least a 50-fold selectivity window versus IGFR1, emerged from this effort, are exemplified in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>. Compound <b>1</b> originated from a general kinase library but was chosen for further investigation because, while it contained a known chemotype used in orthosteric kinase inhibitors, it exhibited high selectivity versus IGFR1 (IC<sub>50</sub> > 50 μM) and as such was followed-up on as a starting reference point for our crystallization efforts. In contrast, compounds <b>2</b>–<b>4</b> were all derived from non-kinase programs and, upon initial ocular inspection, did not resemble chemotypes typical of ATP-competitive binders. We chose to investigate these four compound classes in more detail as hit classes of interest with the goal of elucidating their binding profiles and further optimizing both their intrinsic potency toward TrkA and their physical properties.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0001.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HTS leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i3" class="anchor-spacer"></div><h3 class="article-section__title" id="_i3"> Class I: Pyridopyrimidine Series</h3><div class="NLM_p">The pyridopyrimidine series, exemplified by the high-throughput screening hit <b>1</b>, displayed modest potency toward TrkA, IC<sub>50</sub> ≈ 1 μM, but as mentioned, <b>1</b> displayed favorable selectivity against IGFR1. When assayed against a broader 92-member kinase countersceening panel, compound <b>1</b> exhibited only two hits of greater than 20% activity at 1 μM and <10% activity against the remaining kinases tested.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Initial efforts focused on obtaining increased potency toward TrkA to better gauge its relative selectivity toward the greater kinome. In parallel with our screening efforts, we also pursued methods to obtain X-ray crystallographic data to support follow-up SAR development using a rational structural design approach. Toward this end, we succeeded in obtaining protein crystals of the TrkA kinase domain that were suitable for soaking with inhibitors to obtain structural data in a relatively high-throughput manner.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> The crystallographic structure of <b>1</b> was obtained and was found to bind in the ATP-binding site as seen in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a> depicts a magnified view of the ATP-site highlighting the binding interactions of <b>1</b> in the active site. The pyridopyrimidine was found to bind primarily within the hinge region of the enzyme and would be described as a type I, or DFG-in, inhibitor (vide infra).<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> The main hydrogen bonding interactions between the enzyme and inhibitor <b>1</b> occurs through a direct hydrogen bond between the N1 nitrogen of the pyridopyrimidine and the backbone NH of Met 592. The benzylic pyridine portion of the molecule is tucked in the front pocket and forms a face-to-face π-stacking interaction with the guanidine group of the activation loop residue, Arg 673. The morpholine extends from the binding pocket into the solvent, which is consistent with the observation that morpholine and piperazine groups are commonly preferred substituents in this region of the binding pocket.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a></div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0002.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>1</b> with TrkA. The compound binds in a DFG-in conformation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0003.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hydrogen bonding interactions of <b>1</b> within the active site of TrkA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having elucidated the binding orientation of <b>1</b> to TrkA in the active site, we were able to pursue a rational approach for ligand optimization (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). To track the progress of our optimization efforts in each series and to ensure that we were balancing any improvements in potency with the physicochemical properties of the molecule, we relied on optimizing ligand efficiency metrics based on both molecular mass (LE) and lipophilicity (LLE). Our optimization efforts in the pyridopyrimidine series began with replacing the morpholine ligand in the solvent exposed region with an <i>N</i>-methylpiperazine group, which as previously mentioned is another generic preferred substituent in the hinge/solvent front region of kinase inhibitors. In addition, since the pyridyl nitrogen in the western portion of the molecule did not appear to be making a productive hydrogen-bonding interaction with the protein, we investigated alternative substituents in the region by screening of a variety of benzylic amines and identified meta-chlorobenzylamine as a superior replacement. These two key modifications resulted in compound <b>5</b> that displayed a 90-fold enhancement in intrinsic inhibitory activity toward TrkA (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). In addition, while <b>1</b> displayed activity of greater than 10 μM in the TrkA cell-based assay,<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> the potency improvements realized in <b>5</b> now afforded activity in our cellular assay. More importantly, <b>5</b> retained a high degree of selectivity displaying only three hits of greater than 20% activity at 1 μM against the 92-member kinase panel with a majority still showing <10% activity against the kinases tested. However, while overall ligand binding efficiency increased with these modifications (compound <b>5</b> LE = 0.33 vs compound <b>1</b> LE = 0.27), comparison of the lipophilic ligand efficiencies, LLEs (compound <b>5</b> LLE = 1.38 vs compound <b>1</b> LLE = 2.19) revealed that much of the improved potency was derived from lipophilic interactions.</div><div class="NLM_p">Upon further optimization, the benzylamine was replaced with a difluoropyrrolidine as part of a scaffold hopping exercise incorporating structural motifs found in other known kinase inhibitors.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Next, screening a variety of aniline replacements identified a benzylic imidazothiazole as a preferred substitution resulting in compound <b>6</b>.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13, 14)</a> The synthesis of compound <b>6</b> is described in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>. Compound <b>6</b> displayed impressive single digit nanomolar activity toward TrkA, IC<sub>50</sub> = 1.5 nM, as well as greatly improved potency in our cell-based TrkA assay, IC<sub>50</sub> = 13 nM. The increased potency realized with <b>6</b> was also commensurate with improvements in ligand efficiency with respect to both molecular mass (LE = 0.36) and lipophilicity (LLE = 3.16).</div><figure id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0011.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Evolution of Pyridopyrimidine HTS Lead <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>6</b> was a very interesting lead that exhibited a typical type I kinase inhibitor binding mode. However, in parallel with optimization of <b>1</b>, efforts also continued on some of the other hits identified in the screen that originated from non-kinase programs with the hopes of elucidating additional inhibitors with more novel binding characteristics.</div><figure id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0012.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (<i>S</i>)-2-(2,5-difluorophenyl)pyrrolidine, EtOH, 69%; (b) POCl<sub>3</sub>, 70%; (c) 1-(1<i>H</i>-benzimidazol-2-yl)methanamine, EtOH, 58%.</p></p></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Class II: Phenyltriazole Series</h3><div class="NLM_p">A second series of interest focused on the HTS lead exemplified by compound <b>2</b>. This compound was originally synthesized as part of a legacy neuroscience program and did not constitute a lead originating from a prior kinase program. While <b>2</b> displayed modest potency toward TrkA, IC<sub>50</sub> = 662 nM, it displayed a very favorable selectivity profile registering only one hit greater than 20% at 1 μM in the panel of 92 diverse kinases with the majority showing <10% activity against the kinases tested. Since the structure bore little resemblance to traditional ATP-site binding motifs for kinase inhibitors, we conducted a more detailed investigation of this structural series. Gratifyingly, we were able to obtain crystallographic data of <b>2</b> binding with TrkA.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> In contrast to the type I, or DFG-in, binding mode described above for <b>1</b>, compound <b>2</b> was found to bind to a very different conformational form of the enzyme, commonly referred to as a type II, or DFG-out, conformation.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> The differences between type I and type II inhibitors go beyond the interactions of the inhibitor with the enzyme and involve substantial differences in the tertiary structure of the kinase itself. The primary function of a kinase is to transfer a phosphate group from ATP to another protein substrate in order to initiate a signaling cascade. For a number of kinases, this is regulated by a conformational change in a conserved triad of amino acids, composed of an Asp-Phe-Gly, or DFG sequence, at the start of the activation loop. To propagate the signaling cascade, the inactive kinase is first phosphorylated on its activation loop by an upstream kinase. In the case of the Trks this is accomplished through an autophosphorylation event brought about by dimerization of the enzyme upon binding to its corresponding neurotrophic factor. Once the activation loop is phosphorylated, it undergoes a conformational change that results in an opening of the active site. This conformation of the enzyme is termed the DFG-in conformation. This opening of the active site allows ATP to bind and subsequently transfer its terminal phosphate group. Conversely, in the inactive or nonphosphorylated state, the activation loop occupies the active site and prevents ATP from binding.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> This closed conformation is termed the DFG-out conformation where the DFG segment is rotated out and toward the ATP binding site. The conserved DFG triad plays an integral part in inducing the requisite tertiary structure involved in kinase function. In the active form of the kinase the Asp (<b>D</b>FG) residue plays a critical role by coordinating with a magnesium ion that is also bound to the γ-phosphate of the ATP, thus serving to facilitate the phospho-transfer event. From a structural perspective, in the active form of the enzyme, the Phe of the D<b>F</b>G triad normally occupies a hydrophobic pocket located behind the gatekeeper residue allowing for proper positioning of the catalytic aspartate for the phospho-transfer event. However, in the inactive form the phenylalanine of the DFG triad is rotated out of its binding site behind the gatekeeper residue, thereby revealing a large hydrophobic pocket commonly referred to as the selectivity pocket. The fact that TrkA is able to adopt a DFG-out conformation is particularly unusual, since a small gatekeeper, typically valine or threonine, is often required to allow for this conformational transition, whereas in TrkA the gatekeeper residue is a large phenylalanine. Scientists at GNF have also reported a DFG-out binding conformation for their TrkA inhibitor series in a recent publication.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> In fact, much of the recent efforts in the development of kinase inhibitors have focused on exploiting DFG-out binders, since they have been thought to hold potential advantages over active site orthosteric inhibitors. Since all kinases bind ATP as their orthosteric ligand, targeting the selectivity pocket has been viewed as a strategy to improve selectivity against the broader kinome. Several important new therapeutic agents have already been approved that selectively bind to the DFG-out kinase conformation, with the tyrosine kinase inhibitor imatinib being one of the most notable examples.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> However, while the majority of human kinases contain the DFG-sequence as the start of the activation loop, only a relative few have been observed in both the DFG-in and DFG-out conformations.</div><div class="NLM_p">As mentioned, compound <b>2</b> was found to bind to the DFG-out conformation of TrkA (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a> depicts some of the key binding elements observed in the structure. First, the imidazole was observed to make one hydrogen bond to the hinge backbone NH of Met 592. The central triazole ring makes hydrophobic interactions with the gatekeeper phenylalanine residue, thus serving as a hydrophobic clamp for the inhibitor in the active site. The amide carbonyl forms a hydrogen bond with the NH of the catalytic Asp (668) residue and the amide NH hydrogen bonds to the carboxylate of Glu 560. The <i>N</i>-phenylpyrazole occupies the hydrophobic selectivity pocket normally occupied by Phe 669 in the active, DFG-in, kinase conformation, with the pyrazole nitrogen making an interesting water-mediated hydrogen bond to the carboxylate of the catalytic Asp 668.</div><figure id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0004.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hinge-binding interactions of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0005.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. DFG-out binding of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0013.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Evolution of Triazole HTS Lead <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> SAR Optimization of <b>2</b></h3><div class="NLM_p">Having secured a crystal structure of <b>2</b> in the TrkA active site, we were able to leverage the structural information gleaned from our analysis of the binding mode to rapidly progress the series (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). First, from the structure it was evident that the methoxy group on the western aryl ring of <b>2</b> was oriented toward the solvent front and was not participating in any meaningful interaction with the enzyme. As such, removal of the methoxy group (<b>10</b>) resulted in an improvement in both enzymatic and cellular potency, perhaps due to the conformational effect of the methoxy group that twists the imidazole/phenyl dihedral angle from coplanarity. Removal of methoxy allows the imidazole to attain coplanarity with the aryl ring, the proposed bioactive conformation, affording a 10-fold increase in potency. This modification also resulted in increased metrics for ligand efficiency with the LE increasing from 0.23 to 0.28 and LLE increasing from 2.08 to 3.16, signaling that the increase in potency was not being driven solely by lipophilicity changes. As mentioned in the above discussion, it was evident that <b>2</b> formed only one direct hydrogen bond with the hinge backbone. For our next modification we sought to increase the number of hinge binding interactions through the introduction of a nitrogen into the aryl ring in the form of an aminopyridine. However, instead of a direct interaction with the backbone, the X-ray cocrystallographic structure revealed that the nitrogen lone pair interacted indirectly with the carbonyl of Glu 590 through an intermediary water molecule. Modifications were also made to the portion of the molecule occupying the hydrophobic selectivity pocket. As such, the cyclopropyl group was changed to a bulkier <i>tert</i>-butyl group in order to more optimally fill the hydrophobic void previously occupied by the DFG-phenylalanine in the DFG-out conformation. In addition to this change, the introduction of a nitrogen to the pendent <i>N</i>-phenyl group served to decrease the overall cLogD by 1 log unit while not imparting additional hydrogen bonding interactions with the enzyme. The impact of this modification is apparent in the LLE value, as it increased to 5.78 from 3.16 for compound <b>11</b> when compared to <b>10</b>, indicating more efficient binding with lower overall lipophilicity. Taken together, these modifications that afforded compound <b>11</b> (synthesis described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>) resulted in an additional improvement in both enzymatic and functional activity providing an inhibitor with single digit nanomolar activity in both the enzymatic and cellular assays. The changes to the starting structure not only led to increased potency but were accomplished by maintaining and improving ligand efficiency in a per atom binding basis and also with respect to the overall lipophilic character. Compound <b>11</b> retained the exquisite selectivity against the kinase panel showing high selectivity with the improved potency registering only nine hits with >20% inhibition at 1 μM with a majority showing <10% activity against the kinases tested. Compound <b>11</b> possessed the requisite potency and physical properties to be assessed in vivo and was found to be efficacious in our pain models (vide infra). It should be noted that the superior cellular potency compared with the enzymatic activity of this, and other series, is most likely a result of the effect of conducting the enzymatic activity assay at elevated ATP levels to facilitate an increased dynamic range in the enzymatic assay but that are not necessarily reflective of the native levels of ATP present within the cells.</div><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0014.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route for Compound <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Imidazole, <span class="smallcaps smallerCapital">l</span>-proline, CuI, K<sub>2</sub>CO<sub>3</sub>, DMSO, 61%; (b) TMS–acetylene, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, 78%; (c) KF, MeOH, 100%; (d) 2-chloroacetyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 72%; (e) NaN<sub>3</sub>, EtOH, 92%; (f) Cu powder, CH<sub>2</sub>Cl<sub>2</sub>–<i>t</i>-BuOH, H<sub>2</sub>O, aq CuSO<sub>4</sub>, 72%.</p></p></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Class III: Urea Series</h3><div class="NLM_p">A third series of interest focused on the HTS lead exemplified by compound <b>3</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> This compound displayed remarkable selectivity against all other kinases in the general counterscreen with 0 hits of >20% activity at 1 μM. Compound <b>3</b> was originally synthesized as part of our general screening library. While compound <b>3</b> did not overtly resemble a typical ATP-competitive chemotype, we now recognized that TrkA was capable of binding both DFG-in and DFG-out type inhibitors. Since amide and urea-based kinase inhibitors have been well documented in the literature and are typically DFG-out binders, at first glance it seems plausible that this inhibitor could also be interacting through a similar binding paradigm.<a onclick="showRef(event, 'ref21 ref22 ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref21 ref22 ref23 ref24">(21-24)</a> However, all of the reported inhibitors of this class are diphenyl amides or ureas and are involved in hydrogen bond donor and acceptor roles with the unsubstituted nitrogens which are both involved in key hydrogen bonding interactions with the enzyme. The potential for an atypical binding paradigm for <b>3</b> was reinforced when we performed docking experiments to suggest potential binding conformations. Unfortunately we were unable to achieve such convincing poses with the substituted ureas analogues. In fact, the fully unsubstituted urea (<b>19</b>) was found to be completely inactive in the enzymatic assay with an IC<sub>50</sub> of >100 μM. By analyzing structurally similar compounds contained within the collection, we quickly found that an isopropyl group offered a 30-fold potency enhancement over the cyclopropyl derivative (<b>17</b>) (Scheme <a class="ref internalNav" href="#sch5" aria-label="5">5</a>). Compound <b>17</b> also retained excellent selectivity with only one hit of greater than 20% activity when assayed against the 92-member kinase counterscreen. Concurrent with the aforementioned similarity assessment, we succeeded in obtaining a crystal structure of compound <b>3</b> with the TrkA kinase domain (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>).<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The structural information turned out to be quite revealing: the inhibitor was indeed found to bind to the DFG-out conformation of the kinase, as other amide and urea kinase inhibitors were already known to do, but it did so without some of the more commonly observed characteristics. The thiazole occupied the ATP-binding site but was only found to form a weak hydrogen bond with Met 592. The benzylic aryl ring was involved in hydrophobic interactions with the gatekeeper residue, Phe 617. The para-trifluoromethoxyphenyl group was situated in the hydrophobic selectivity pocket normally occupied by Phe in the D<b>F</b>G-in conformation, as is typical in DFG-out inhibitors, and the amide carbonyl was shown to form a hydrogen bond with the catalytic aspartate (D668) as is typical with the literature precedence. The cyclopropyl group on the adjacent nitrogen was shown to occupy a hydrophobic cleft and was tucked neatly against Val 524. This is interesting, since inhibitors of most kinases are typically unsubstituted and involved in a hydrogen bond with the homologous residue of α-C helix Glu 560. Our interpretation of the SAR around this group is that a critical hydrophobic mass is required to fill the small pocket near Val 524, Ala 542, Lys 544, and Phe 589, perhaps to displace a water molecule that may otherwise unfavorably occupy this region.</div><figure id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0006.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Crystal structure of <b>3</b> bound with TrkA. (b) Hinge-binding interactions of <b>3</b>. (c) View of <b>3</b> bound in the selectivity pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Having solved the crystal structure and elucidated that the thiazole, while occupying the ATP binding site, was not making optimal interactions with the protein, we sought to replace it with an alternative heterocycle with a greater potential to make favorable hydrogen bonding interactions with the hinge. This was accomplished by replacement of the thiazole with an azaindole group and resulted in compound <b>18</b> (synthesis described in Scheme <a class="ref internalNav" href="#sch6" aria-label="6">6</a>). Here the azaindole functions as a hydrogen-bond acceptor interacting with the NH of Met 592. Conversely, the indole NH serves as a hydrogen bond donor interacting with the carbonyl of Glu 590 in the backbone. Hence, optimization of the interaction with the hinge region and increasing the hydrophobic size of the heterocycle in the adenine site resulted in 10-fold improvement in both enzymatic and functional activity. It should also be noted that, similar to the two series previously described, optimization of the binding affinity for this series was also accomplished while maximizing the ligand binding and the lipophilic binding efficiencies.</div><figure id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0015.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. SAR Progression of HTS Lead <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0016.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route for Compound <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Isopropylamine, NaCNBH<sub>3</sub>, MeOH; (b) 1-isocyanato-4-(trifluoromethoxy)benzene, THF, 98% over two steps.</p></p></figure></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i13" class="anchor-spacer"></div><h3 class="article-section__title" id="_i13"> Class IV: Azaindole Series</h3><div class="NLM_p">The fourth and final series described here focused on the HTS lead exemplified by compound <b>4</b>. Pursuant to our strategy of investigating novel chemotypes, compound <b>4</b> was chosen for further investigation, since it displayed no activity against IGFR1 as part of the HTS counterscreening protocol. In addition, <b>4</b> showed no activity against any of the broader 92-membered kinase panel which was supported by our inability to dock this structural class into the TrkA active site, in either a DFG-in or DFG-out conformation, in a reasonable way. Intriguingly, while compound <b>4</b> was identified as a hit possessing moderate potency toward TrkA in the high throughput screen, i.e., IC<sub>50</sub> = 163 nM, when compound <b>4</b> was tested in our confirmation assay, it was found to display a severe disconnect between the screening and follow-up assays, exhibiting approximately a 100-fold difference in activity. The team was initially perplexed at the disparity between the two assays and sought to identify the cause for the difference in activity. In turned out that two slightly different assays were used for the HTS screen and subsequent confirmation assay, with the HTS screen utilizing a homogeneous time-dependent fluorescence (HTRF) assay, whereas the confirmation assay employed a caliper assay. More importantly, upon reinvestigation of the assay protocols, it was discovered that the TrkA protein used for the high throughput screen was nonphosphorylated protein whereas the protein that was used in the confirmation assay was provided as a phosphorylated TrkA protein. To investigate this phenomenon further, Thermofluor analysis was conducted using both forms of the protein, phosphorylated and nonphosphorylated. Compound <b>4</b> displayed a Δ<i>T</i><sub>m</sub> of 11 °C when assayed using the unphosphorylated protein. In contrast, no change in melting temperature was observed when the phosphorylated protein was utilized. These results provided support that compound <b>4</b> was exhibiting phosphorylation-state dependent binding. Phosphorylation state-dependent binding to kinases is an emerging avenue for inhibitor design. Since the DFG-out conformation represents the inactive, unphosphorylated protein, many compounds that exhibit this type of binding profile have shown differential binding activities between the active and inactive forms, but most DFG-out inhibitors are capable of binding both forms of the protein. However, there are several recent reports in the literature of inhibitor series that are active only versus the unphosphorylated form of the kinase of interest and have unmeasurable, or weak, inhibition of the phosphorylated form.<a onclick="showRef(event, 'ref26 ref27'); return false;" href="javascript:void(0);" class="ref ref26 ref27">(26, 27)</a> Having discerned the cause of discrepancy between the activity in the two assay formats, we subsequently assayed compound <b>4</b> in our caliper-based assay using nonphosphorylated TrkA protein. Under these conditions <b>4</b> displayed IC<sub>50</sub> = 2300 nM. While the potency was improved under these conditions versus the 17 μM IC<sub>50</sub> obtained using the phosphorylated enzyme, the IC<sub>50</sub> was still ∼10-fold higher than the original HTS HTRF IC<sub>50</sub> of 0.16 μM. This shift can partially be explained by the difference in ATP concentrations between the assays. For the standard caliper-based assay we employed a higher ATP concentration (i.e., 10 mM) compared to the 2 mM ATP concentration used in the HTS screen allowing more effective binding competition and an upward shift in IC<sub>50</sub> values. The shift to higher ATP concentrations for use in the follow-up assay was done to allow for more dynamic range in the assay for our optimization efforts. However, it should also be noted that it is difficult to determine if the original 17 μM IC<sub>50</sub> observed when assayed using phosphorylated substrate was derived from residual levels of nonphosphorylated enzyme in the supplied protein and may not reflect an accurate IC<sub>50</sub> against pure phosphorylated material. As such, the IC<sub>50</sub> values for all subsequent compounds for this particular series were determined using nonphosphorylated enzyme to have measurable and consistent activity by which to conduct SAR analysis. Prior to determining the importance of the phosphorylation state for the enzymatic assay the series was progressed using the cell-based potencies, since the cellular system exists in a dynamic equilibrium between the active and inactive forms of the protein and provides a more physiological assessment of a compound’s activity in the presence of endogenous ATP levels.</div><figure id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0007.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Binding pose of <b>4</b> in the TrkA active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> Binding of Azaindole Series</h3><div class="NLM_p">To elucidate the binding mode and obtain the structural insights necessary to design more potent inhibitors, we obtained the structure of compound <b>4</b> complexed with the TrkA kinase domain (Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>).<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> The structure clearly showed that <b>4</b> binds to the DFG-out conformation of TrkA. The structure revealed several unusual binding features for compound <b>4</b>. First, the inhibitor was found not to have a direct interaction with hinge backbone. Instead, the N5 nitrogen of the azaindole was shown to participate in a water-mediated hydrogen bond to two hinge residues, Asp 590 and Met 592. The naphthalene moiety was buried in the hydrophobic cleft at the front of the hinge flanked by the activation loop residue Met 670. This conformation was further stabilized through hydrophobic interactions with the DFG phenylalanine just behind the naphthyl ring inside the adenosine site. The isoxazole ring was situated under the gatekeeper phenylalanine residue, stabilized by hydrophobic van der Waals interactions and orienting the terminal phenyl ring into the selectivity pocket. One of the more unusual binding interactions was that of the indole carboxylic acid. Here the carboxylate was interacting with two backbone NHs in the activation loop, donated by Gly 671 and Met 670. A third hydrogen bonding interaction was also evident between the carboxylate and Lys 544 on the roof of the adenosine binding pocket. As stated previously, several of the inhibitors described previously were also found to bind to a DFG-out conformation but they did not show the phosphorylation-dependent binding that compound <b>4</b> exhibited. We believe that it is this unusual binding conformation between the indole carboxylate and the activation loop that leads to the phosphorylation-state dependent binding. This can be visualized in Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>, which depicts the interaction between Tyr 676 and Asp 595 in the crystallographic structure of TrkA bound to compound <b>4</b>. In this structure tyrosine 676 is involved in a hydrogen-bonding interaction with Asp 596. Since Tyr 676 is a known phosphorylation site on TrkA, it is apparent that phosphorylation of Tyr 676 would introduce a repulsive electrostatic interaction and disrupt this interaction with Asp 596, thereby forcing the activation loop away from the active site and thus stabilizing the active conformation. As such, the phosphorylated form of the enzyme is not able to adopt the tertiary conformation needed to bind compound <b>4</b> because of this repulsive interaction. A second, similar interaction also exists between Asp 650 and Tyr 680 (not depicted), another known TrkA phosphorylation site.</div><figure id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0008.jpeg" id="gr17" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. View of stabilizing interaction of inactive conformation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0017.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. SAR Progression of HTS Lead <b>4</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> SAR Optimization of <b>4</b></h3><div class="NLM_p last">Having solved the structure and elucidated the key interactions of <b>4</b> with TrkA, we were now positioned to follow a rational design approach toward ligand optimization (Scheme <a class="ref internalNav" href="#sch7" aria-label="7">7</a>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> First, the lipophilic naphthyl group that was found to bind in the hydrophobic cleft at the front of the hinge was replaced with a 3-ethoxyphenyl group. It was also discovered that the isoxazole could be replaced by a β-ethoxy linker (compound <b>22</b>), which maintained the linear orientation and trajectory for positioning of the arene ring into the selectivity pocket. These modifications resulted in approximately 10-fold improvements in both functional and intrinsic activities. It was also evident that the unsubstituted aryl ring did not optimally fill the selectivity pocket, presumably instead leaving an unfavorable water molecule at the bottom of the pocket. As such, a para-chloro group was added, providing compound <b>23</b>, which effectively displaced the water molecule and more efficiently occupied the hydrophobic cavity resulting in a further improvement in potency. This interaction was further optimized through the use of a para-trifluoromethoxy group (compound <b>24</b>) to more optimally fill the unoccupied space, as inspired by crystallographic overlays with compound <b>3</b>, resulting in an additional increase in potency (synthesis described in Scheme <a class="ref internalNav" href="#sch9" aria-label="9">9</a>). While advances were realized toward increasing potency with concomitant increases in ligand efficiencies, it was apparent that the majority of the binding affinity was being derived from lipophilic interactions as represented in the low LLE values. In order to obtain more acceptable druglike physiochemical properties, we endeavored to improve on this parameter by lowering the clogP of the series.</div></div><div id="sec2_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> Introduction of Hinge Binding Interaction</h3><div class="NLM_p">In order to address the high lipophilicity of the series, we envisaged that further optimizing hydrogen bonding interactions with the hinge could provide increased affinity without adding to the lipophilicity of the molecule. We began by removing the very hydrophobic ethoxy arene that was involved in hydrophobic van der Waals interactions with the hydrophobic cleft to allow room for alternative substitution of the indole ring. While removal of this hydrophobic interaction resulted in a precipitous 35-fold loss in potency (compound <b>25</b>, Scheme <a class="ref internalNav" href="#sch8" aria-label="8">8</a>), it should be noted that ligand binding efficiency stayed on par with compound <b>24</b> while the lipophilic contributions to affinity were improved, as is apparent in the increase in LLE to 0.61 for compound <b>25</b> compared with −0.48 for compound <b>24</b>. Since the indole N5 nitrogen lone pair was directed toward the backbone residue Met 592 with an intervening water molecule, we decided to introduce a nitrile group in an attempt to form a direct hydrogen bonding interaction with the backbone (compound <b>26</b>). Gratifyingly, this modification led to a 100-fold increase in both enzymatic and cellular potency. Finally, replacement of the nitrile with a pyrazole, a common hinge binding motif, led to compound <b>27</b> which has an IC<sub>50</sub> value of 51 nM in the enzymatic TrkA assay and an IC<sub>50</sub> of 29 nM in the TrkA cell-based assay. Thus, by removing a large contributor to lipophilic binding and focusing on optimizing the binding interactions with the hinge, we were able to significantly improve the LLE value while maintaining good overall per atom binding efficiency.</div><figure id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0018.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Optimization of Hinge Binding Interaction with Azaindole Series</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="sch9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0019.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthetic Route for Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 3-Ethoxyphenylboronic acid, Pd(OAc)<sub>2</sub>, XPhos, KF, 1,4 dioxane 73%; (b) NaH, 2-bromophenyl ether, DMF, 1 N NaOH; (c) 2 N NaOH, 75% over two steps.</p></p></figure><div class="NLM_p">Selectivity against other kinases was somewhat difficult to assess for this series because of its unique phosphorylation-state dependent binding paradigm. As mentioned, <b>4</b> was inactive against IGFR1 in our original HTS screen. In addition when <b>4</b> was assayed against the full kinase panel, there was no activity noted against any of the 92 kinases. This was not entirely surprising, since all of the kinases used in the panel were presumed to be the active form of the protein; i.e., they were phosphorylated kinases. Since we already determined that <b>4</b> did not bind to the active, phosphorylated form of TrkA, it was conjectured that it would not bind to the activated forms of other kinases either. These results were also confirmed with compound <b>24</b>. In order to more fully assess the functional selectivity of this series, we submitted <b>4</b> and <b>24</b> to a panel of cell-based assays where the kinase should be in a dynamic equilibrium between the activated and unactivated states, but here again we were unable to detect any significant activity.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Binding Affinity of Inhibitor Series</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">compd</th><th class="colsep0 rowsep0" align="center" char="."><i>k</i><sub>on</sub> (M<sup>–1</sup> s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>k</i><sub>off</sub> (s<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center"><i>K</i><sub>D</sub> (nM)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>2</b></td><td class="colsep0 rowsep0" align="char" char=".">62 000</td><td class="colsep0 rowsep0" align="left">1.7 × 10<sup>–3</sup></td><td class="colsep0 rowsep0" align="left">27</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">180 000</td><td class="colsep0 rowsep0" align="left">1.7 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="left">0.94</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3</b></td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left">1.5 × 10<sup>–2</sup></td><td class="colsep0 rowsep0" align="left">∼400</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>17</b></td><td class="colsep0 rowsep0" align="char" char=".">30 000</td><td class="colsep0 rowsep0" align="left">1.9 × 10<sup>–3</sup></td><td class="colsep0 rowsep0" align="left">63</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>4</b></td><td class="colsep0 rowsep0" align="char" char=".">22 000</td><td class="colsep0 rowsep0" align="left">1.7 × 10<sup>–4</sup></td><td class="colsep0 rowsep0" align="left">7.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>23</b></td><td class="colsep0 rowsep0" align="char" char=".">26 000</td><td class="colsep0 rowsep0" align="left">9.0 × 10<sup>–5</sup></td><td class="colsep0 rowsep0" align="left">3.5</td></tr></tbody></table></div></div></div><div id="sec2_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> Binding Kinetics</h3><div class="NLM_p last">Surface plasmon resonance (SPR) studies using Biacore were performed with several inhibitors to investigate differences in their binding kinetics. Rates for inhibitor association (<i>k</i><sub>on</sub>) and disassociation (<i>k</i><sub>off</sub>) with the enzyme were measured to reveal the underlying drivers of differences in the disassociation constant <i>K</i><sub>D</sub> (where <i>K</i><sub>D</sub><i>= k</i><sub>on</sub>/<i>k</i><sub>off</sub>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). Compound <b>5</b>, which bound in a DFG-in conformation, displayed very fast on and off rates (yielding a “square wave” in the Biacore sensogram); fitting the plateau value gave a <i>K</i><sub>D</sub> in line with its intrinsic activity (<i>K</i><sub>D</sub> = 25 nM vs IC<sub>50</sub> = 10 nM). In contrast, all of the inhibitor series that bound in the DFG-out conformation displayed significantly slower on and off rates with the enzyme. The triazole HTS lead <b>2</b> was shown to have a <i>k</i><sub>off</sub> = 1.7 × 10<sup>–3</sup> s<sup>–1</sup> (<i>t</i><sub>1/2</sub> = 6.8 min); further optimization to <b>11</b> led to a dramatic reduction in the off rate, <i>k</i><sub>off</sub> = 1.7 × 10<sup>–4</sup> s<sup>–1</sup> (<i>t</i><sub>1/2</sub> = 68 min). Similarly, in the urea inhibitor series, the initial hit compound <b>3</b> displayed a relatively fast off rate of 1.5 × 10<sup>–2</sup> s<sup>–1</sup> (<i>t</i><sub>1/2</sub> = 0.8 min) and <i>K</i><sub>D</sub> ≈ 400 nM. Potency of the series was improved with compound <b>17</b>, and this tracked with a 10-fold improvement in disassociation constant, providing <i>K</i><sub>D</sub> = 63 nM that was driven by a 10-fold improvement in off rate, <i>k</i><sub>off</sub> = 1.9 × 10<sup>–3</sup> s<sup>–1</sup> (<i>t</i><sub>1/2</sub> = 6 min). Finally, the azaindole series had the longest off rates of the four series investigated where the initial hit, <b>4</b>, displayed <i>k</i><sub>off</sub> = 1.7 × 10<sup>–4</sup> s<sup>–1</sup> (<i>t</i><sub>1/2</sub> = 68 min). Interestingly, the dissociation constants for this series were much lower than the intrinsic potency compared to the other series. Here the disassociation constant for <b>4</b> had <i>K</i><sub>D</sub> = 7.9 nM versus IC<sub>50</sub> = 2300 nM. Further optimization of this series resulted in compound <b>23</b> which displayed a 2-fold improvement in both <i>K</i><sub>D</sub> and residence time, <i>K</i><sub>D</sub> = 3.5 nM; <i>k</i><sub>off</sub> = 9.0 × 10<sup>–5</sup> s<sup>–1</sup>; <i>t</i><sub>1/2</sub> = 128 min. Since the on rates remained relatively constant between the series, these results suggest that the increases in potency realized during lead optimization were largely driven by decreased off rates. This also suggests that DGF-out inhibitors should have significantly longer residence times on the receptor compared with DFG-in inhibitors. These data align with other type II binders that have also been reported to display lower disassociation rates and extended residence times.<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30, 31)</a> This further highlights the advantages of targeting the DGF-out conformation in inhibitor design, since they not only have the potential to exhibit increased selectivity toward other kinases but may have the added advantage of slower off rates prolonging binding to the receptor.</div></div><div id="sec2_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> In Vivo Activity</h3><div class="NLM_p">While efficacy for the TrkA pathway has already been established both clinically and preclinically, those studies were conducted using an anti-NGF antibody approach. We sought to validate the use of a small molecule TrkA inhibitor in preclinical in vivo pain models.<a onclick="showRef(event, 'ref32 ref33'); return false;" href="javascript:void(0);" class="ref ref32 ref33">(32, 33)</a> To support these studies, compound <b>11</b> was chosen because it exhibited excellent cellular potency and an extended residence time on the enzyme. As such, compound <b>11</b> was profiled in rats and displayed pharmacokinetic properties suitable for in vivo studies with a clearance of 16 mL min<sup>–1</sup> kg<sup>–1</sup>, a half-life of 2.6 h, an oral bioavailability of 30%, and a plasma protein binding of 99.5%. To fully explore the in vivo efficacy of a small molecule TrkA inhibitor, we investigated the effects of compound <b>11</b> in both an inflammatory and a neuropathic pain model. For the inflammatory pain studies, we employed the complete Freund’s adjuvant-induced hind-paw (CFA) model. Compound <b>11</b> was dosed orally b.i.d. for 7 days after administration of the Freund’s adjuvant, similar to previous studies using an anti-NGF antibody where reversal of allodynia was reported on day 3 through day 7 after treatment.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a> displays the percentage reversal of mechanical hypersensitivity at both the predose and 2 h postdose time points on day 7 of the study. As exemplified in Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>, compound <b>11</b> inhibited mechanical allodynia with naproxen-like efficacy at both the 30 and 100 mg/kg dose levels. Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> lists the plasma levels of compound <b>11</b> at the 2 h postdose time point. When corrected for plasma protein binding, significant effects are achieved at unbound drug concentration at or above the IC<sub>50</sub> values obtained in the cell-based TrkA assay, with residual effects on mechanical allodynia remaining at the trough (predose, plasma levels were not obtained) prior to compound readministration. To investigate in vivo efficacy in a rat model for neuropathic pain, we employed the Chung spinal nerve ligation model where compound <b>11</b> demonstrated approximately a 50% reversal of mechanical hypersensitivity at the 100 mg/kg dose (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>), similar to the effect observed with the positive control, pregabalin. Here, similar plasma levels were obtained at the 2 h time point compared to those measured at 2 h in the CFA study. Again, efficacy was observed at plasma concentration in moderate excess of the cellular IC<sub>50</sub> when corrected for plasma protein binding (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>).</div><figure id="fig9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0009.jpeg" id="gr18" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. CFA-induced mechanical hypersensitivity assay (inflammatory pain) with compound <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Plasma Concentrations in CFA Study at 2 h</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">[plasma] (μM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>u,plasma</sub> (nM)</th><th class="colsep0 rowsep0" align="center">fold IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1–2</td><td class="colsep0 rowsep0" align="left">5–10</td><td class="colsep0 rowsep0" align="left">1–2 ×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">4–9</td><td class="colsep0 rowsep0" align="left">20–45</td><td class="colsep0 rowsep0" align="left">4–9 ×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">16–45</td><td class="colsep0 rowsep0" align="left">80–226</td><td class="colsep0 rowsep0" align="left">16–45 ×</td></tr></tbody></table></div></div><figure id="fig10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0010.jpeg" id="gr19" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Spinal nerve ligation assay (neuropathic pain) after oral dosing of compound <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Plasma Concentrations in SNL Study</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">dose (mg/kg)</th><th class="colsep0 rowsep0" align="center">[plasma] (μM)</th><th class="colsep0 rowsep0" align="center"><i>C</i><sub>u,plasma</sub> (nM)</th><th class="colsep0 rowsep0" align="center">fold IC<sub>50</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">10</td><td class="colsep0 rowsep0" align="left">1</td><td class="colsep0 rowsep0" align="left">5</td><td class="colsep0 rowsep0" align="left">1×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">30</td><td class="colsep0 rowsep0" align="left">6.7</td><td class="colsep0 rowsep0" align="left">34</td><td class="colsep0 rowsep0" align="left">6×</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">100</td><td class="colsep0 rowsep0" align="left">23</td><td class="colsep0 rowsep0" align="left">115</td><td class="colsep0 rowsep0" align="left">23×</td></tr></tbody></table></div></div></div></div><div id="sec2_11" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i25">Summary</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68051" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68051" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">The intention of this manuscript is to serve as an overview of our efforts to identify novel chemotypes for the development of selective kinase inhibitors. We have identified several series of small molecule inhibitors of TrkA with unique binding modes in the field of kinase inhibitors. The crystallographic structures have been solved for all four inhibitor series with the TrkA kinase domain, and their unique binding modes have been elucidated. These leads were optimized for potency and selectivity. We employed a rational structure based drug design approach to progress these series. During the optimization process we strived to abide by the principles of ligand efficiency to maximize binding affinity without relying excessively on lipophilic interactions. While all of the described inhibitor series were found to display very high selectivity against a diverse panel of kinases, because of the high homology in the Trk active site, they exhibited no selectivity versus the other Trk homologues, i.e., TrkB and TrkC, and as such are considered pan-Trk inhibitors. We have also demonstrated efficacy in both inflammatory and neuropathic pain models upon oral dosing. More detailed discussions with respect to the SAR of the individual series and optimization of their physical properties will be the subject of future communications.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i26">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_53837" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_53837" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec3_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> General Chemistry Information</h3><div class="NLM_p last">Reagents and solvents, including anhydrous THF, dichloromethane, and DMF, were purchased from Aldrich, Acros, or other commercial sources and were used without further purification. Reactions that were moisture sensitive or that required the use of anhydrous solvents were performed under either nitrogen or argon atmosphere. Analytical thin layer chromatography (TLC) was performed on precoated silica gel plates obtained from Analtech. Visualization was accomplished with UV light or by staining with basic KMnO<sub>4</sub> solution or ethanolic H<sub>2</sub>SO<sub>4</sub> solution. Compounds were purified by flash chromatography using an automated purification system (ISCO, Biotage, Analogix) using disposable silica gel prepacked cartridges. Alternatively, compounds were purified by preparative reverse-phase HPLC using a Gilson 215 liquid handler and a Phenomenex Luna C18 column (150 mm × 20 mm i.d.) with a linear gradient over 15 min (95:5 to 0:100 H<sub>2</sub>O containing 0.1% trifluoroacetic acid/acetonitrile or 0.1% formic acid/acetonitrile). NMR spectra were recorded on 400 or 500 MHz on a Bruker or Varian spectrometer with CDCl<sub>3</sub> or DMSO-<i>d</i><sub>6</sub> as solvent. The chemical shifts are given in ppm, referenced to the deuterated solvent signal. Purity of target compounds was determined using LCMS and HPLC. LCMS analyses were performed using an Applied Biosystems API-150 mass spectrometer and Shimadzu SCL-10A LC system: column, Phenomenex Gemini C18, 5 μm, 50 mm × 4.6 mm i.d.; gradient, from 90% water, 10% CH<sub>3</sub>CN, 0.05% TFA, 5 min, to 5% water, 95% CH<sub>3</sub>CN, 0.05% TFA in 5 min; UV detection, 254 nm. Compound purity was determined by integrating peak areas of the liquid chromatogram, monitored at 254 nm. Purity of targets compounds was ≥95%.</div></div><div id="sec3_1_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> <i>N</i>4-(4-Morpholinophenyl)-<i>N</i>6-(pyridin-3-ylmethyl)pyrido[3,2-<i>d</i>]pyrimidine-4,6-diamine (<b>1</b>)</h3><div class="NLM_p"><i>Step 1.</i> Commercially available 4,6-dichloropyrido[3,2-<i>d</i>]pyrimidine (0.20 g, 1.0 mmol), 4-morpholinoaniline (0.19 g, 1.1 mmol), and DIPEA (0.18 mL, 1.1 mmol) were dissolved in DMF (3 mL), and the mixture was stirred at 80 °C for 12 h. The reaction mixture was cooled to room temperature, and water (30 mL) was added. The aqueous solution was extracted using ethyl acetate (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified using silica gel chromatography (24 Gm Si gel, 0–20% MeOH in DCM) to afford 6-chloro-<i>N</i>-(4-morpholinophenyl)pyrido[3,2-<i>d</i>]pyrimidin-4-amine (0.34 g, 99% yield). <sup>1</sup>H NMR (400 Hz, CDCl<sub>3</sub>) δ 8.76 (s, 1H), 8.72 (s, 1 H), 8.10 (d, <i>J</i> = 8.8 Hz, 1 H), 7.76 (d, <i>J</i> = 8.8 Hz, 2 H), 7.67 (d, <i>J</i> = 8.8 Hz, 1H), 6.99 (d, <i>J</i> = 9.0 Hz, 2 H), 3.88 (m, 4H), 3.18 (m, 4 H). LRMS, M + H: 342.8.</div><div class="NLM_p last"><i>Step 2.</i> A solution of 6-chloro-<i>N</i>-(4-morpholinophenyl)pyrido[3,2-<i>d</i>]pyrimidin-4-amine (0.15 g, 0.44 mmol), pyridin-3-ylmethane amine (0.10 g, 0.88 mmol), and DIPEA (0.15 mL, 0.88 mmol) in NMP (3 mL) was heated to 90 °C for 48 h. The reaction mixture was then cooled, diluted with water (30 mL), and extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified using silica gel chromatography (24 Gm Si gel, 0–20% MeOH in DCM) to afford <i>N</i>4-(4-morpholinophenyl)-<i>N</i>6-(pyridin-3-ylmethyl)pyrido[3,2-<i>d</i>]pyrimidine-4,6-diamine (0.09 g, 51%). <sup>1</sup>H NMR (400 Hz, CDCl<sub>3</sub>) δ 8.74 (s, 1H), 8.57 (d, <i>J</i> = 4.9 Hz, 1 H), 8.54 (s, 1H), 8.44 (s, 1H), 7.87 (d, <i>J</i> = 8.8 Hz, 1H), 7.75 (d, <i>J</i> = 7.8 Hz, 1H), 7.70 (d, <i>J</i> = 9.0 Hz, 2H), 7.30 (m, 1H), 6.98–6.94 (m, 3H), 5.33 (m, 1H), 4.75 (d, <i>J</i> = 5.6 Hz, 2H), 3.88 (m, 4H), 3.15 (m, 4H). HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>23</sub>H<sub>23</sub>N<sub>7</sub>O = 413.1964. Found [M + H]<sup>+</sup>: 414.2048.</div></div><div id="sec3_1_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> <i>N</i>-(3-Cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-2-(4-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl-1<i>H</i>-1,2,3-triazol-1-yl)acetamide (<b>2</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a stirred solution of 3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-amine (2.00 g, 10.0 mmol) and Et<sub>3</sub>N (1.32 g, 13.1 mmol) in THF (50 mL) at room temperature was added 2-chloroacetyl chloride (1.36 g, 12.1 mmol) dropwise. After being stirred overnight, the reaction mixture was concentrated. The crude product was purified by silica gel chromatography (80 g SiO<sub>2</sub>, 3–50% EtOAc in hexanes) to afford 2-chloro-<i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)acetamide (2.3 g, 82%). LRMS: [M + H]<sup>+</sup> 276.0.</div><div class="NLM_p"><i>Step 2.</i> A mixture of 2-chloro-<i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)acetamide (2.77 g, 10.1 mmol) and NaN<sub>3</sub> (0.98 g, 15.1 mmol) in EtOH (35 mL) was heated at 60 °C for 16 h. The reaction mixture was concentrated, diluted with water, and extracted with EtOAc (3 × 30 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Purification by silica gel chromatography (80 g SiO<sub>2</sub>, 3–60% EtOAc in hexanes) afforded 2-azido-<i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)acetamide (2.0 g, 71%). LRMS: [M + H]<sup>+</sup> 283.1.</div><div class="NLM_p last"><i>Step 3.</i> To a solution of 2-azido-<i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)acetamide (0.596 g, 2.11 mmol) and 1-(4-ethynyl-2-methoxyphenyl-4-methyl-1<i>H</i>-imidazole (0.471 g, 2.22 mmol) in 1:1 <i>tert</i>-butanol/water (12 mL) was added a 1 M solution of copper(II) sulfate (0.422 mL, 0.422 mmol) and copper dust (0.107 g, 1.69 mmol), and the mixture was heated in a sealed vial at 125 °C for 1 h. The mixture was cooled and diluted with water. Concentrated ammonium hydroxide was added to convert all of the remaining copper to copper–hexaamine complex and extracted with EtOAc (3 × 15 mL). The combined organics were dried over sodium sulfate, filtered, and concentrated. Purification by silica gel chromatography (isocratic 10% MeOH/EtOAc) afforded <i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-2-(4-(3-methoxy-4-(4-methyl-1<i>H</i>-imidazol-1-yl)phenyl-1<i>H</i>-1,2,3-triazol-1-yl)acetamide (0.6 g, 58%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.59 (s, 1 H), 9.38 (s, 1H), 8.76 (s, 1H), 7.79 (m, 2H), 7.67 (m, 2H), 7.52 (m, 3H), 7.40 (m, 1H), 6.20 (s, 1H), 5.42 (s, 2H), 3.96 (s, 3H), 2.36 (s, 3H), 1.94 (m, 1H), 0.91 (m, 2H), 0.69 (m, 2H). HRMS calculated for C<sub>27</sub>H<sub>26</sub>N<sub>8</sub>O<sub>2</sub>, 494.2179; found (ES) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 495.2251.</div></div><div id="sec3_1_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> 1-Cyclopropyl-1-(3-(thiazol-2-yl)benzyl)-3-(4-(trifluoromethoxy)phenyl)urea (<b>3</b>)</h3><div class="NLM_p"><i>Step 1.</i> A 20 L flask fitted with an overhead mechanical stirrer was charged with 4.1 L of toluene, followed by aqueous K<sub>2</sub>CO<sub>3</sub> (4.5 L, 1M). The reaction mixture was stirred and degassed with nitrogen over 15–30 min, after which 2-bromothiazole (325 g, 1.8 mol) was quickly charged to the flask. The solution was degassed with stirring for a further 30 min. Tetrakis(triphenylphosphine)palladium(0) (41.6 g, 0.036 mol) was added to the mixture under an inert atmosphere and the mixture degassed over 30 min. 3-(Formylphenyl)boronic acid (270 g, 1.98 mol) was dissolved in ethanol (2 L) in a 5 L conical flask and the suspension degassed with nitrogen (30 min). The ethanol mixture was rapidly charged to the 20 L flask and the reaction mixture degassed for a further 30 min. With vigorous stirring the mixture was heated at 80 °C under an atmosphere of nitrogen overnight (12 h). Approximately 2–4 L of solvent was initially distilled from the reaction to aid the workup procedure. Upon cooling, the reaction solution was transferred to a sinter using a siphon and filtered through Celite. The Celite was washed with toluene (2 × 500 mL) and the combined organic layer separated. The aqueous layer was then washed with successive portions of toluene (2 × 2 L), and the organic layers were combined and washed with 1 M aqueous K<sub>2</sub>CO<sub>3</sub> (2 × 2.5 L). The organic phase was separated, dried over MgSO<sub>4</sub> and filtered through Celite. The solvent was removed in vacuo to provide 3-(thiazol-2-yl)benzaldehyde (356.9 g, 59%).</div><div class="NLM_p"><i>Step 2.</i> 3-(Thiazol-2-yl)benzaldehyde (13.1 g, 0.069 mol) was charged to a 250 mL flask, followed by 65 mL of THF and TMOF (7.51 mL, 0.069 mol). Cyclopropylamine (5.90 g, 0.102 mol) was subsequently added to the flask and the reaction solution shaken overnight at room temperature. The solvent was removed in vacuo, and the imine was used directly in the reduction step without further purification. The imine (69 mmol) was dissolved in MeOH (100 mL) and charged to a 250 mL flask. The solution was cooled in an ice bath and NaBH<sub>4</sub> (5.20 g, 0.138 mol) was carefully added, maintaining the reaction temperature below 30 °C. The mixture was shaken overnight at room temperature. Reduction of the imine was monitored by HPLC–MS, and upon reaction completion the solution was concentrated to dryness in vacuo, redissolved in ethyl acetate (100 mL), and washed with 1 M aqueous K<sub>2</sub>CO<sub>3</sub> (2 × 100 mL). Following separation, the aqueous layer was washed with two further portions of ethyl acetate (2 × 50 mL) and the organic phases were combined, dried over MgSO<sub>4</sub>, and concentrated in vacuo. PS-CHO (43g, 1.3 mmol/g, 0.6 equiv) and PS-AMPS (29.3 g, 1.9 mmol/g, 0.6 equiv) were transferred to the vessel, and the mixture was shaken at room temperature for 1–2 days. The mixture was filtered. The resin was washed with acetonitrile (2 × 50 mL) and the filtrate concentrated under vacuum. The crude amine was purified by silica gel chromatography (heptane/ethyl acetate; DCM/ethyl acetate) to afford <i>N</i>-(3-(thiazo-2-yl)benzyl)cyclopropanamine (9.30 g, 61%).</div><div class="NLM_p last"><i>Step 3.</i> The secondary amine was prepared as a stock solution in DCE to give 0.4 mmol (∼100 mg) per 0.5 mL of solvent and dispensed into a 10 mL plate. A stock solution of 1-isocyanato-4-(trifluoromethoxy)benzene in DCE (0.6 mmol) was added to the amine, and the reaction plate was agitated for 2 days at room temperature. By use of the Radley’s Titan resin loader, PS isocyanate (350 mg, 0.4 mmol, 1 equiv, 1.2 mmol/g), and PS-AMPS (210 mg, 0.4 mmol, 1 equiv, 1.9 mmol/g), scavenger resins were added to the reaction plates. A further 2–3 mL of DCE was added to the well to induce resin mobility and the plate was shaken for 2 days at room temperature. The reaction well was individually agitated after 1 day of scavenging. After this scavenging period the DCE solution was removed using a Lissy liquid handler to a 5 mL plate using the following protocol for Lissy transfer from 10 mL plate to 5 mL plate:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">(1)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Add 1 mL of MeOH to each well, and manually agitate the well.</p></td></tr><tr class="li1"><td valign="top">(2)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Transfer 3.5 mL of solvent from the 10 mL master plate to a 5 mL plate using level tracking.</p></td></tr><tr class="li1"><td valign="top">(3)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Remove solvent from 5 mL plate in a Genevac.</p></td></tr><tr class="li1"><td valign="top">(4)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Add 2 mL of methanol to the well of the 10 mL master plate and mix.</p></td></tr><tr class="li1"><td valign="top">(5)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Transfer remaining solvent from the 10 mL master plate to the 5 mL plate using level tracking.</p></td></tr><tr class="li1"><td valign="top">(6)</td><td colspan="5" valign="top" class="paragraph"><p class="last">Remove solvent from 5 mL plate in a Genevac.</p></td></tr></table>Purification was performed on a reverse-phase Gilson Prep LC module Xterra Prep MS C18, 50 mm × 19 mm i.d., 5 μm column, with 10 mM ammonium bicarbonate, buffered to pH 10 (water/ACN) over 7 min at [20 mL/min]. Product fractions were concentrated under reduced pressure to afford 1-cyclopropyl-1-(3-(thiazol-2-yl)benzyl)-3-(4-(trifluoromethoxy)phenyl)urea (158 mg, 46%). <sup>1</sup>H NMR δ (DMSO-<i>d</i><sub>6</sub>): 8.59 (s, 1H), 7.92 (d, <i>J</i> = 3.2 Hz, 1H), 7.78–7.86 (m, 3H), 7.67–7.69 (m, 2H), 7.48 (t, <i>J</i> = 7.67 Hz, 1H), 7.37 (d, <i>J</i> = 7.6 Hz, 1H), 7.27 (d, <i>J</i> = 8.77 Hz, 2H), 4.62 (s, 2H), 2.62–2.65 (m, 1H), 0.90 (t, <i>J</i> = 6.38 Hz, 2H), 0.77–0.79 (m, 2H). HRMS (ESI), <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>18</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>S: 433.1100. Found [M + H]<sup>+</sup>: 434.1151.</div></div><div id="sec3_1_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> 4-(Naphthylen-10-yl)-1-((5-phenyl-1,2,4-oxadiazol-3-yl)methyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic Acid (<b>4</b>)</h3><div class="NLM_p last">Compound <b>4</b>, 4-(naphthylen-10-yl)-1-((5-phenyl-1,2,4-oxadiazol-3-yl)methyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid, was part of the HTS screen collection and was not independently synthesized again after validation, as such full experimental procedures are not available, but the final compound has been characterized. <sup>1</sup>H NMR (CDCl<sub>3</sub>): δ 8.78 (d, <i>J</i> = 6.6 Hz, 1H), 8.15–7.95 (m, 3H), 7.86 (d, <i>J</i> = 8.1 Hz, 1H), 7.82 (d, <i>J</i> = 6.8 Hz, 1H), 7.73 (d, <i>J</i> = 7.1 Hz, 1H), 7.59–7.51 (m, 3H), 7.48–7.44 (m, 3H), 7.36 (t, <i>J</i> = 7.6 Hz, 1H), 7.13 (s, 1H), 6.06 (s, 2H). HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>27</sub>H<sub>18</sub>N<sub>4</sub>O<sub>3</sub> 446.1379. Found: [M + H<sup>+</sup>]<sup>+</sup>: 447.1474.</div></div><div id="sec3_1_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> <i>N</i>6-(3-Chlorobenzyl)-<i>N</i>4-(4-(4-methylpiperazin-1-yl)phenyl)pyrido[3,2-<i>d</i>]pyrimidine-4,6-diamine (<b>5</b>)</h3><div class="NLM_p"><i>Step 1.</i> Commercially available 4,6-dichloropyrido[3,2-<i>d</i>]pyrimidine (0.20 g, 1.0 mmol), 4-(4-methylpiperazin-1-yl)aniline (0.201 g, 1.05 mmol), and DIPEA (0.183 mL, 1.05 mmol) were dissolved in DMF (3 mL), and the mixture was stirred at 80 °C for 12 h. The reaction mixture was then cooled to room temperature, and water (30 mL) was added. The aqueous solution was extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified using silica gel chromatography (24 Gm Si gel, 0–20% MeOH in DCM) to afford 6-chloro-<i>N</i>-(4-(4-methylpiperazin-1-yl)phenyl)pyrido[3,2-<i>d</i>]pyrimidin-4-amine (0.21 g, 59% yield). <sup>1</sup>H NMR (400 Hz, CDCl<sub>3</sub>) δ 8.73 (s, 1 H), 8.72 (s, 1H), 8.09 (d, <i>J</i> = 8.8 Hz, 1H), 7.74 (d, <i>J</i> = 8.8 Hz, 2H), 7.66 (d, <i>J</i> = 8.8 Hz, 1H), 7.00 (d, <i>J</i> = 8.8 Hz, 2H), 3.25 (m, 4H), 2.62 (m, 4H), 2.39 (s, 3H). LRMS, M + H: 355.1.</div><div class="NLM_p last"><i>Step 2.</i> A solution of 6-chloro-<i>N</i>-(4-(4-methylpiperazin-1-yl)phenyl)pyrido[3,2-<i>d</i>]pyrimidin-4-amine (0.10 g, 0.28 mmol), (3-chlorophenyl)methanamine (0.08 g, 0.56 mmol), and DIPEA (0.098 mL, 0.56 mmol) was dissolved in NMP (3 mL) and heated to 90 °C for 48 h. The reaction mixture was cooled, diluted with water (30 mL), and extracted with EtOAc (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated. The crude product was purified using silica gel chromatography (24 Gm Si gel, 0–20% MeOH in DCM) to afford <i>N</i>6-(3-chlorobenzyl)-<i>N</i>4-(4-(4-methylpiperazin-1-yl)phenyl)pyrido[3,2-<i>d</i>]pyrimidine-4,6-diamine (0.038 g, 29%). <sup>1</sup>H NMR (400 Hz, CDCl<sub>3</sub>) δ 8.53 (s, 1H), 8.44 (s, 1H), 7.84 (d, <i>J</i> = 9.0 Hz, 1H), 7.67 (d, <i>J</i> = 8.8 Hz, 2H), 7.43 (s, 1 H), 7.31–7.26 (m, 3H), 6.98 (d, <i>J</i> = 8.8 Hz, 2H), 6.93 (d, <i>J</i> = 9.0 Hz, 1H), 5.30 (s, 1H), 4.68 (d, <i>J</i> = 5.4 Hz, 2H), 3.21 (m, 4H), 2.61 (m, 4H), 2.37 (s, 3H). LRMS, M + H: 460.2. HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>25</sub>H<sub>26</sub>ClN<sub>7</sub> 459.1928. Found [M + H] <sup>+</sup>: 460.2037.</div></div><div id="sec3_1_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> <i>N</i>-(1<i>H</i>-Benzimidazol-2-ylmethyl)-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidin-4-amine (<b>6</b>)</h3><div class="NLM_p last"><i>Step 3.</i> 4-Chloro-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidine (compound <b>9</b>) (10 mg, 0.029 mmol), 1-(1<i>H</i>-benzimidazol-2-yl)methanamine (21 mg, 0.087 mmol), and DIPEA (30 μL, 0.17 mmol) were dissolved in 2 mL of EtOH. The vial was irradiated in a microwave reactor at 110 °C for 15 min. The mixture was concentrated and the crude product was purified by reverse phase HPLC (0–95% 0.01% TFA–acetonitrile gradient over 20 min) to afford <i>N</i>-(1<i>H</i>-benzimidazol-2-ylmethyl)-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidin-4-amine (7.9 mg, 58%) . <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 10.51 (NH, s, 1 H), 8.65 (s, 1 H), 7.82 (m, 1 H), 7.73 (m, 2 H), 7.46 (dd, <i>J</i> = 6.4, 3.2 Hz, 2 H), 7.07 (m, 1 H), 6.93 (m, 1 H); 6.68 (m, 2 H), 5.52 (d, <i>J</i> = 6.7 Hz, 2 H), 5.17 (m, 1 H), 4.12 (m, 1 H), 3.95 (m, 1 H), 2.68–2.46 (m, 1 H), 2.10 (m, 4 H). HRMS (ES) <i>m</i>/<i>z</i> calculated for C<sub>24</sub>H<sub>21</sub>F<sub>2</sub>N<sub>7</sub>S 477.1547. Found [M + H<sup>+</sup>]<sup>+</sup>: 478.1610.</div></div><div id="sec3_1_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> 4-Chloro-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidine (<b>8</b>)</h3><div class="NLM_p last">Commerically available 6-chloropyrido[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (compound <b>7</b>) (250 mg, 1.38 mmol) and (2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidine (504 mg, 2.75 mmol) were dissolved in EtOH (2 mL). The vial was irradiated in a microwave reactor at 150 °C for 2 h. The mixture was concentrated and the crude product was purified by reverse phase HPLC (0–95% 0.01% TFA–acetonitrile gradient over 20 min) to give 4-chloro-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidine (317 mg, 69%). LRMS (ES) <i>m</i>/<i>z</i> M + H calcd, 329; found, 329.</div></div><div id="sec3_1_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> 4-Chloro-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidine (<b>9</b>)</h3><div class="NLM_p last">6-[(2<i>R</i>)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidin-4(3<i>H</i>)-one (compound <b>8</b>) (465 mg, 1.42 mmol) was suspended in POCl<sub>3</sub> (132 μL, 1.42 mmol). The mixture was heated at 100 °C for 2 h. The reaction mixture was added to a mixture of ice, ethyl acetate (20 mL), and aqueous sodium hydrogen carbonate (saturated, 20 mL). The mixture was shaken well, and the aqueous solution was adjusted to be around pH 8. The aqueous layer was extracted with EtOAc (2 × 20 mL). The combined organic fractions were washed with aqueous sodium hydrogen carbonate (saturated, 20 mL), followed by brine and then dried, filtered and the solvent was evaporated under reduced pressure to provide 4-chloro-6-[(2<i>R</i>)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrido[3,2-<i>d</i>]pyrimidine (343 mg, 70%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 2.05–2.20 (m, 3 H), 2.48–2.61 (m, 1 H), 3.75–4.25 (m, 2 H), 5.20–5.75 (bs, 1 H), 6.74–6.80 (m, 1 H), 6.86–6.96 (m, 1 H), 7.10–7.50 (m, 1 H), 7.92–8.02 (m, 1 H), 8.76 (s, 1 H). LRMS (ES) <i>m</i>/<i>z</i> M + H calcd, 347; found, 347.</div></div><div id="sec3_1_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> <i>N</i>-(3-Cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-2-(4-(4-(4-methyl-1<i>H</i>-imidazole-1-yl)phenyl-1<i>H</i>-1,2,3-triazol-1-yl)acetamide (<b>10</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of 4-fluorobenzaldehyde (5.00 g, 40.3 mmol) and 4-methyl-1<i>H</i>-imidazole (6.68 g, 81 mmol) in DMF (20 mL), under nitrogen, was added K<sub>2</sub>CO<sub>3</sub> (8.35 g, 60.4 mmol). The reaction mixture was heated at 100 °C for 19 h. The reaction mixture was cooled to room temperature and diluted with EtOAc (200 mL). The organic solution was washed with saturated aqueous NaHCO<sub>3</sub> (2 × 50 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Purification by flash chromatography (120 g SiO<sub>2</sub>, 0–10% MeOH in DCM) afforded 4-(4-methyl-1<i>H</i>-imidazole-1-yl)benzaldehyde (822 mg, 11%). LRMS: [M + H]<sup>+</sup> 187.1.</div><div class="NLM_p"><i>Step 2.</i> To a solution of 4-(4-methyl-1<i>H</i>-imidazole-1-yl)benzaldehyde (500 mg, 2.69 mmol) and dimethyl (1-diazo-2-oxopropyl)phosphonate (619 mg, 3.22 mmol) in anhydrous MeOH (10 mL) was added K<sub>2</sub>CO<sub>3</sub> (742 mg, 5.4 mmol). The reaction mixture was stirred at room temperature for 24 h, diluted with DCM (60 mL), and washed with water (1 × 50 mL). The aqueous solution was extracted with DCM (1 × 50 mL). Combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Purification by silica gel chromatography (24 g SiO<sub>2</sub>, 0–10% MeOH in DCM) afforded 1-(4-ethynylphenyl)-4-methyl-1<i>H</i>-imidazole (466 mg, 95%). LRMS: [M + H]<sup>+</sup> 183.1.</div><div class="NLM_p last"><i>Step 3.</i> To a solution of 1-(4-ethynylphenyl)-4-methyl-1<i>H</i>-imidazole (43 mg, 0.237 mmol) and 2-azido-<i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)acetamide (67 mg, 0.237 mmol) in <i>t</i>-BuOH–H<sub>2</sub>O (1:1, 3 mL) were added copper powder (15 mg, 0.237 mmol) and aqueous CuSO<sub>4</sub> (1 M, 0.237 mL). The reaction mixture was heated at 125 °C, under microwave irradiation, for 10 min. After cooling to room temperature, concentrated NH<sub>4</sub>OH (10 mL) was added. The mixture was stirred for 5 min, and then the aqueous portion was extracted with EtOAc (3 × 20 mL). Combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Purification by reverse-phase HPLC (5–95% MeCN in water, 0.05% TFA modifier used for the mobile phase) afforded <i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)-2-(4-(4-(4-methyl-1<i>H</i>-imidazole-1-yl)phenyl-1<i>H</i>-1,2,3-triazol-1-yl)acetamide (37 mg, 34%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.52 (s, 1H), 8.59 (s, 1H), 8.26 (s, 1H), 7.98 (d, <i>J</i> = 7.2 Hz, 2H), 7.71 (d, <i>J</i> = 7.2 Hz, 2H), 7.53–7.48 (m, 5H), 7.41–7.37 (m, 1H), 6.20 (s, 1H), 5.37 (s, 2H), 2.18 (s, 3H), 1.93–1.87 (m, 1H), 0.92–0.87 (m, 2H), 0.71–0.67 (m, 2H). HRMS calculated for C<sub>26</sub>H<sub>46</sub>N<sub>8</sub>O, 464.2073; found (ES) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 465.2145.</div></div><div id="sec3_1_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> 2-(4-(6-(1<i>H</i>-Imidazol-1-yl)pyridin-3-yl-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(3-<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-yl)acetamide (<b>11</b>)</h3><div class="NLM_p last">To a solution of 5-ethynyl-2-(1<i>H</i>-imidazol-1-yl)pyridine compound (<b>14</b>) (2.30 g, 13.4 mmol) and 2-azido-<i>N</i>-(3-cyclopropyl-1-phenyl-1<i>H</i>-pyrazol-5-yl)acetamide (compound <b>15</b>) (4.07 g, 13.6 mmol) in DCM–<i>t</i>-BuOH (1:12, 65 mL) was added copper powder (0.691 g, 10.9 mmol) followed by water (20 mL) and aqueous CuSO<sub>4</sub> (1 M, 2.72 mL). The reaction mixture was heated at 90 °C for 2 h, cooled to room temperature, and diluted with EtOAc (300 mL). To the resulting solution were added concentrated NH<sub>4</sub>OH (60 mL) and water (20 mL). The biphasic mixture was stirred vigorously for 30 min. Layers were separated. The aqueous solution was saturated with NaCl and extracted with EtOAc (4 × 200 mL). Combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. The resulting solid was recrystallized from hot EtOAc to afford 2-(4-(6-(1<i>H</i>-imidazol-1-yl)pyridin-3-yl-1<i>H</i>-1,2,3-triazol-1-yl)-<i>N</i>-(3-<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-yl)acetamide (4.60 g, 72%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.67 (br, 1H), 8.99 (d, <i>J</i> = 0.9 Hz, 1H), 8.81 (d, <i>J</i> = 1.4 Hz, 1H), 8.71 (s, 1H), 8.59 (s, 2H), 8.46–8.43 (m, 1H), 8.01–7.93 (m, 3H), 7.56–7.53 (m, 1H), 7.15 (s, 1H), 6.46 (s, 1H), 5.42 (s, 2H), 1.28 (s, 9H). HRMS calculated for C<sub>25</sub>H<sub>24</sub>N<sub>10</sub>O, 468.2138; found (ES) <i>m</i>/<i>z</i> [M + H]<sup>+</sup>, 469.2207.</div></div><div id="sec3_1_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> 5-Bromo-2-(1<i>H</i>-imidazol-1-yl)pyridine (<b>13</b>)</h3><div class="NLM_p last"><i>Step 1.</i> A mixture of commercially available 2,5-dibromopyridine (compound <b>12</b>) (2.00 g, 8.44 mmol), imidazole (0.575 g, 8.44 mmol), <span class="smallcaps smallerCapital">l</span>-proline (0.194 g, 1.69 mmol), CuI (0.080 g, 0.42 mmol), and K<sub>2</sub>CO<sub>3</sub> (2.33 g, 16.89 mmol) in DMSO (8 mL) was heated at 90 °C, under nitrogen, for 15 h. The reaction mixture was then cooled to room temperature and partitioned between ether (200 mL) and water (100 mL). The aqueous layer was separated and extracted with ether (2 × 100 mL). Combined organic extracts were washed with saturated aqueous NaHCO<sub>3</sub>, dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated to afford 5-bromo-2-(1<i>H</i>-imidazol-1-yl)pyridine (1.16 g, 61%) which was used as is in the next step. LRMS: [M + H]<sup>+</sup> 225.9.</div></div><div id="sec3_1_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> 5-Ethynyl-2-(1<i>H</i>-imidazol-1-yl)pyridine (<b>14</b>)</h3><div class="NLM_p">To a mixture of 5-bromo-2-(1<i>H</i>-imidazol-1-yl)pyridine (200 mg, 0.893 mmol), PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub> (50 mg, 0.071 mmol), and CuI (27 mg, 0.143 mmol), under nitrogen, were added DMF (4 mL) and Et<sub>3</sub>N (1 mL, 7.17 mmol) followed by trimethylsilylacetylene (0.5 mL, 3.57 mmol). The reaction mixture was heated at 90 °C, under nitrogen, for 3 h and then cooled to room temperature, diluted with ether (30 mL), and filtered through a pad of Celite. The filtrate was washed with water (1 × 20 mL) and brine (1 × 20 mL), dried over Na<sub>2</sub>SO<sub>4</sub>, and concentrated. Purification by silica gel chromatographic (12 g SiO<sub>2</sub>, 70–100% EtOAc in hexanes) afforded 2-(1<i>H</i>-imidazol-1-yl)-5-((trimethylsilyl)ethynyl)pyridine (167 mg, 78%). LRMS: [M + H]<sup>+</sup> 242.1.</div><div class="NLM_p last"><i>Step 2.</i> Potassium fluoride (48 mg, 0.83 mmol) was added to a solution of 2-(1<i>H</i>-imidazol-1-yl)-5-((trimethylsilyl)ethynyl)pyridine (166 mg, 0.688 mmol) in MeOH (1 mL) and stirred at room temperature for 1 h. The reaction mixture was diluted with water and extracted with DCM (3 × 10 mL). Sodium chloride was then added to the aqueous solution until saturation and extracted with EtOAc (2 × 10 mL). The combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated to provide 5-ethynyl-2-(1<i>H</i>-imidazol-1-yl)pyridine (116 mg, 100%). LRMS: [M + H]<sup>+</sup> 170.1.</div></div><div id="sec3_1_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> 2-Azido-<i>N</i>-(3-(<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-yl)acetamide (<b>15</b>)</h3><div class="NLM_p">To a stirring solution of commercially available 3-(<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-amine (compound <b>16</b>) (700 mg, 3.24 mmol) and Et<sub>3</sub>N (426 mg, 4.21 mmol) in DCM (12 mL) at 0 °C was added 2-chloroacetyl chloride (439 mg, 3.88 mmol) dropwise. After 20 min, the reaction mixture was concentrated and purified by silica gel chromatography (40 g SiO<sub>2</sub>, 10–100% EtOAc in hexanes) to afford <i>N</i>-(3-(<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-yl)-2-chloroacetamide (682 mg, 72%). LRMS: [M + H]<sup>+</sup> 293.0.</div><div class="NLM_p last">A mixture of <i>N</i>-(3-(<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-yl)-2-chloroacetamide (682 mg, 2.33 mmol) and NaN<sub>3</sub> (227 mg, 3.49 mmol) in EtOH (25 mL) was heated at 60 °C for 16 h. The reaction mixture was concentrated, diluted with water, and extracted with EtOAc (3 × 100 mL). Combined organic extracts were dried over Na<sub>2</sub>SO<sub>4</sub> and concentrated. Purification by silica gel chromatographic (24 g SiO<sub>2</sub>, 30–100% EtOAc in hexanes) afforded 2-azido-<i>N</i>-(3-(<i>tert</i>-butyl)-1-(pyridin-3-yl)-1<i>H</i>-pyrazol-5-yl)acetamide (640 mg, 92%). LRMS: [M + H]<sup>+</sup> 300.1.</div></div><div id="sec3_1_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> 1-Isopropyl-1-(3-(thiazol-2-yl)benzyl)-3-(4-(trifluoromethoxy)phenyl)urea (<b>17</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of <i>N</i>-(3-(thiazol-2-yl)phenyl)methanamine (1.23 g, 6.46 mmol) in dichloroethane (20 mL) was added acetone (0.32 mL, 4.30 mmol) followed by acetic acid (0.26 mL, 4.30 mmol). The reaction mixture was allowed to stir for 10 min after which a white solid precipitated. To the mixture was then added sodium triacetoxy borohydride (1.37 g, 6.46 mmol), and the mixture was allowed to stir at ambient temperature for 16 h. The reaction mixture was concentrated under reduced pressure and partitioned between 1 N NaOH (50 mL) and ethyl acetate (3 × 50 mL). The combined organic layers were washed with water (1 × 50 mL) followed by brine (1 × 50 mL). The combined organic layers were dried over sodium sulfate, filtered, and concentrated under reduced pressure. Purification by silica gel chromatography (80 g SiO<sub>2</sub>, 5–10% MeOH/DCM over 45 min) afforded <i>N</i>-(3-(thiazol-2-yl)benzyl)propan-2-amine (782 mg, 78%). <sup>1</sup>H NMR δ (CDCl<sub>3</sub>): 7.94 (s, 1 H), 7.81–7.86 (m, 2 H), 7.39–7.40 (m, 2 H), 7.33 (d, <i>J</i> = 3.3 Hz, 1 H), 3.85 (s, 2 H), 2.86–2.92 (m, 1 H), 1.12 (d, <i>J</i> = 6.2 Hz, 6 H). LCMS: <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 233.1.</div><div class="NLM_p last"><i>Step 2.</i> To a solution of <i>N</i>-(3-(thiazol-2-yl)benzyl)propan-2-amine (150 mg, 0.65 mmol) in dichloroethane (2 mL) was added 4-(trifluoromethoxy)phenyl isocyanate (131 mg, 0.65 mmol). The mixture was stirred at ambient temperature for 2 h, concentrated under reduced pressure. Purification by silica gel chromatography (40 g SiO<sub>2</sub>, 0–50% ethyl acetate/hexanes, over 45 min) afforded 1-isopropyl-1-(3-(thiazol-2-yl)benzyl)-3-(4-(trifluoromethoxy)phenyl)urea (263 mg, 94%). <sup>1</sup>H NMR δ (CDCl<sub>3</sub>): 8.00 (1 H, s), 7.88–7.91 (m, 2 H), 7.37–7.51 (m, 3 H), 7.20 (d, <i>J</i> = 8.7 Hz, 2 H), 7.06 (d, <i>J</i> = 8.6 Hz, 2 H), 6.23 (s, 1 H), 4.70–4.77 (m, 1 H), 4.53 (s, 2 H), 1.26 (d, <i>J</i> = 6.8 Hz, 6 H). HRMS (ESI), <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>20</sub>F<sub>3</sub>N<sub>3</sub>O<sub>2</sub>S: 436.1301. Found: [M + H]<sup>+</sup> 436.1301.</div></div><div id="sec3_1_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 1-((1<i>H</i>-Pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methyl)-1-isopropyl-3-(4-(trifluoromethoxy)phenyl)urea (<b>18</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of isopropylamine (0.360 g, 6.09 mmol) in methanol (10 mL) was added commercially available 1-(<i>tert-</i>butoxycarbonyl)-3-formyl-7-azaindole (compound <b>20</b>) (1.50 g, 6.09 mmol). The mixture was stirred at ambient temperature for 2 h to allow for imine formation. Sodium borohydride was added (0.576 g, 15.2 mmol) and stirred for 16 h at ambient temperature. The solution was concentrated under reduced pressure and partitioned between ether (50 mL) and 10% potassium carbonate (50 mL). Extraction was with ether (2 × 50 mL). The combined organic layers were washed with water (10 mL) and brine (10 mL), dried over sodium sulfate, filtered, and concentrated under reduced pressure to provide <i>N</i>-((1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methyl)propan-2-amine (compound <b>21</b>) that was used for step 2 without additional purification. LCMS: <i>m</i>/<i>z</i> [M + H<sup>+</sup>] = 290.2.</div><div class="NLM_p last"><i>Step 2.</i> To a solution of the crude <i>N</i>-((1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methylpropan-2- amine (100 mg, 0.528 mmol) in dichloromethane (20 mL) was added 1-isocyanato-4-(trifluoromethoxy)benzene (0.08 mL, 0.528 mmol). The mixture was allowed to stir at ambient temperature for 30 min. The mixture was concentrated under reduced pressure, dissolved in 2 mL of DMSO, and injected on a Gilson preparative reversed-phase HPLC instrument (Waters Sun Fire Prep C18 5 μm, 30 mm × 150 mm column, 5–95% CH<sub>3</sub>CN/water + 0.1% TFA over 15 min at 40 mL/min with a 2 min start collection time). The desired product fractions were combined, and saturated sodium carbonate was added until pH 12 (5 mL) was obtained. The aqueous portion was extracted with EtOAc (3 × 50 mL). The combined organic layers were washed with water (25 mL) and brine (50 mL), dried over sodium sulfate, filtered, and concentrated to afford 1-((1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-3-yl)methyl)-1-isopropyl-3-(4-(trifluoromethoxy)phenyl)urea (97 mg, 98%). <sup>1</sup>H NMR δ (CDCl<sub>3</sub>): 9.35 (s, 1 H), 8.38 (d, <i>J</i> = 4.6 Hz, 1 H), 7.99 (d, <i>J</i> = 7.9 Hz, 1 H), 7.32 (s, 1 H), 7.13–7.16 (m, 3 H), 7.03 (d, <i>J</i> = 8.6 Hz, 2 H), 6.52 (s, 1 H), 4.69–4.76 (m, 1 H), 4.59 (s, 2 H), 1.23–1.28 (d, <i>J</i> = 6.9 Hz, 6 H). HRMS (ESI): <i>m</i>/<i>z</i> calculated for C<sub>19</sub>H<sub>19</sub>F<sub>3</sub>N<sub>4</sub>O<sub>2</sub>: 392.1460. Found: [M + H]<sup>+</sup> 393.1533.</div></div><div id="sec3_1_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 1-(3-(Thiazol-2-yl)benzyl)-3-(4-(trifluoromethoxy)phenyl)urea (<b>19</b>)</h3><div class="NLM_p last">To a solution of (3-1,3-thiazol-2-yl)phenyl)methylamine (170 mg, 0.893 mmol) in hexane (10 mL) and EtOAc (3 mL) was added 4-(trifluoromethoxy)phenyl isocyanate (200 mg, 0.985 mmol). A white solid precipitated, and the mixture was stirred for 16 h at ambient temperature. The white precipitate was filtered, washed with hexanes, and dried to provide 1-(3-(thiazol-2-yl)benzyl)-3-(4-(trifluoromethoxy)phenyl)urea. <sup>1</sup>H NMR δ (DMSO-<i>d</i><sub>6</sub>): 8.86 (s, 1 H), 7.92–7.93 (m, 2 H), 7.77–7.82 (m, 2 H), 7.41–7.53 (m, 4 H), 7.23 (d, <i>J</i> = 8.6 Hz, 2 H), 6.81 (t, <i>J</i> = 6.0 Hz, 1 H), 4.39 (d, <i>J</i> = 5.9 Hz, 2 H). LCMS [M + H]<sup>+</sup> = 394.1.</div></div><div id="sec3_1_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> 4-(3-Ethoxyphenyl)-1-(2-phenoxyethyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic Acid (<b>22</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of (racemic)-benzyloxycarbonyl-α-phosphonoglycine trimethyl ester (12.1 g, 36.5 mmol) in 80 mL of dichloromethane was added DBU (6.34 mL, 42.1 mmol) slowly at room temperature. After 30 min a solution of 2- chloro-3-formyl-4-iodopyridine (7.5 g, 28.0 mmol) in CH<sub>2</sub>Cl<sub>2</sub> (20 mL) was added slowly at room temperature. During the addition the reaction became slightly exothermic and the mixture was cooled via a cold water bath. After 4 h the mixture was diluted with dichloromethane and washed with 1 N aqueous HCl (2 × 20 mL) and water (1 × 30 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification by silica gel chromatography (ISCO Redi-Sep, 330 g SiO<sub>2</sub>, 20% EtOAc/hexanes) afforded methyl (2<i>Z</i>)-2-{[(benzyloxy)carbonyl]amino}-3-(2-chloro-4-iodopyridin-3-yl)prop-2-enoate (11.46 g, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.89 (d, <i>J</i> = 5.1 Hz, 1 H); 7.70 (d, <i>J</i> = 5.1 Hz, 1 H); 7.33 (m, 3 H); 7.24 (m, 2 H); 7.06 (s, 1 H); 6.96 (s, 1 H); 4.97 (s, 2 H); 3.91 (s, 3 H).</div><div class="NLM_p"><i>Step 2.</i> Methyl (2<i>Z</i>)-2-{[(benzyloxy)carbonyl]amino}-3-(2-chloro-4-iodopyridin-3-yl)prop-2-enoate (11.46 g, 24.25 mmol), K<sub>2</sub>C0<sub>3</sub> (10.05 g, 72.7 mmol), CuI (0.462 g, 2.43 mmol), and <span class="smallcaps smallerCapital">l</span>-proline (0.558 g, 4.85 mmol) were combined in 1,4-dioxane (120 mL). The mixture was degassed (3 × pump/N<sub>2</sub>) and heated to reflux. After being stirred at reflux overnight, the mixture was cooled to room temperature and diluted with saturated aqueous 1 N HCl and extracted with dichloromethane (3 × 50 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered through a pad of Celite, and concentrated. The resulting solid was triturated with Et<sub>2</sub>O/hexanes to give methyl-4-chloro-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (4.6 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.25 (s, 1 H), 8.18 (d, <i>J</i> = 5.8 Hz, 1 H), 7.35 (d, <i>J</i> = 2.1 Hz, 1 H), 7.29 (d, <i>J</i> = 5.9 Hz, 1 H), 3.99 (s, 3 H).</div><div class="NLM_p"><i>Step 3.</i> Methyl 4-chloro-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (1.00 g, 4.75 mmol), 3-ethoxyphenylboronic acid (1.03 g, 6.21 mmol), Pd(OAc)<sub>2</sub> (0.064 g, 0.285 mmol), XPhos (0.226 g, 0.475 mmol), and potassium fluoride (0.828 g, 14.2 mmol) were combined in 1,4-dioxane (20 mL). The mixture was degassed (3 × pump/N<sub>2</sub>) then heated to 100 °C. After 4 h the mixture was cooled to room temperature, diluted with EtOAc, filtered through a pad of Celite washing with EtOAc, and concentrated. Purification by silica gel chromotography (Biotage-SNAP, 50 g SiO<sub>2</sub>, 50% EtOAc/hexanes) provided methyl 4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (1.02 g, 72.5%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.20 (bs, 1 H), 8.51 (d, <i>J</i> = 5.8 Hz, 1 H), 7.54–7.49 (m, 3 H), 7.47–7.38 (m, 1 H), 7.29 (d, <i>J</i> = 5.9 Hz, 1 H), 7.04–7.00 (m, 1 H), 4.14 (q, <i>J</i> = 6.83 Hz, 2 H), 3.97 (s, 3 H), 1.45 (t, <i>J</i> = 7.12 Hz, 3 H).</div><div class="NLM_p last"><i>Step 4.</i> To a solution of methyl 4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (30 mg, 0.10 mmol) in DMF (0.5 mL) was added NaH (60% dispersion in mineral oil, 5.5 mg, 0.148 mmol) at room temperature. After gas evolution had ceased, 2-bromoethyl phenyl ether (27 mg, 0.13 mmol) was added all at once as a solid. After the mixture was stirred overnight 2 M NaOH (200 mL, 0.40 mmol) was added, and stirring continued at room temperature. After 4 h the mixture was concentrated. The crude material was taken up in DMSO and acidified with TFA. The resulting solution was purified by preparative reversed-phase HPLC (30 mm × 100 mm Phenomenex AXIA-Gemini-NX, 15–40% CH<sub>3</sub>CN/water containing 0.1% TFA over 18 min at 50 mL/min) to afford 4-(3-ethoxyphenyl)-1-(2-phenoxyethyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid as the TFA salt (39 mg, 75%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.59 (d, <i>J</i> = 6.6 Hz, 1 H), 8.17 (s, 1 H), 7.60–7.56 (m, 2 H), 7.52 (m, 1 H), 7.48 (m, 1 H), 7.27–7.19 (m, 3H), 6.92–6.87 (m, 1 H), 6.81 (d, <i>J</i> = 8.1 Hz, 2 H), 5.16 (m, 2 H), 4.37 (m, 2 H), 4.16 (q, <i>J</i> = 6.9 Hz, 2 H), 1.38 (t, <i>J</i> = 6.6 Hz, 3 H). HRMS (ESI) calcd (M + H)<sup>+</sup> = 403.1652; found 403.1656.</div></div><div id="sec3_1_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> 1-(2-(4-Chlorophenoxy)ethyl)-4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic Acid (<b>23</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of (±)-benzyloxycarbonyl-α-phosphonoglycine trimethyl ester (12.1 g, 36.5 mmol) in 80 mL of DCM was added DBU (6.34 mL, 42.1 mmol) slowly at room temperature. After 30 min a solution of 2-chloro-3-formyl-4-iodopyridine (7.50 g, 28.0 mmol) in 20 mL of DCM was added slowly at room temperature. During the addition the reaction became slightly exothermic and the mixture was cooled via a cold water bath. After 4 h the mixture was diluted with DCM and washed with 1 N HCl (2 × 50 mL) and H<sub>2</sub>O (1 × 50 mL). The organic layer was dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification by silica gel chromatography (330 g SiO<sub>2</sub>, 20% EtOAc/hexanes) afforded (<i>Z</i>)-methyl 2-(((benzyloxy)carbonyl)amino)-3-(2-chloro-4-iodopyridin-3-yl)acrylate (11.4 g, 86%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.89 (d, <i>J</i> = 5.2 Hz, 1 H), 7.70 (d, <i>J</i> = 5.2 Hz, 1 H), 7.33 (d, <i>J</i> = 6.8 Hz, 3 H), 7.25–7.26 (m, 2 H), 7.06 (s, 1 H), 6.96 (bs, 1 H), 4.97 (s, 2 H), 3.91 (s, 3 H).</div><div class="NLM_p"><i>Step 2.</i> (<i>Z</i>)-Methyl 2-(((benzyloxy)carbonyl)amino)-3-(2-chloro-4-iodopyridin-3-yl)acrylate (11.46 g, 24.25 mmol), K<sub>2</sub>CO<sub>3</sub> (10.05 g, 72.7 mmol), copper(I) iodide (0.462 g, 2.425 mmol), and <span class="smallcaps smallerCapital">l</span>-proline (0.558 g, 4.85 mmol) were combined in 1,4-dioxane (120 mL). The mixture was degassed (3 × pump/N<sub>2</sub>) and then heated to reflux. After refluxing overnight, the mixture was cooled to room temperature, diluted with saturated aqueous NH<sub>4</sub>Cl, and extracted with dichloromethane (3 × 100 mL). The combined organic layers were dried over MgSO<sub>4</sub>, filtered through a pad of Celite, and concentrated. The resulting solid was triturated with Et<sub>2</sub>O/hexanes to provide methyl 4-chloro-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (4.6 g, 90%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.25 (bs, 1 H), 8.18 (d, <i>J</i> = 5.8 Hz, 1 H), 7.35 (d, <i>J</i> = 2.1 Hz, 1 H), 7.29 (d, <i>J</i> = 5.9 Hz, 1 H), 3.99 (s, 3 H).</div><div class="NLM_p"><i>Step 3.</i> Methyl 4-chloro-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (1.00 g, 4.75 mmol), 3-ethoxyphenylboronic acid (1.03 g, 6.21 mmol), Pd(OAc)<sub>2</sub> (0.064 g, 0.285 mmol), XPhos (0.226 g, 0.475 mmol), and KF (0.828 g, 14.24 mmol) were combined in 1,4-dioxane (20 mL). The mixture was degassed (3 × pump/N<sub>2</sub>) and then heated to 100 °C. After 4 h the mixture was cooled to room temperature, diluted with EtOAc, filtered through a pad of Celite washing with EtOAc, and concentrated. Purification by silica gel chromatography (50 g SiO<sub>2</sub>, 50% EtOAc/hexanes) afforded methyl 4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (1.02 g, 72%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 9.20 (s, 1 H), 8.51 (d, <i>J</i> = 5.8 Hz, 1 H), 7.50–7.53 (m, 3 H), 7.43 (t, <i>J</i> = 7.9 Hz, 1 H), 7.29 (d, <i>J</i> = 5.9 Hz, 1 H), 7.02 (dd, <i>J</i> = 8.2, 2.5 Hz, 1 H), 4.14 (q, <i>J</i> = 7.0 Hz, 2 H), 3.97 (s, 3 H), 1.45 (t, <i>J</i> = 7.0 Hz, 3 H).</div><div class="NLM_p last"><i>Step 4.</i> To a solution of methyl 4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (30 mg, 0.10 mmol) in 0.5 mL of THF was added NaH (60% in mineral oil, 6.0 mg, 0.15 mmol) at room temperature. After gas evolution had ceased 1-(2-bromoethoxy)-4-chlorobenzene (31 mg, 0.13 mmol) was added and the mixture heated to 60 °C. After stirring overnight 0.16 mL of 2 M NaOH was added and heating continued. After 4 h the mixture was cooled to room temperature and concentrated. The crude material was taken up in DMSO (1.0 mL), filtered using a 0.45 μm PTFE syringe filter, then purified by preparative reversed-phase HPLC (CH<sub>3</sub>CN/H<sub>2</sub>O with 0.1% TFA modifier). Fractions containing pure product were concentrated to afford 1-(2-(4-chlorophenoxy)ethyl)-4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid (9.7 mg, 17%) as a TFA salt. <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.51 (d, <i>J</i> = 6.2 Hz, 1 H), 7.88 (bs, 1 H), 7.51 (m, 3 H), 7.46 (s, 1 H), 7.27 (d, <i>J</i> = 8.7 Hz, 2 H), 7.14 (bs, 1 H), 6.84 (d, <i>J</i> = 8.7 Hz, 2 H), 5.07 (m, 2 H), 4.35 (m, 2 H), 4.13 (q, <i>J</i> = 7.0 Hz, 2 H), 1.38 (t, <i>J</i> = 6.9 Hz, 3 H). HRMS C<sub>24</sub>H<sub>21</sub>ClN<sub>2</sub>O<sub>4</sub> (M + H)<sup>+</sup> calculated, 437.1263; found, 437.1262.</div></div><div id="sec3_1_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> 4-(3-Ethoxyphenyl)1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic Acid (<b>24</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of methyl-4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (230 mg, 0.776 mmol) in DMF (7 mL) was added NaH (60% dispersion in mineral oil, 40 mg, 1.00 mmol) at room temperature. After gas evolution had ceased 1,2-dibromoethane (1 mL, 11.60 mmol) was added rapidly. After being stirred overnight, the mixture was diluted with water and extracted with EtOAc (3 × 30 mL). The combined organic layers were washed with water and brine and then dried over MgSO<sub>4</sub>, filtered, and concentrated. Purification by silica gel chromatography (Biotage-SNAP, 25 g SiO<sub>2</sub>, 0–50% EtOAc/hexanes) afforded methyl-1-2(bromoethyl)-4-(3-ethoxy-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (135 mg, 43%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.51 (d, <i>J</i> = 6.0 Hz, 1 H), 7.60 (d, <i>J</i> = 1.0 Hz, 1 H), 7.49–7.45 (m, 2H), 7.40 (m, <i>J</i> = 7.9 Hz, 1 H), 7.31 (dd, <i>J</i> = 6.0, 1.0 Hz, 1 H), 6.99 (ddd, <i>J</i> = 8.2, 2.6, 1.1 Hz, 1 H), 4.92 (t, <i>J</i> = 6.8 Hz, 2 H), 4.12 (q, <i>J</i> = 7.0 Hz, 2 H), 3.91 (s, 3 H), 3.71 (t, <i>J</i> = 7.1 Hz, 2 H), 1.43 (t, <i>J</i> = 7.12 Hz, 2 H).</div><div class="NLM_p last"><i>Step 2.</i> 4-(Trifluoromethoxy)phenol (15.4 mg, 0.086 mmol) and K<sub>2</sub>CO<sub>3</sub> (24 mg, 0.17 mmol) were combined in a screw cap vial. To this was added a solution of methyl-1-(2-bromoethyl)-4-(3-ethoxyphenyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (22 mg, 0.056 mmol) in DMF (0.5 mL). The vial was capped and then heated to 60 °C. After being stirred overnight, the mixture was cooled to room temperature. Then 2 N NaOH (100 mL) was added. After 4 h at room temperature the mixture was concentrated. The crude material was taken up in DMSO and acidified with TFA. The resulting solution was purified by preparative reversed-phase HPLC (21 mm × 100 mm Phenomenex AXIA-Gemini-NX, 20–45% CH<sub>3</sub>CN/water containing 0.1% THF over 18 min at 20 mL/min) to afford 4-(3-ethoxyphenyl)1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid as the TFA salt (5 mg, 15%). <sup>1</sup>H NMR (500 MHz,DMSO-<i>d</i><sub>6</sub>): δ 8.58 (d, <i>J</i> = 6.6 Hz, 1 H), 8.16 (bs, 1 H), 7.58 (m, 2 H), 7.52 (d, <i>J</i> = 7.7 Hz, 1 H), 7.47 (m, 1 H), 7.23 (m, 3H), 6.91 (d, <i>J</i> = 8.8 Hz, 2 H), 5.16 (m, 2 H), 4.40 (m, 2 H), 4.15 (q, <i>J</i> = 6.7 Hz, 2 H), 1.38 (t, <i>J</i> = 7.0 Hz, 3H). HRMS (ESI) calcd (M + H) = 487.1475, found 487.1482.</div></div><div id="sec3_1_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> 1-(2-[4-(Trifluoromethoxy)phenoxy)ethyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic Acid (<b>25</b>)</h3><div class="NLM_p last">Methyl 4-chloro-1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylate (25 mg, 0.060 mmol) was hydrogenated (balloon) with 10% Pd/C (10 mg, 9.40 mmol) in MeOH (3 mL) at room temperature. After 4 h the mixture was filtered using a 0.45 μm PTFE syringe filter and then concentrated. The residue was taken up in 0.5 mL of MeOH. To this was added 2 M NaOH (0.15 mL, 0.300 mmol), and then the mixture was heated to 60 °C. After being stirred overnight the mixture was cooled to room temperature and concentrated. The crude material was taken up in DMSO and acidified with TFA. The resulting solution was filtered using a 0.45 μm PTFE syringe filter and then purified by preparative reversed-phase HPLC (21 mm × 100 mm Phenomenex AXIA-Gemini-NX, 20–45% CH<sub>3</sub>CN/water containing 0.1% TFA over 18 min at 20 mL/min) to afford 1-(2-[4-(trifluoromethoxy)phenoxy)ethyl)-1<i>H</i>-pyrrolo[3,2-<i>c</i>]pyridine-2-carboxylic acid as the TFA salt (22 mg, 75%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.36 (s, 1 H), 8.58 (d, <i>J</i> = 6.7 Hz, 1 H), 8.26 (d, <i>J</i> = 6.8 Hz, 1 H), 7.70 (s, 1 H), 7.22 (d, <i>J</i> = 8.5 Hz, 2H), 6.87 (d, <i>J</i> = 8.6 Hz, 2 H), 5.14 (m, 2 H), 4.38 (m, 2 H). HRMS (ESI) calcd (M + H)<sup>+</sup> = 367.0900, found 367.0907.</div></div><div id="sec3_1_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> 5-Cyano-1-{2-[4-(trifluoromethoxy)phenoxylethyl}-1<i>H</i>-indole-2-carboxylic Acid (<b>26</b>)</h3><div class="NLM_p last">To a solution ethyl 5-cyano-1<i>H</i>-indole-2-carboxylate (37 mg, 0.17 mmol), 2-[4-(trifluoromethoxy)phenoxy]ethanol (42 mg, 0.19 mmol), and triphenylphosphine (227 mg, 0.518 mmol) in toluene (1 mL) was add DIAD (0.044 mL, 0.225 mmol) dropwise at room temperature, and the mixture was stirred overnight. The mixture was diluted with EtOAc and quenched with water. The two layers were separated, and the aqueous phase was further extracted twice with EtOAc. The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo. Purification by silica gel chromatography (0–30% EtOAc in hexanes) provided ethyl-5-cyano-l-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-indole-2-carboxylate (15 mg, 0.04 mmol) that was subsequently dissolved in THF (1 mL), MeOH (300 μL), and 1 M NaOH (200 μL). The reaction mixture was stirred at room temperature for 5 h, after which water was added, the pH was adjusted to 3 with 1 N HCl, and the solvent was removed in vacuo. EtOAc was added to the resulting aqueous solution. The two layers were separated, and the aqueous phase was further extracted with EtOAc (2 × 10 mL). The combined organic layers were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated in vacuo to afford 5-cyano-1-{2-[4-(trifluoromethoxy)phenoxylethyl}-1<i>H</i>-indole-2-carboxylic acid (13.4 mg, 20%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.03 (s, 1H), 7.66 (d, <i>J</i> = 8.8 HZ, 1H), 7.57 (d, <i>J</i> = 8.8 Hz, 1H), 7.39 (s, 1H), 7.07 (d, <i>J</i> = 8.8 Hz, 2H), 6.73 (d, <i>J</i> = 9.2 Hz, 2H), 4.97 (t, <i>J</i> = 5.1 Hz, 2H), 4.46–4.34 (m, 4H), 1.43 (t, <i>J</i> = 7.1 Hz, 3H). HRMS: calcd for C<sub>l9</sub>H<sub>13</sub>F<sub>3</sub>N<sub>2</sub>O<sub>4</sub> 413.0720. Found: 413.0718.</div></div><div id="sec3_1_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> 5-(1<i>H</i>-Pyrazol-3-yl)-1-(2-(4-(trifluoromethoxy)phenoxy)ethyl)-1<i>H</i>-indole-2-carboxylic Acid (<b>27</b>)</h3><div class="NLM_p"><i>Step 1.</i> To a solution of ethyl 5-bromo-1<i>H</i>-indole-2-carboxylate (1.7 g, 6.3 mmol), 2-[4-(trifluoromethoxy)phenoxy]ethanol (1.7 g, 7.6 mmol), and triphenylphosphine (3.3 g, 12.7 mmol) in toluene (20 mL) was added DIAD (1.85 mL, 9.5 mmol) dropwise at 0 °C. The mixture was left to warm to room temperature and stirred overnight. The mixture was then concentrated in vacuo and purified by silica gel chromatography (0–20% EtOAc in hexanes) to afford ethyl 5-bromo-1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-indole-2-carboxylate (1.6 g, 52%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 7.79 (s, 1H), 7.45 (s, 1H), 7.25 (m, 2H), 7.01 (d, <i>J</i> = 9.2 Hz, 2H), 6.75 (m, 2H), 4.92 (t, <i>J</i> = 5.6 Hz, 2H), 4.37 (q, <i>J</i> = 6.8 Hz, 2H), 4.32 (t, <i>J</i> = 5.6 Hz, 2H), 1.41 (t, <i>J</i> = 6.8 Hz, 3H). LRMS (M + H): calcd for C<sub>20</sub>H<sub>18</sub>BrF<sub>3</sub>NO<sub>4</sub> 472.1/474.1. Found: 472.1/474.1.</div><div class="NLM_p"><i>Step 2.</i> Ethyl 5-bromo-1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-indole-2-carboxylate (812 mg, 1.7 mmol), pinacol borane (873 mg, 3.4 mmol), XPhos (98 mg, 0.21 mmol), and KOAc (540 mg, 5.5 mmol) were combined in dioxane (8 mL). The mixture was degassed under vacuum and back-filled with N<sub>2</sub>. Palladium acetate (23 mg, 0.1 mmol) was added, and the mixture was degassed and back-filled again. The mixture was left to stir overnight at 85 °C. EtOAc was added, and the mixture was filtered through a pad of Celite, concentrated in vacuo, and purified by silica chromatography (0–30% EtOAc in hexanes) to provide ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-indole-2-carboxylate (675 mg, 76%). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>): δ 8.19 (s, 1H), 7.78 (dd, <i>J</i> = 8.4 Hz, 1.2 Hz, 1H), 7.75 (d, <i>J</i> = 8.8 Hz, 1H), 7.33 (s, 1H), 7.05 (d, <i>J</i> = 8.8 Hz, 2H), 6.77 (m, 2H), 4.95 (t, <i>J</i> = 5.6 Hz, 2H), 4.38 (q, <i>J</i> = 7.2 Hz, 2H), 4.32 (t, <i>J</i> = 5.6 Hz, 2H), 1.42 (t, <i>J</i> = 7.2 Hz, 3H). LRMS (M + H): calcd for C<sub>26</sub>H<sub>30</sub>BF<sub>3</sub>NO<sub>6</sub> 520.3. Found: 520.3.</div><div class="NLM_p last"><i>Step 3.</i> Ethyl 5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-{2-[4-(trifluoromethoxy)phenoxy]ethyl}-1<i>H</i>-indole-2-carboxylate (75 mg, 0.14 mmol), 3-bromo-1-(phenylsulfonyl)-1<i>H</i>-pyrazole (83 mg, 0.29 mmol), K<sub>2</sub>CO<sub>3</sub> (60 mg, 0.43 mmol), and SPhos (6 mg, 0.014 mmol) were combined in dioxane (2 mL). The reaction was degassed and filled with nitrogen 2×. Water (0.4 mL) was added and purged again with nitrogen. Palladium acetate (1.6 mg, 0.007 mmol) was added under nitrogen, and the mixture was heated to 80 °C overnight. EtOAc was added and the crude mixture was filtered through a pad of Celite, concentrated in vacuo, and purified by silica gel chromatography (0–40% EtOAc in hexanes) to provide ethyl 5-(1-(phenylsulfonyl)-1<i>H</i>-pyrazol-3-yl)-1-(2-(4-(trifluoromethoxy)phenoxy)ethyl)-1<i>H</i>-indole-2-carboxylate (50 mg, 58%). This material was then dissolved in THF (1 mL) and MeOH (1 mL), and NaOH (1 M, 0.5 mL) was added. The reaction mixture was then heated to 80 °C overnight. The solvent was removed in vacuo and the mixture was dissolved in DMSO, purified by reverse phase HPLC (10–95% ACN in H<sub>2</sub>O (with 0.1% TFA)) to afford 5-(1<i>H</i>-pyrazol-3-yl)-1-(2-(4-(trifluoromethoxy)phenoxy)ethyl)-1<i>H</i>-indole-2-carboxylic acid (22 mg, 28%). <sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.07 (s, 1H), 7.77 (d, <i>J</i> = 9.0 Hz, 1H), 7.70 (m, 2H), 7.27 (s, 1H), 7.22 (d, <i>J</i> = 9.0 Hz, 2H), 6.92 (d, <i>J</i> = 9.0 Hz, 2H), 6.69 (d, <i>J</i> = 2 Hz, 1H), 4.98 (t, <i>J</i> = 5.5 Hz, 2H), 4.32 (t, <i>J</i> = 5.5 Hz, 2H). HRMS: calcd for C<sub>21</sub>H<sub>17</sub>F<sub>3</sub>N<sub>3</sub>O<sub>4</sub> 432.1166. Found: 432.1183.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i50"><a href="/doi/suppl/10.1021/jm5006429">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_85465" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_85465" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for protein crystallography, SPR, and details of in vitro and in vivo assays. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5006429/suppl_file/jm5006429_si_001.pdf">jm5006429_si_001.pdf (178.53 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Structure coordinates have been deposited in the PDB: codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT">4PMT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP">4PMP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS">4PMS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>.</p><div class="testing" data-doi="10.1021/jm5006429" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_63588" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_63588" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shawn J. Stachel</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b6c5ded7c1d8e9c5c2d7d5ded3daf6dbd3c4d5dd98d5d9db"><span class="__cf_email__" data-cfemail="2b58434a5c4574585f4a48434e476b464e59484005484446">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">John M. Sanders</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Darrell A. Henze</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mike T. Rudd</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Hua-Poo Su</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yiwei Li</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kausik K. Nanda</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Melissa S. Egbertson</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter J. Manley</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristen L. G. Jones</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Edward J. Brnardic</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ahren Green</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jay A. Grobler</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Hanney</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Leitl</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ming-Tain Lai</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Vandna Munshi</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dennis Murphy</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Keith Rickert</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Riley</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Alicja Krasowska-Zoladek</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher Daley</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Zuck</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stephanie A. Kane</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark T. Bilodeau</span> - <span class="hlFld-Affiliation affiliation">Departments
of Medicinal
Chemistry, Biological Chemistry, Pain & Migraine, Molecular Systems, and Structural Biology, Merck Research Laboratories, P.O. Box 4, West Point, Pennsylvania 19486, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i52" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i52"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i53" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i53"> Abbreviations Used</h2><tr><td class="NLM_term">Trk</td><td class="NLM_def"><p class="first last">tropomyosin-related kinase</p></td></tr><tr><td class="NLM_term">ATP</td><td class="NLM_def"><p class="first last">adenosine 5′-triphosphate</p></td></tr><tr><td class="NLM_term">NGF</td><td class="NLM_def"><p class="first last">nerve growth factor</p></td></tr><tr><td class="NLM_term">BDNF</td><td class="NLM_def"><p class="first last">brain-derived neurotrophic factor</p></td></tr><tr><td class="NLM_term">NT-3</td><td class="NLM_def"><p class="first last">neurotrophin 3</p></td></tr><tr><td class="NLM_term">HTS</td><td class="NLM_def"><p class="first last">high-throughput screening</p></td></tr><tr><td class="NLM_term">IGFR1</td><td class="NLM_def"><p class="first last">insulin-like growth factor receptor 1</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">lipophilic ligand efficiency</p></td></tr><tr><td class="NLM_term">SPR</td><td class="NLM_def"><p class="first last">surface plasmon resonance</p></td></tr><tr><td class="NLM_term">CFA</td><td class="NLM_def"><p class="first last">complete Freund’s adjuvant</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_23084" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_23084" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The Protein Kinase Compliment of the Human Genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+Protein+Kinase+Compliment+of+the+Human+Genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Compliment%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">Neurotrophin-Regulated Signalling Pathways</span> <span class="citation_source-journal">Philos. Trans. R. Soc. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1098%2Frstb.2006.1894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=16939974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFakurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2006&pages=1545-1564&author=L.+F.+Reichardt&title=Neurotrophin-Regulated+Signalling+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophin-regulated signalling pathways</span></div><div class="casAuthors">Reichardt, Louis F.</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">1473</span>),
    <span class="NLM_cas:pages">1545-1564</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  Neurotrophins are a family of closely related proteins that were identified initially as survival factors for sensory and sympathetic neurons, and have since been shown to control many aspects of survival, development and function of neurons in both the peripheral and the central nervous systems.  Each of the four mammalian neurotrophins has been shown to activate one or more of the three members of the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB and TrkC).  In addn., each neurotrophin activates p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor receptor superfamily.  Through Trk receptors, neurotrophins activate Ras, phosphatidyl inositol-3 (PI3)-kinase, phospholipase C-γ1 and signalling pathways controlled through these proteins, such as the MAP kinases.  Activation of p75NTR results in activation of the nuclear factor-κB (NF-κB) and Jun kinase as well as other signalling pathways.  Limiting quantities of neurotrophins during development control the no. of surviving neurons to ensure a match between neurons and the requirement for a suitable d. of target innervation.  The neurotrophins also regulate cell fate decisions, axon growth, dendrite growth and pruning and the expression of proteins, such as ion channels, transmitter biosynthetic enzymes and neuropeptide transmitters that are essential for normal neuronal function.  Continued presence of the neurotrophins is required in the adult nervous system, where they control synaptic function and plasticity, and sustain neuronal survival, morphol. and differentiation.  They also have addnl., subtler roles outside the nervous system.  In recent years, three rare human genetic disorders, which result in deleterious effects on sensory perception, cognition and a variety of behaviors, have been shown to be attributable to mutations in brain-derived neurotrophic factor and two of the Trk receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0o5HD04qQ7Vg90H21EOLACvtfcHk0ljAoJpVLi3hiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFakurfF&md5=bfe4323cece6bc7e53fb1687917b86d7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1098%2Frstb.2006.1894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2006.1894%26sid%3Dliteratum%253Aachs%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DNeurotrophin-Regulated%2520Signalling%2520Pathways%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%2520B%26date%3D2006%26volume%3D361%26spage%3D1545%26epage%3D1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group">Watson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span> </span><span class="NLM_article-title">Targeting Nerve Growth Factor in Pain</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=349-359&author=J.+L.+Watsonauthor=S.+J.+Allenauthor=D.+Dawbarn&title=Targeting+Nerve+Growth+Factor+in+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BL.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DDawbarn%26aufirst%3DD.%26atitle%3DTargeting%2520Nerve%2520Growth%2520Factor%2520in%2520Pain%26jtitle%3DBioDrugs%26date%3D2008%26volume%3D22%26spage%3D349%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span> </span><span class="NLM_article-title">Trk Kinase Inhibitors as New Treatments for Cancer Pain</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1517%2F13543770902721261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=305-319&author=T.+Wangauthor=D.+Yuauthor=M.+L.+Lamb&title=Trk+Kinase+Inhibitors+as+New+Treatments+for+Cancer+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Trk kinase inhibitors as new treatments for cancer and pain</span></div><div class="casAuthors">Wang, Tao; Yu, Dingwei; Lamb, Michelle L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-319</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Tropomyosin-related kinases (Trks) are a family of receptor tyrosine kinases activated by neurotrophins.  Trks play important roles in pain sensation as well as tumor cell growth and survival signaling.  Thus, inhibitors of Trk receptor kinases might provide targeted treatments for pain and cancer.  Objective: This paper reviews those patent applications since 2002 claiming small-mol. inhibitors of Trk receptor kinases.  Methods: Primary literature and patents were searched with SciFinder and Google Scholar.  Patents were selected based on their relevance to Trks and were evaluated and representative compds. were listed as examples.  Results/conclusion: Several series of Trk inhibitors with excellent in vitro potencies have been reported and a no. of compds. have gone into the clinic.  It should be noted that few of these inhibitors are Trk selective, demonstrating that targeting Trk kinases for treatment of pain and/or cancer offers a promising but also challenging approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvknvXUUz2DbVg90H21EOLACvtfcHk0ljNCWkemwTHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D&md5=ffc2d3e33102631cac7b89dce7f96a5a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543770902721261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902721261%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26atitle%3DTrk%2520Kinase%2520Inhibitors%2520as%2520New%2520Treatments%2520for%2520Cancer%2520Pain%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D305%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Lane, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitzer, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birbara, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtarani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. T.</span><span> </span><span class="NLM_article-title">Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1056%2FNEJMoa0901510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=20942668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1521-1531&author=N.+E.+Laneauthor=T.+J.+Schnitzerauthor=C.+A.+Birbaraauthor=M.+Mokhtaraniauthor=D.+L.+Sheltonauthor=M.+D.+Smithauthor=M.+T.+Brown&title=Tanezumab+for+the+Treatment+of+Pain+from+Osteoarthritis+of+the+Knee"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tanezumab for the treatment of pain from osteoarthritis of the knee</span></div><div class="casAuthors">Lane, Nancy E.; Schnitzer, Thomas J.; Birbara, Charles A.; Mokhtarani, Masoud; Shelton, David L.; Smith, Mike D.; Brown, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1521</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Increased expression of nerve growth factor in injured or inflamed tissue is assocd. with increased pain.  This proof-of-concept study was designed to investigate the safety and analgesic efficacy of tanezumab, a humanized monoclonal antibody that binds and inhibits nerve growth factor.  Methods: We randomly assigned 450 patients with osteoarthritis of the knee to receive tanezumab (administered at a dose of 10, 25, 50, 100, or 200 Ag per kg of body wt.) or placebo on days 1 and 56.  The primary efficacy measures were knee pain while walking and the patient's global assessment of response to therapy.  We also assessed pain, stiffness, and phys. function using the Western Ontario and Mc-Master Universities Osteoarthritis Index (WOMAC); the rate of response using the criteria of the Outcome Measures for Rheumatol.  Committee and Osteoarthritis Research Society International Standing Committee for Clin. Trials Response Criteria Initiative (OMERACT-OARSI); and safety.  Results: When averaged over weeks 1 through 16, the mean redns. from baseline in knee pain while walking ranged from 45 to 62% with various doses of tanezumab, as compared with 22% with placebo (P < 0.001).  Tanezumab, as compared with placebo, was also assocd. with significantly greater improvements in the response to therapy as assessed with the use of the patients' global assessment measure (mean increases in score of 29 to 47% with various doses of tanezumab, as compared with 19% with placebo; P ≤ 0.001).  The rate of response according to the OMERACT-OARSI criteria ranged from 74 to 93% with tanezumab treatment, as compared with 44% with placebo (P < 0.001).  The rates of adverse events were 68% and 55% in the tanezumab and placebo groups, resp.  The most common adverse events among tanezumab-treated patients were headache (9% of the patients), upper respiratory tract infection (7%), and paresthesia (7%).  Conclusions: In this proof-of-concept study, treatment with tanezumab was assocd. with a redn. in joint pain and improvement in function, with mild and moderate adverse events, among patients with moderate-to-severe osteoarthritis of the knee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCmt4PNNZ44LVg90H21EOLACvtfcHk0ljNCWkemwTHqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltrbI&md5=fe69490dfa3d47fe8a0c286d6b020d57</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0901510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0901510%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DN.%2BE.%26aulast%3DSchnitzer%26aufirst%3DT.%2BJ.%26aulast%3DBirbara%26aufirst%3DC.%2BA.%26aulast%3DMokhtarani%26aufirst%3DM.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DM.%2BT.%26atitle%3DTanezumab%2520for%2520the%2520Treatment%2520of%2520Pain%2520from%2520Osteoarthritis%2520of%2520the%2520Knee%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1521%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="note"><p class="first last">Invitrogen 92 member kinase panel used as the general counterscreen at 1 μM to assess kinase selectivity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="note"><p class="first last">Protein crystallography conditions and procedured are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited in the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT">4PMT</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="note"><p class="first last">Additional hinge binding TrkA inhibitors have also been previously reported in the literature; see the following:</p></div><div class="NLM_citation" id="cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Identification of 4-Aminopyrazolylpyrimidines as Potent Inhibitors of Trk Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4672</span><span class="NLM_x">–</span> <span class="NLM_lpage">4684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800343j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4672-4684&author=T.+Wangauthor=M.+L.+Lambauthor=D.+A.+Scottauthor=H.+Wangauthor=M.+H.+Blockauthor=P.+D.+Lyneauthor=J.+W.+Leeauthor=A.+M.+Daviesauthor=H.-J.+Zhangauthor=Y.+Zhuauthor=F.+Guauthor=Y.+Hanauthor=B.+Wangauthor=P.+J.+Mohrauthor=R.+J.+Kausauthor=J.+A.+Joseyauthor=E.+Hoffmannauthor=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=C.+A.+Omerauthor=D.+Yu&title=Identification+of+4-Aminopyrazolylpyrimidines+as+Potent+Inhibitors+of+Trk+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm800343j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800343j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DH.-J.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DKaus%26aufirst%3DR.%2BJ.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DIdentification%2520of%25204-Aminopyrazolylpyrimidines%2520as%2520Potent%2520Inhibitors%2520of%2520Trk%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4672%26epage%3D4684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of 3,5-Disubstituted 7-Azaindoles as Trk Inhibitors with Anticancer and Antiangiogenic Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5337</span><span class="NLM_x">–</span> <span class="NLM_lpage">5349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3002982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5337-5349&author=S.+Hongauthor=J.+Kimauthor=J.+H.+Seoauthor=K.+H.+Jungauthor=S.-S.+Hongauthor=S.+Hong&title=Design%2C+Synthesis+and+Evaluation+of+3%2C5-Disubstituted+7-Azaindoles+as+Trk+Inhibitors+with+Anticancer+and+Antiangiogenic+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm3002982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002982%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%25203%252C5-Disubstituted%25207-Azaindoles%2520as%2520Trk%2520Inhibitors%2520with%2520Anticancer%2520and%2520Antiangiogenic%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5337%26epage%3D5349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Van Linden, O. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooistra, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graff, C.</span><span> </span><span class="NLM_article-title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400378w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=249-277&author=O.+P.+J.+Van+Lindenauthor=A.+J.+Kooistraauthor=R.+Leursauthor=I.+J.+P.+de+Eschauthor=C.+de+Graff&title=KLIFS%3A+A+Knowledge-Based+Structural+Database+To+Navigate+Kinase%E2%80%93Ligand+Interaction+Space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400378w%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLinden%26aufirst%3DO.%2BP.%2BJ.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3Dde%2BGraff%26aufirst%3DC.%26atitle%3DKLIFS%253A%2520A%2520Knowledge-Based%2520Structural%2520Database%2520To%2520Navigate%2520Kinase%25E2%2580%2593Ligand%2520Interaction%2520Space%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D249%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="note"><p class="first last">The cell-based assay is performed using the Discover X- Pathhunter assay platform. Experimental details are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group">Bouhana, K. S.; Impastato, R.; Pheneger, J.; Jiang, Y.; Wallace, R. D.; Do, M. G.; Zaute, N. A.; Andrews, S. W.</span><span> </span><span class="NLM_article-title">Analgesic Effects of a Potent and Selective Kinase Inhibitor of Neurotrophin Receptors TRKA, TRKB and TRKC</span>. WO2010033941,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>WO2010048312,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>WO2011006074,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.arraybiopharma.com" class="extLink">www.arraybiopharma.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+S.+Bouhana&author=R.+Impastato&author=J.+Pheneger&author=Y.+Jiang&author=R.+D.+Wallace&author=M.+G.+Do&author=N.+A.+Zaute&author=S.+W.+Andrews&title=Analgesic+Effects+of+a+Potent+and+Selective+Kinase+Inhibitor+of+Neurotrophin+Receptors+TRKA%2C+TRKB+and+TRKC"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26atitle%3DAnalgesic%2520Effects%2520of%2520a%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitor%2520of%2520Neurotrophin%2520Receptors%2520TRKA%252C%2520TRKB%2520and%2520TRKC%26date%3D2010%26date%3D2010%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Green, A.; Li, Y.; Stachel, S. J.</span><span> </span><span class="NLM_article-title">Preparation of Pyridotriazole and Benzotriazole Compounds as TrkA Kinase Inhibitors</span>. PCT Int. Appl. WO 2012125667 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Green&author=Y.+Li&author=S.+J.+Stachel&title=Preparation+of+Pyridotriazole+and+Benzotriazole+Compounds+as+TrkA+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Pyridotriazole%2520and%2520Benzotriazole%2520Compounds%2520as%2520TrkA%2520Kinase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Green, A.; Li, Y.; Stachel, S. J.</span><span> </span><span class="NLM_article-title">TrkA kinase Inhibitors Compositions and Methods of Use</span> PCT Int. Appl. WO2012125668 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Green&author=Y.+Li&author=S.+J.+Stachel&title=TrkA+kinase+Inhibitors+Compositions+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%26atitle%3DTrkA%2520kinase%2520Inhibitors%2520Compositions%2520and%2520Methods%2520of%2520Use%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited with the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><div class="note"><p class="first last">For an excellent review on type I and type II kinase inhibitors see the following:</p></div><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span> </span><span class="NLM_article-title">Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2681</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901443h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2681-2694&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%9CGatekeeper+Door%E2%80%9D%3A+Exploiting+the+Active+Kinase+Conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%259CGatekeeper%2520Door%25E2%2580%259D%253A%2520Exploiting%2520the%2520Active%2520Kinase%2520Conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2681%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group">Huse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">The Conformational Plasticity of Protein Kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1016%2FS0092-8674%2802%2900741-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=12015977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=275-282&author=M.+Huseauthor=J.+Kuriyan&title=The+Conformational+Plasticity+of+Protein+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The conformational plasticity of protein kinases</span></div><div class="casAuthors">Huse, Morgan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 48 refs.  Protein kinases operate in a large no. of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms.  The catalytic domains of different kinases adopt strikingly similar structures when they are active.  By contrast, crystal structures of inactive kinases have revealed a marked plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrn7F3h4ej7Vg90H21EOLACvtfcHk0li-mTqfedMlXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D&md5=cd56edae94ad239f2ce7a5d6c8930cbb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900741-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900741-9%26sid%3Dliteratum%253Aachs%26aulast%3DHuse%26aufirst%3DM.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520Conformational%2520Plasticity%2520of%2520Protein%2520Kinases%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D275%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Albaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanewsky, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span> </span><span class="NLM_article-title">Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200261d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFCm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=140-145&author=P.+Albaughauthor=Y.+Fanauthor=Y.+Miauthor=F.+Sunauthor=F.+Adrianauthor=N.+Liauthor=Y.+Jiaauthor=Y.+Sarkisovaauthor=A.+Kreuschauthor=T.+Hoodauthor=M.+Luauthor=G.+Liuauthor=S.+Huangauthor=Z.+Liuauthor=J.+Lorenauthor=T.+Tuntlandauthor=D.+S.+Karanewskyauthor=H.+M.+Seidelauthor=V.+Molteni&title=Discovery+of+GNF-5837%2C+a+Selective+TRK+Inhibitor+with+Efficacy+in+Rodent+Cancer+Tumor+Models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models</span></div><div class="casAuthors">Albaugh, Pam; Fan, Yi; Mi, Yuan; Sun, Fangxian; Adrian, Francisco; Li, Nanxin; Jia, Yong; Sarkisova, Yelena; Kreusch, Andreas; Hood, Tami; Lu, Min; Liu, Guoxun; Huang, Shenlin; Liu, Zuosheng; Loren, Jon; Tuntland, Tove; Karanewsky, Donald S.; Seidel, H. Martin; Molteni, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-145</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotrophins and their receptors (TRKs) play key roles in the development of the nervous system and the maintenance of the neural network.  Accumulating evidence points to their role in malignant transformations, chemotaxis, metastasis, and survival signaling and may contribute to the pathogenesis of a variety of tumors of both neural and non-neural origin.  By screening the GNF kinase collection, a series of novel oxindole inhibitors of TRKs were identified.  Optimization led to the identification of GNF-5837 (I), a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.  The properties of I make it a good tool for the elucidation of TRK biol. in cancer and other nononcol. indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF4DjLhCqRFrVg90H21EOLACvtfcHk0ljeShXayxlL2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFCm&md5=d355489fe9f791a8547699fa65ebba51</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml200261d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200261d%26sid%3Dliteratum%253Aachs%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DSarkisova%26aufirst%3DY.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520GNF-5837%252C%2520a%2520Selective%2520TRK%2520Inhibitor%2520with%2520Efficacy%2520in%2520Rodent%2520Cancer%2520Tumor%2520Models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D140%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1126%2Fscience.289.5486.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=10988075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1938-1942&author=T.+Schindlerauthor=W.+Bornmannauthor=P.+Pellicenaauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Structural+Mechanism+for+STI-571+Inhibition+of+Abelson+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span></div><div class="casAuthors">Schindler, Thomas; Bornmann, William; Pellicena, Patricia; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5486</span>),
    <span class="NLM_cas:pages">1938-1942</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML).  A small-mol. inhibitor of Abl (STI-571) is effective in the treatment of CML.  We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571.  Crit. to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated.  The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases.  These results suggest that compds. that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eAZqIQ1aebVg90H21EOLACvtfcHk0ljeShXayxlL2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D&md5=56bb233f010f099d0073020ac6b9db59</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5486.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5486.1938%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DPellicena%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520Mechanism%2520for%2520STI-571%2520Inhibition%2520of%2520Abelson%2520Tyrosine%2520Kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Stachel, S. J.; Egbertson, M.; Brnardic, E.; Jones, K.; Sanders, J. M.; Henze, D. A.</span><span> </span><span class="NLM_article-title">TrkA Kinase Inhibitors, Composition and Methods Thereof</span>. PCT Int. Appl. WO 2013/176970, Nov<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+J.+Stachel&author=M.+Egbertson&author=E.+Brnardic&author=K.+Jones&author=J.+M.+Sanders&author=D.+A.+Henze&title=TrkA+Kinase+Inhibitors%2C+Composition+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DTrkA%2520Kinase%2520Inhibitors%252C%2520Composition%2520and%2520Methods%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge Based Predictions of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+Based+Predictions+of+Ligand+Binding+Modes+and+Rational+Inhibitor+Design+for+Kinase+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520Based%2520Predictions%2520of%2520Ligand%2520Binding%2520Modes%2520and%2520Rational%2520Inhibitor%2520Design%2520for%2520Kinase%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Dar, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Small Molecule Recognition of c-Src via the Imantinib-Binding Conformation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1016%2Fj.chembiol.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=18940662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1015-1022&author=A.+C.+Darauthor=M.+S.+Lopezauthor=K.+M.+Shokat&title=Small+Molecule+Recognition+of+c-Src+via+the+Imantinib-Binding+Conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation</span></div><div class="casAuthors">Dar, Arvin C.; Lopez, Michael S.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1015-1022</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The cancer drug, Imatinib, is a selective Abl kinase inhibitor that does not inhibit the closely related kinase c-Src.  This one drug and its ability to selectively inhibit Abl over c-Src has been a guiding principle in virtually all kinase drug discovery efforts in the last 15 years.  A prominent hypothesis explaining the selectivity of Imatinib is that Abl has an intrinsic ability to adopt an inactive conformation (termed DFG-out), whereas c-Src appears to pay a high intrinsic energetic penalty for adopting this conformation, effectively excluding Imatinib from its ATP pocket.  This explanation of the difference in binding affinity of Imatinib for Abl vs. c-Src makes the striking prediction that it would not be possible to design an inhibitor that binds to the DFG-out conformation of c-Src with high affinity.  The authors report the discovery of a series of such inhibitors.  The authors use structure-activity relationships and x-ray crystallog. to confirm the authors' findings.  These studies suggest that small mols. are capable of inducing the generally unfavorable DFG-out conformation in c-Src.  Structural comparison between c-Src in complex with these inhibitors allows the authors to speculate on the differential selectivity of Imatinib for c-Src and Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgbxnfmxtR-LVg90H21EOLACvtfcHk0ljeShXayxlL2A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP&md5=f1047f4a56359511939164a3c2604cb6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DDar%26aufirst%3DA.%2BC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DSmall%2520Molecule%2520Recognition%2520of%2520c-Src%2520via%2520the%2520Imantinib-Binding%2520Conformation%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Cassina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Nido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-Specific Inhibitor AR-A014418</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">45937</span><span class="NLM_x">–</span> <span class="NLM_lpage">45945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=45937-45945&author=R.+Bhatauthor=Y.+Xueauthor=S.+Bergauthor=S.+Hellbergauthor=M.+Ormoauthor=Y.+Nilssonauthor=A.-C.+Radesaterauthor=E.+Jerningauthor=P.-O.+Markgrenauthor=T.+Borgegardauthor=M.+Nylofauthor=A.+Gimenez-Cassinaauthor=F.+Hernandezauthor=J.+J.+Lucasauthor=J.+Diaz-Nidoauthor=J.+Avila&title=Structural+Insights+and+Biological+Effects+of+Glycogen+Synthase+Kinase+3-Specific+Inhibitor+AR-A014418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DOrmo%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DRadesater%26aufirst%3DA.-C.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DMarkgren%26aufirst%3DP.-O.%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DNylof%26aufirst%3DM.%26aulast%3DGimenez-Cassina%26aufirst%3DA.%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DDiaz-Nido%26aufirst%3DJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DStructural%2520Insights%2520and%2520Biological%2520Effects%2520of%2520Glycogen%2520Synthase%2520Kinase%25203-Specific%2520Inhibitor%2520AR-A014418%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D45937%26epage%3D45945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Boije af Gennas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mologni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajaratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindholm, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viltadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scappozza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yli-Kauhaluoma, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Urea Derivatives as Anaplastic Lymphoma Kinase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1680</span><span class="NLM_x">–</span> <span class="NLM_lpage">1692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1680-1692&author=G.+Boije+af+Gennasauthor=L.+Mologniauthor=S.+Ahmedauthor=M.+Rajaratnamauthor=O.+Marinauthor=N.+Lindholmauthor=M.+Viltadiauthor=C.+Gambacorti-Passeriniauthor=L.+Scappozzaauthor=J.+Yli-Kauhaluoma&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Urea+Derivatives+as+Anaplastic+Lymphoma+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoije%2Baf%2BGennas%26aufirst%3DG.%26aulast%3DMologni%26aufirst%3DL.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DRajaratnam%26aufirst%3DM.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DLindholm%26aufirst%3DN.%26aulast%3DViltadi%26aufirst%3DM.%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26aulast%3DScappozza%26aufirst%3DL.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Urea%2520Derivatives%2520as%2520Anaplastic%2520Lymphoma%2520Kinase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1680%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited in the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP">4PMP</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behshad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klabe, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margulis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker-Pasha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span> </span><span class="NLM_article-title">Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase</span> <span class="citation_source-journal">Curr. Chem. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.2174%2F1875397301004010027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtl2jtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=27-33&author=E.+Behshadauthor=R.+M.+Klabeauthor=A.+Margulisauthor=M.+Becker-Pashaauthor=M.+J.+Ruparauthor=P.+Collierauthor=P.+C.+Liuauthor=G.+F.+Hollisauthor=T.+C.+Burnauthor=R.+Wynn&title=Phosphorylation+State-Dependent+High+Throughput+Screening+of+the+c-Met+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation state-dependent high throughput screening of the c-Met kinase</span></div><div class="casAuthors">Behshad, Elham; Klabe, Ronald M.; Margulis, Alexander; Becker-Pasha, Mary; Rupar, Mark J.; Collier, Paul; Liu, Phillip C.; Hollis, Gregory F.; Burn, Timothy C.; Wynn, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-33</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">High-throughput screening (HTS) of ∼50,000 chem. compds. against phosphorylated and unphosphorylated c-Met, a tyrosine kinase receptor for hepatocyte growth factor (HGF), was carried out in order to compare hit rates, hit potencies and also to explore scaffolds that might serve as potential leads targeting only the unphosphorylated form of the enzyme.  The hit rate and potency for the confirmed hit mols. were higher for the unphosphoryalted form of c-Met.  While the target of small mol. inhibitor discovery efforts has traditionally been the phosphorylated form, there are now examples of small mols. that target unphosphorylated kinases.  Screening for inhibitors of unphosphorylated kinases may represent a complementary approach for prioritizing chem. scaffolds for hit-to-lead follow ups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzBg5DtPZ3rbVg90H21EOLACvtfcHk0lgBvIY6wXxt0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtl2jtr0%253D&md5=02751141e17718e2febfa1ff552e55eb</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.2174%2F1875397301004010027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397301004010027%26sid%3Dliteratum%253Aachs%26aulast%3DBehshad%26aufirst%3DE.%26aulast%3DKlabe%26aufirst%3DR.%2BM.%26aulast%3DMargulis%26aufirst%3DA.%26aulast%3DBecker-Pasha%26aufirst%3DM.%26aulast%3DRupar%26aufirst%3DM.%2BJ.%26aulast%3DCollier%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DP.%2BC.%26aulast%3DHollis%26aufirst%3DG.%2BF.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DWynn%26aufirst%3DR.%26atitle%3DPhosphorylation%2520State-Dependent%2520High%2520Throughput%2520Screening%2520of%2520the%2520c-Met%2520Kinase%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2010%26volume%3D4%26spage%3D27%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krupka, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizizad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span> </span><span class="NLM_article-title">Structural Characterization of Autoinhibited c-Met Kinase Produced by Coexpression in Bacteria with Phosphatase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3563</span><span class="NLM_x">–</span> <span class="NLM_lpage">3568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3563-3568&author=W.+Wangauthor=A.+Marimuthiauthor=J.+Tsaiauthor=A.+Kumarauthor=H.+I.+Krupkaauthor=C.+Zhangauthor=B.+Powellauthor=Y.+Suzukiauthor=H.+Nguyenauthor=M.+Tabrizizadauthor=C.+Luuauthor=B.+L.+West&title=Structural+Characterization+of+Autoinhibited+c-Met+Kinase+Produced+by+Coexpression+in+Bacteria+with+Phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMarimuthi%26aufirst%3DA.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DKrupka%26aufirst%3DH.%2BI.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DWest%26aufirst%3DB.%2BL.%26atitle%3DStructural%2520Characterization%2520of%2520Autoinhibited%2520c-Met%2520Kinase%2520Produced%2520by%2520Coexpression%2520in%2520Bacteria%2520with%2520Phosphatase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D3563%26epage%3D3568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group">Whelligan, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas-Droux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barillari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grummitt, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Aminopyrazine Inhibitors Binding to Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7682</span><span class="NLM_x">–</span> <span class="NLM_lpage">7698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1008727" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7682-7698&author=D.+K.+Whelliganauthor=S.+Solankiauthor=D.+Taylorauthor=D.+W.+Thomsonauthor=K.-M.+J.+Cheungauthor=K.+Boxallauthor=C.+Mas-Drouxauthor=C.+Barillariauthor=S.+Burnsauthor=C.+G.+Grummittauthor=I.+Collinsauthor=R.+L.+M.+van+Montfortauthor=G.+W.+Aherneauthor=R.+Baylissauthor=S.+Hoelder&title=Aminopyrazine+Inhibitors+Binding+to+Unusual+Inactive+Conformation+of+the+Mitotic+Kinase+Nek2%3A+SAR+and+Structural+Characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008727%26sid%3Dliteratum%253Aachs%26aulast%3DWhelligan%26aufirst%3DD.%2BK.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarillari%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DGrummitt%26aufirst%3DC.%2BG.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DAminopyrazine%2520Inhibitors%2520Binding%2520to%2520Unusual%2520Inactive%2520Conformation%2520of%2520the%2520Mitotic%2520Kinase%2520Nek2%253A%2520SAR%2520and%2520Structural%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7682%26epage%3D7698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited in the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS">4PMS</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Hanney, B.; Manley, P.; Rudd, M. T.; Sanders, J. M.; Stachel, S. J.; Henze, D.</span><span> </span><span class="NLM_article-title">TrkA Kinase Inhibitors, Compositions and Methods Thereof</span>. PCT. Int. Appl.  WO2013009582 A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Hanney&author=P.+Manley&author=M.+T.+Rudd&author=J.+M.+Sanders&author=S.+J.+Stachel&author=D.+Henze&title=TrkA+Kinase+Inhibitors%2C+Compositions+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHanney%26aufirst%3DB.%26atitle%3DTrkA%2520Kinase%2520Inhibitors%252C%2520Compositions%2520and%2520Methods%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">The Kinetics of Binding to p38 MAP Kinase by Analogues of BIRB 796</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">–</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1016%2FS0960-894X%2803%2900656-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=12941343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3101-3104&author=J.+Reganauthor=C.+A.+Pargellisauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=E.+R.+Hickeyauthor=G.+W.+Peetauthor=A.+Protoauthor=A.+Swinamerauthor=N.+Moss&title=The+Kinetics+of+Binding+to+p38+MAP+Kinase+by+Analogues+of+BIRB+796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of binding to p38 MAP kinase of analogues of BIRB 796</span></div><div class="casAuthors">Regan, John; Pargellis, Christopher A.; Cirillo, Pier F.; Gilmore, Thomas; Hickey, Eugene R.; Peet, Gregory W.; Proto, Alfred; Swinamer, Alan; Moss, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3101-3104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BIRB 796, a member of the N-pyrazole-N'-naphthyl urea class of p38 MAPK inhibitors, binds to the kinase with both slow assocn. and dissocn. rates.  Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a crit. binding domain.  We demonstrate that, independent of the loop movement, assocn. rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring.  As anticipated, the dissocn. rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions.  The value of structure-kinetic relationships (SKR) in drug design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr1jPKElIlvrVg90H21EOLACvtfcHk0lj4KYBwvCJpoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D&md5=1ca2cb661cf037790ec1b0b43a105cf3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900656-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900656-5%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DThe%2520Kinetics%2520of%2520Binding%2520to%2520p38%2520MAP%2520Kinase%2520by%2520Analogues%2520of%2520BIRB%2520796%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3101%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP Kinase by Utilizing a Novel Allosteric Binding Site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+Kinase+by+Utilizing+a+Novel+Allosteric+Binding+Site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lj4KYBwvCJpoQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520Kinase%2520by%2520Utilizing%2520a%2520Novel%2520Allosteric%2520Binding%2520Site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="note"><p class="first last">Array BioPharma recently reported on the use of a small molecule pan-Trk inhibitor in models of bone cancer and skeletal fracture pain:</p></div><div class="NLM_citation" id="cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ghilardi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Andrade, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuskowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, P. W.</span><span> </span><span class="NLM_article-title">Administration of a Tropomysin Receptor Kinase Inhibitor Attenuates Sarcoma-Induced Nerve Sprouting, Neuroma Formation and Bone Cancer Pain</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1186%2F1744-8069-6-87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=21138586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=87-97&author=J.+R.+Ghilardiauthor=K.+T.+Freemanauthor=J.+M.+Jimenez-Andradeauthor=W.+G.+Mantyhauthor=A.+P.+Bloomauthor=M.+A.+Kuskowskiauthor=P.+W.+Mantyh&title=Administration+of+a+Tropomysin+Receptor+Kinase+Inhibitor+Attenuates+Sarcoma-Induced+Nerve+Sprouting%2C+Neuroma+Formation+and+Bone+Cancer+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain</span></div><div class="casAuthors">Ghilardi, Joseph R.; Freeman, Katie T.; Jimenez-Andrade, Juan M.; Mantyh, William G.; Bloom, Aaron P.; Kuskowski, Michael A.; Mantyh, Patrick W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>CODEN:
                <span class="NLM_cas:coden">MPOAC5</span>;
        ISSN:<span class="NLM_cas:issn">1744-8069</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Pain often accompanies cancer and most current therapies for treating cancer pain have significant unwanted side effects.  Targeting nerve growth factor (NGF) or its cognate receptor tropomyosin receptor kinase A (TrkA) has become an attractive target for attenuating chronic pain.  In the present report, we use a mouse model of bone cancer pain and examine whether oral administration of a selective small mol. Trk inhibitor (ARRY-470, which blocks TrkA, TrkB and TrkC kinase activity at low nm concns.) has a significant effect on cancer-induced pain behaviors, tumor-induced remodeling of sensory nerve fibers, tumor growth and tumor-induced bone remodeling.  Early/sustained (initiated day 6 post cancer cell injection), but not late/acute (initiated day 18 post cancer cell injection) administration of ARRY-470 markedly attenuated bone cancer pain and significantly blocked the ectopic sprouting of sensory nerve fibers and the formation of neuroma-like structures in the tumor bearing bone, but did not have a significant effect on tumor growth or bone remodeling.  These data suggest that, like therapies that target the cancer itself, the earlier that the blockade of TrkA occurs, the more effective the control of cancer pain and the tumor-induced remodeling of sensory nerve fibers.  Developing targeted therapies that relieve cancer pain without the side effects of current analgesics has the potential to significantly improve the quality of life and functional status of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFTSrmfi4yxLVg90H21EOLACvtfcHk0liOrOX27HdZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrrF&md5=67b3fe45cb035787f8822389107f8896</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-6-87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-6-87%26sid%3Dliteratum%253Aachs%26aulast%3DGhilardi%26aufirst%3DJ.%2BR.%26aulast%3DFreeman%26aufirst%3DK.%2BT.%26aulast%3DJimenez-Andrade%26aufirst%3DJ.%2BM.%26aulast%3DMantyh%26aufirst%3DW.%2BG.%26aulast%3DBloom%26aufirst%3DA.%2BP.%26aulast%3DKuskowski%26aufirst%3DM.%2BA.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DAdministration%2520of%2520a%2520Tropomysin%2520Receptor%2520Kinase%2520Inhibitor%2520Attenuates%2520Sarcoma-Induced%2520Nerve%2520Sprouting%252C%2520Neuroma%2520Formation%2520and%2520Bone%2520Cancer%2520Pain%26jtitle%3DMol.%2520Pain%26date%3D2010%26volume%3D6%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ghilardi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Andrade, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhana, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuskowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, P. W.</span><span> </span><span class="NLM_article-title">Sustained Blockage of Neurotrophin Receptors TrkA, TrkB, and TrkC Reduces Non-Malignant Skeletal Pain but Not the Maintenance of Sensory and Sympathetic Nerve Fibers</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=389-398&author=J.+R.+Ghilardiauthor=K.+T.+Freemanauthor=J.+M.+Jimenez-Andradeauthor=W.+G.+Mantyhauthor=A.+P.+Bloomauthor=K.+S.+Bouhanaauthor=D.+Trollingerauthor=J.+Winklerauthor=P.+Leeauthor=S.+W.+Andrewsauthor=M.+A.+Kuskowskiauthor=P.+W.+Mantyh&title=Sustained+Blockage+of+Neurotrophin+Receptors+TrkA%2C+TrkB%2C+and+TrkC+Reduces+Non-Malignant+Skeletal+Pain+but+Not+the+Maintenance+of+Sensory+and+Sympathetic+Nerve+Fibers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhilardi%26aufirst%3DJ.%2BR.%26aulast%3DFreeman%26aufirst%3DK.%2BT.%26aulast%3DJimenez-Andrade%26aufirst%3DJ.%2BM.%26aulast%3DMantyh%26aufirst%3DW.%2BG.%26aulast%3DBloom%26aufirst%3DA.%2BP.%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26aulast%3DTrollinger%26aufirst%3DD.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DKuskowski%26aufirst%3DM.%2BA.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DSustained%2520Blockage%2520of%2520Neurotrophin%2520Receptors%2520TrkA%252C%2520TrkB%252C%2520and%2520TrkC%2520Reduces%2520Non-Malignant%2520Skeletal%2520Pain%2520but%2520Not%2520the%2520Maintenance%2520of%2520Sensory%2520and%2520Sympathetic%2520Nerve%2520Fibers%26jtitle%3DBone%26date%3D2011%26volume%3D28%26spage%3D389%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Wild, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span> </span><span class="NLM_article-title">Antibodies to Nerve Growth Factor Reverse Established Tactile Allodynia in Rodent Models of Neuropathic Pain without Tolerance</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1124%2Fjpet.106.116236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=17431136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=282-287&author=K.+D.+Wildauthor=D.+Bianauthor=D.+Zhuauthor=J.+Davisauthor=A.+W.+Bannonauthor=T.+J.+Zhangauthor=J.-C.+Louis&title=Antibodies+to+Nerve+Growth+Factor+Reverse+Established+Tactile+Allodynia+in+Rodent+Models+of+Neuropathic+Pain+without+Tolerance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance</span></div><div class="casAuthors">Wild, Kenneth D.; Bian, Di; Zhu, Dawn; Davis, James; Bannon, Anthony W.; Zhang, Tie J.; Louis, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-287</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A considerable body of evidence implicates endogenous nerve growth factor (NGF) in conditions in which pain is a prominent feature, including neuropathic pain.  However, previous studies of NGF antagonism in animal models of neuropathic pain have examd. only the prevention of hyperalgesia and allodynia after injury, whereas the more relevant issue is whether treatment can provide relief of established pain, particularly without tolerance.  In the current work, we studied the effects of potent, neutralizing anti-NGF antibodies on the reversal of tactile allodynia and thermal hyperalgesia in established models of neuropathic and inflammatory pain in rats and mice.  In the complete Freund's adjuvant-induced hind-paw inflammation, spinal nerve ligation and streptozotocin-induced neuropathic pain models, a single i.p. injection of a polyclonal anti-NGF antibody reversed established tactile allodynia from approx. day 3 to day 7 after treatment.  Effects on thermal hyperalgesia were variable with a significant effect obsd. only in the spinal nerve ligation model.  In the mouse chronic constriction injury (CCI) model, a mouse monoclonal anti-NGF antibody reversed tactile allodynia when administered 2 wk after surgery.  Repeated administration of this antibody to CCI mice for 3 wk produced a sustained reversal (days 4 to 21) of tactile allodynia that returned 5 days after the end of dosing.  In conclusion, NGF seems to play a crit. role in models of established neuropathic and inflammatory pain in both rats and mice, with no development of tolerance to antagonism.  Antagonists of NGF, such as fully human monoclonal anti-NGF antibodies, may have therapeutic utility in analogous human pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplYoeF2Jtt_7Vg90H21EOLACvtfcHk0liOrOX27HdZ-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLs%253D&md5=0fc8d32552951e9e9543f1313df8da40</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116236%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DK.%2BD.%26aulast%3DBian%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DZhang%26aufirst%3DT.%2BJ.%26aulast%3DLouis%26aufirst%3DJ.-C.%26atitle%3DAntibodies%2520to%2520Nerve%2520Growth%2520Factor%2520Reverse%2520Established%2520Tactile%2520Allodynia%2520in%2520Rodent%2520Models%2520of%2520Neuropathic%2520Pain%2520without%2520Tolerance%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D282%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':[],'ref7':[],'ref8':[],'ref9':['cit9a','cit9b'],'ref10':['cit10'],'ref11':[],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':[],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':[],'ref26':['cit26a','cit26b'],'ref27':['cit27'],'ref28':[],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32a','cit32b'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 38 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Samuel Obeng, Takato Hiranita, Francisco León, Lance R. McMahon, <span class="NLM_string-name hlFld-ContribAuthor">Christopher R. McCurdy</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Approaches, Drug Candidates, and Targets in Pain Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (10)
                                     , 6523-6548. <a href="https://doi.org/10.1021/acs.jmedchem.1c00028" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00028%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DNovel%252BApproaches%25252C%252BDrug%252BCandidates%25252C%252Band%252BTargets%252Bin%252BPain%252BDrug%252BDiscovery%26aulast%3DObeng%26aufirst%3DSamuel%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D07012021%26date%3D06052021%26volume%3D64%26issue%3D10%26spage%3D6523%26epage%3D6548" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Zhouling Xie, Xiaoxiao Yang, Yajun Duan, Jihong Han, <span class="NLM_string-name hlFld-ContribAuthor">Chenzhong Liao</span>. </span><span class="cited-content_cbyCitation_article-title">Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (3)
                                     , 1283-1345. <a href="https://doi.org/10.1021/acs.jmedchem.0c01511" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c01511</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c01511&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.0c01511%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSmall-Molecule%252BKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BNononcologic%252BDiseases%26aulast%3DXie%26aufirst%3DZhouling%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D29082020%26date%3D22012021%26volume%3D64%26issue%3D3%26spage%3D1283%26epage%3D1345" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Govindan Subramanian, Paul D. Johnson, Theresa Zachary, Nicole Roush, Yaqi Zhu, Scott J. Bowen, Ann Janssen, Brian A. Duclos, Tracey Williams, Christopher Javens, Nancy Dekki Shalaly, Daniel Martinez Molina, Arthur J. Wittwer, <span class="NLM_string-name hlFld-ContribAuthor">Jeffrey L. Hirsch</span>. </span><span class="cited-content_cbyCitation_article-title">Deciphering the Allosteric Binding Mechanism of the Human Tropomyosin Receptor Kinase A (hTrkA) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Biology</span><span> <strong>2019,</strong> <em>14 </em>
                                    (6)
                                     , 1205-1216. <a href="https://doi.org/10.1021/acschembio.9b00126" title="DOI URL">https://doi.org/10.1021/acschembio.9b00126</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschembio.9b00126&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschembio.9b00126%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Biology%26atitle%3DDeciphering%252Bthe%252BAllosteric%252BBinding%252BMechanism%252Bof%252Bthe%252BHuman%252BTropomyosin%252BReceptor%252BKinase%252BA%252B%252528hTrkA%252529%252BInhibitors%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D15022019%26date%3D06052019%26date%3D14052019%26date%3D06052019%26volume%3D14%26issue%3D6%26spage%3D1205%26epage%3D1216" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Yan, Naga Rajiv Lakkaniga, Francesca Carlomagno, Massimo Santoro, Neil Q. McDonald, Fengping Lv, Naresh Gunaganti, Brendan Frett, <span class="NLM_string-name hlFld-ContribAuthor">Hong-yu Li</span>. </span><span class="cited-content_cbyCitation_article-title">Insights into Current Tropomyosin Receptor Kinase (TRK) Inhibitors: Development and Clinical Application. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>62 </em>
                                    (4)
                                     , 1731-1760. <a href="https://doi.org/10.1021/acs.jmedchem.8b01092" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b01092</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b01092&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b01092%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DInsights%252Binto%252BCurrent%252BTropomyosin%252BReceptor%252BKinase%252B%252528TRK%252529%252BInhibitors%25253A%252BDevelopment%252Band%252BClinical%252BApplication%26aulast%3DYan%26aufirst%3DWei%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D11072018%26date%3D19092018%26date%3D06092018%26volume%3D62%26issue%3D4%26spage%3D1731%26epage%3D1760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Samo Turk, Benjamin Merget, Sameh Eid, <span class="NLM_string-name hlFld-ContribAuthor">Simone Fulle</span>. </span><span class="cited-content_cbyCitation_article-title">From Cancer to Pain Target by Automated Selectivity Inversion of a Clinical Candidate. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (11)
                                     , 4851-4859. <a href="https://doi.org/10.1021/acs.jmedchem.8b00140" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00140</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00140&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00140%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DFrom%252BCancer%252Bto%252BPain%252BTarget%252Bby%252BAutomated%252BSelectivity%252BInversion%252Bof%252Ba%252BClinical%252BCandidate%26aulast%3DTurk%26aufirst%3DSamo%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D27012018%26date%3D24052018%26date%3D10052018%26volume%3D61%26issue%3D11%26spage%3D4851%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bryan H.  Norman</span> and <span class="hlFld-ContribAuthor ">Jeff S.  McDermott</span>  . </span><span class="cited-content_cbyCitation_article-title">Targeting the Nerve Growth Factor (NGF) Pathway in Drug Discovery. Potential Applications to New Therapies for Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (1)
                                     , 66-88. <a href="https://doi.org/10.1021/acs.jmedchem.6b00964" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.6b00964</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.6b00964&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.6b00964%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTargeting%252Bthe%252BNerve%252BGrowth%252BFactor%252B%252528NGF%252529%252BPathway%252Bin%252BDrug%252BDiscovery.%252BPotential%252BApplications%252Bto%252BNew%252BTherapies%252Bfor%252BChronic%252BPain%26aulast%3DNorman%26aufirst%3DBryan%2BH.%26date%3D2017%26date%3D2016%26date%3D2016%26date%3D01072016%26date%3D25102016%26date%3D12012017%26volume%3D60%26issue%3D1%26spage%3D66%26epage%3D88" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ha-Soon  Choi</span>, <span class="hlFld-ContribAuthor ">Paul V.  Rucker</span>, <span class="hlFld-ContribAuthor ">Zhicheng  Wang</span>, <span class="hlFld-ContribAuthor ">Yi  Fan</span>, <span class="hlFld-ContribAuthor ">Pamela  Albaugh</span>, <span class="hlFld-ContribAuthor ">Greg  Chopiuk</span>, <span class="hlFld-ContribAuthor ">Francois  Gessier</span>, <span class="hlFld-ContribAuthor ">Fangxian  Sun</span>, <span class="hlFld-ContribAuthor ">Francisco  Adrian</span>, <span class="hlFld-ContribAuthor ">Guoxun  Liu</span>, <span class="hlFld-ContribAuthor ">Tami  Hood</span>, <span class="hlFld-ContribAuthor ">Nanxin  Li</span>, <span class="hlFld-ContribAuthor ">Yong  Jia</span>, <span class="hlFld-ContribAuthor ">Jianwei  Che</span>, <span class="hlFld-ContribAuthor ">Susan  McCormack</span>, <span class="hlFld-ContribAuthor ">Allen  Li</span>, <span class="hlFld-ContribAuthor ">Jie  Li</span>, <span class="hlFld-ContribAuthor ">Auzon  Steffy</span>, <span class="hlFld-ContribAuthor ">AnneMarie  Culazzo</span>, <span class="hlFld-ContribAuthor ">Celine  Tompkins</span>, <span class="hlFld-ContribAuthor ">Van  Phung</span>, <span class="hlFld-ContribAuthor ">Andreas  Kreusch</span>, <span class="hlFld-ContribAuthor ">Min  Lu</span>, <span class="hlFld-ContribAuthor ">Bin  Hu</span>, <span class="hlFld-ContribAuthor ">Apurva  Chaudhary</span>, <span class="hlFld-ContribAuthor ">Mahavir  Prashad</span>, <span class="hlFld-ContribAuthor ">Tove  Tuntland</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Jennifer  Harris</span>, <span class="hlFld-ContribAuthor ">H. Martin  Seidel</span>, <span class="hlFld-ContribAuthor ">Jon  Loren</span>, and <span class="hlFld-ContribAuthor ">Valentina  Molteni</span>  . </span><span class="cited-content_cbyCitation_article-title">(R)-2-Phenylpyrrolidine Substituted Imidazopyridazines: A New Class of Potent and Selective Pan-TRK Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>6 </em>
                                    (5)
                                     , 562-567. <a href="https://doi.org/10.1021/acsmedchemlett.5b00050" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.5b00050</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.5b00050&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.5b00050%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3D%252528R%252529-2-Phenylpyrrolidine%252BSubstituted%252BImidazopyridazines%25253A%252BA%252BNew%252BClass%252Bof%252BPotent%252Band%252BSelective%252BPan-TRK%252BInhibitors%26aulast%3DChoi%26aufirst%3DHa-Soon%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D30012015%26date%3D16032015%26date%3D19032015%26date%3D14052015%26date%3D16032015%26volume%3D6%26issue%3D5%26spage%3D562%26epage%3D567" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thin  Nguyen</span>, <span class="hlFld-ContribAuthor ">Hang  Le</span>, <span class="hlFld-ContribAuthor ">Thomas P  Quinn</span>, <span class="hlFld-ContribAuthor ">Tri  Nguyen</span>, <span class="hlFld-ContribAuthor ">Thuc Duy  Le</span>, <span class="hlFld-ContribAuthor ">Svetha  Venkatesh</span>, . </span><span class="cited-content_cbyCitation_article-title">GraphDTA: predicting drug–target binding affinity with graph neural networks. </span><span class="cited-content_cbyCitation_journal-name">Bioinformatics</span><span> <strong>2021,</strong> <em>37 </em>
                                    (8)
                                     , 1140-1147. <a href="https://doi.org/10.1093/bioinformatics/btaa921" title="DOI URL">https://doi.org/10.1093/bioinformatics/btaa921</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1093/bioinformatics/btaa921&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1093%2Fbioinformatics%2Fbtaa921%26sid%3Dliteratum%253Aachs%26jtitle%3DBioinformatics%26atitle%3DGraphDTA%25253A%252Bpredicting%252Bdrug%2525E2%252580%252593target%252Bbinding%252Baffinity%252Bwith%252Bgraph%252Bneural%252Bnetworks%26aulast%3DNguyen%26aufirst%3DThin%26date%3D2021%26date%3D2020%26volume%3D37%26issue%3D8%26spage%3D1140%26epage%3D1147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Francis  Giraud</span>, <span class="hlFld-ContribAuthor ">Elisabeth  Pereira</span>, <span class="hlFld-ContribAuthor ">Fabrice  Anizon</span>, <span class="hlFld-ContribAuthor ">Pascale  Moreau</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in Pain Management: Relevant Protein Kinases and Their Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2696. <a href="https://doi.org/10.3390/molecules26092696" title="DOI URL">https://doi.org/10.3390/molecules26092696</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092696&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092696%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252BPain%252BManagement%25253A%252BRelevant%252BProtein%252BKinases%252Band%252BTheir%252BInhibitors%26aulast%3DGiraud%26aufirst%3DFrancis%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2696" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tingting  Jiang</span>, <span class="hlFld-ContribAuthor ">Guan  Wang</span>, <span class="hlFld-ContribAuthor ">Yao  Liu</span>, <span class="hlFld-ContribAuthor ">Lu  Feng</span>, <span class="hlFld-ContribAuthor ">Meng  Wang</span>, <span class="hlFld-ContribAuthor ">Jie  Liu</span>, <span class="hlFld-ContribAuthor ">Yi  Chen</span>, <span class="hlFld-ContribAuthor ">Liang  Ouyang</span>. </span><span class="cited-content_cbyCitation_article-title">Development of small-molecule tropomyosin receptor kinase (TRK) inhibitors for NTRK fusion cancers. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2021,</strong> <em>11 </em>
                                    (2)
                                     , 355-372. <a href="https://doi.org/10.1016/j.apsb.2020.05.004" title="DOI URL">https://doi.org/10.1016/j.apsb.2020.05.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2020.05.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2020.05.004%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DDevelopment%252Bof%252Bsmall-molecule%252Btropomyosin%252Breceptor%252Bkinase%252B%252528TRK%252529%252Binhibitors%252Bfor%252BNTRK%252Bfusion%252Bcancers%26aulast%3DJiang%26aufirst%3DTingting%26date%3D2021%26volume%3D11%26issue%3D2%26spage%3D355%26epage%3D372" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franz  Hefti</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacology of nerve growth factor and discovery of tanezumab, an anti-nerve growth factor antibody and pain therapeutic. </span><span class="cited-content_cbyCitation_journal-name">Pharmacological Research</span><span> <strong>2020,</strong> <em>154 </em>, 104240. <a href="https://doi.org/10.1016/j.phrs.2019.04.024" title="DOI URL">https://doi.org/10.1016/j.phrs.2019.04.024</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.phrs.2019.04.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.phrs.2019.04.024%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmacological%2520Research%26atitle%3DPharmacology%252Bof%252Bnerve%252Bgrowth%252Bfactor%252Band%252Bdiscovery%252Bof%252Btanezumab%25252C%252Ban%252Banti-nerve%252Bgrowth%252Bfactor%252Bantibody%252Band%252Bpain%252Btherapeutic%26aulast%3DHefti%26aufirst%3DFranz%26date%3D2020%26volume%3D154%26spage%3D104240" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Rajendran  Vairagoundar</span>, <span class="hlFld-ContribAuthor ">Scott J.  Bowen</span>, <span class="hlFld-ContribAuthor ">Nicole  Roush</span>, <span class="hlFld-ContribAuthor ">Theresa  Zachary</span>, <span class="hlFld-ContribAuthor ">Christopher  Javens</span>, <span class="hlFld-ContribAuthor ">Tracey  Williams</span>, <span class="hlFld-ContribAuthor ">Ann  Janssen</span>, <span class="hlFld-ContribAuthor ">Andrea  Gonzales</span>. </span><span class="cited-content_cbyCitation_article-title">Synthetic inhibitor leads of human tropomyosin receptor kinase A (
              h
              TrkA). </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2020,</strong> <em>11 </em>
                                    (3)
                                     , 370-377. <a href="https://doi.org/10.1039/C9MD00554D" title="DOI URL">https://doi.org/10.1039/C9MD00554D</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C9MD00554D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC9MD00554D%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DSynthetic%252Binhibitor%252Bleads%252Bof%252Bhuman%252Btropomyosin%252Breceptor%252Bkinase%252BA%252B%252528%252Bh%252BTrkA%252529%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2020%26date%3D2020%26volume%3D11%26issue%3D3%26spage%3D370%26epage%3D377" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Yaqi  Zhu</span>, <span class="hlFld-ContribAuthor ">Scott J.  Bowen</span>, <span class="hlFld-ContribAuthor ">Nicole  Roush</span>, <span class="hlFld-ContribAuthor ">Julie A.  White</span>, <span class="hlFld-ContribAuthor ">Dennis  Huczek</span>, <span class="hlFld-ContribAuthor ">Theresa  Zachary</span>, <span class="hlFld-ContribAuthor ">Christopher  Javens</span>, <span class="hlFld-ContribAuthor ">Tracey  Williams</span>, <span class="hlFld-ContribAuthor ">Ann  Janssen</span>, <span class="hlFld-ContribAuthor ">Andrea  Gonzales</span>. </span><span class="cited-content_cbyCitation_article-title">Lead identification and characterization of hTrkA type 2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (22)
                                     , 126680. <a href="https://doi.org/10.1016/j.bmcl.2019.126680" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126680</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126680%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DLead%252Bidentification%252Band%252Bcharacterization%252Bof%252BhTrkA%252Btype%252B2%252Binhibitors%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2019%26volume%3D29%26issue%3D22%26spage%3D126680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Govindan  Subramanian</span>, <span class="hlFld-ContribAuthor ">Scott J.  Bowen</span>, <span class="hlFld-ContribAuthor ">Yaqi  Zhu</span>, <span class="hlFld-ContribAuthor ">Nicole  Roush</span>, <span class="hlFld-ContribAuthor ">Theresa  Zachary</span>, <span class="hlFld-ContribAuthor ">Christopher  Javens</span>, <span class="hlFld-ContribAuthor ">Tracey  Williams</span>, <span class="hlFld-ContribAuthor ">Ann  Janssen</span>, <span class="hlFld-ContribAuthor ">Andrea  Gonzales</span>. </span><span class="cited-content_cbyCitation_article-title">Type 2 inhibitor leads of human tropomyosin receptor kinase (hTrkA). </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (19)
                                     , 126624. <a href="https://doi.org/10.1016/j.bmcl.2019.126624" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.126624</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.126624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.126624%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DType%252B2%252Binhibitor%252Bleads%252Bof%252Bhuman%252Btropomyosin%252Breceptor%252Bkinase%252B%252528hTrkA%252529%26aulast%3DSubramanian%26aufirst%3DGovindan%26date%3D2019%26volume%3D29%26issue%3D19%26spage%3D126624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Andrew V.  Mossine</span>, <span class="hlFld-ContribAuthor ">Peter J. H.  Scott</span>, <span class="hlFld-ContribAuthor ">Lena  Kaiser</span>, <span class="hlFld-ContribAuthor ">Peter  Bartenstein</span>, <span class="hlFld-ContribAuthor ">Simon  Lindner</span>, <span class="hlFld-ContribAuthor ">David R.  Kaplan</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Gert  Fricker</span>, <span class="hlFld-ContribAuthor ">Anne  Mahringer</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Esther  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Carmen  Wängler</span>, <span class="hlFld-ContribAuthor ">Björn  Wängler</span>, <span class="hlFld-ContribAuthor ">Alexander  Thiel</span>, <span class="hlFld-ContribAuthor ">Jean-Paul  Soucy</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceuticals</span><span> <strong>2019,</strong> <em>12 </em>
                                    (1)
                                     , 7. <a href="https://doi.org/10.3390/ph12010007" title="DOI URL">https://doi.org/10.3390/ph12010007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ph12010007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fph12010007%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceuticals%26atitle%3DRadioligands%252Bfor%252BTropomyosin%252BReceptor%252BKinase%252B%252528Trk%252529%252BPositron%252BEmission%252BTomography%252BImaging%26aulast%3DSchirrmacher%26aufirst%3DRalf%26date%3D2019%26date%3D2019%26volume%3D12%26issue%3D1%26spage%3D7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wendy A.  Loughlin</span>, <span class="hlFld-ContribAuthor ">Asmaa  Boufridi</span>. </span><span class="cited-content_cbyCitation_article-title">6-6 Bicyclic Systems: Three Heteroatoms 1:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,<a href="https://doi.org/10.1016/B978-0-12-409547-2.14794-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-409547-2.14794-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-409547-2.14794-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-409547-2.14794-8%26sid%3Dliteratum%253Aachs%26atitle%3D6-6%252BBicyclic%252BSystems%25253A%252BThree%252BHeteroatoms%252B1%25253A2%26aulast%3DLoughlin%26aufirst%3DWendy%2BA.%26date%3D2019%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alan David  Kaye</span>, <span class="hlFld-ContribAuthor ">Elyse M.  Cornett</span>, <span class="hlFld-ContribAuthor ">Brendon  Hart</span>, <span class="hlFld-ContribAuthor ">Shilpadevi  Patil</span>, <span class="hlFld-ContribAuthor ">Andrew  Pham</span>, <span class="hlFld-ContribAuthor ">Matthew  Spalitta</span>, <span class="hlFld-ContribAuthor ">Kenneth F.  Mancuso</span>. </span><span class="cited-content_cbyCitation_article-title">Novel Pharmacological Nonopioid Therapies in Chronic Pain. </span><span class="cited-content_cbyCitation_journal-name">Current Pain and Headache Reports</span><span> <strong>2018,</strong> <em>22 </em>
                                    (4)
                                     <a href="https://doi.org/10.1007/s11916-018-0674-8" title="DOI URL">https://doi.org/10.1007/s11916-018-0674-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11916-018-0674-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11916-018-0674-8%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Pain%2520and%2520Headache%2520Reports%26atitle%3DNovel%252BPharmacological%252BNonopioid%252BTherapies%252Bin%252BChronic%252BPain%26aulast%3DKaye%26aufirst%3DAlan%2BDavid%26date%3D2018%26date%3D2018%26volume%3D22%26issue%3D4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rand  Shahin</span>, <span class="hlFld-ContribAuthor ">Iman  Mansi</span>, <span class="hlFld-ContribAuthor ">Lubna  Swellmeen</span>, <span class="hlFld-ContribAuthor ">Tahani  Alwidyan</span>, <span class="hlFld-ContribAuthor ">Nabil  Al-Hashimi</span>, <span class="hlFld-ContribAuthor ">Yaser  Al-Qarar’h</span>, <span class="hlFld-ContribAuthor ">Omar  Shaheen</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand-based computer aided drug design reveals new tropomycin receptor kinase a (TrkA) inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2018,</strong> <em>80 </em>, 327-352. <a href="https://doi.org/10.1016/j.jmgm.2018.01.004" title="DOI URL">https://doi.org/10.1016/j.jmgm.2018.01.004</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2018.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2018.01.004%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DLigand-based%252Bcomputer%252Baided%252Bdrug%252Bdesign%252Breveals%252Bnew%252Btropomycin%252Breceptor%252Bkinase%252Ba%252B%252528TrkA%252529%252Binhibitors%26aulast%3DShahin%26aufirst%3DRand%26date%3D2018%26volume%3D80%26spage%3D327%26epage%3D352" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Neha  Sami</span>, <span class="hlFld-ContribAuthor ">Vijay  Kumar</span>, <span class="hlFld-ContribAuthor ">Asimul  Islam</span>, <span class="hlFld-ContribAuthor ">Sher  Ali</span>, <span class="hlFld-ContribAuthor ">Faizan  Ahmad</span>, <span class="hlFld-ContribAuthor ">Imtaiyaz  Hassan</span>. </span><span class="cited-content_cbyCitation_article-title">Exploring Missense Mutations in Tyrosine Kinases Implicated with Neurodegeneration. </span><span class="cited-content_cbyCitation_journal-name">Molecular Neurobiology</span><span> <strong>2017,</strong> <em>54 </em>
                                    (7)
                                     , 5085-5106. <a href="https://doi.org/10.1007/s12035-016-0046-5" title="DOI URL">https://doi.org/10.1007/s12035-016-0046-5</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s12035-016-0046-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs12035-016-0046-5%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Neurobiology%26atitle%3DExploring%252BMissense%252BMutations%252Bin%252BTyrosine%252BKinases%252BImplicated%252Bwith%252BNeurodegeneration%26aulast%3DSami%26aufirst%3DNeha%26date%3D2017%26date%3D2016%26volume%3D54%26issue%3D7%26spage%3D5085%26epage%3D5106" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Franziska  Denk</span>, <span class="hlFld-ContribAuthor ">David L.  Bennett</span>, <span class="hlFld-ContribAuthor ">Stephen B.  McMahon</span>. </span><span class="cited-content_cbyCitation_article-title">Nerve Growth Factor and Pain Mechanisms. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Neuroscience</span><span> <strong>2017,</strong> <em>40 </em>
                                    (1)
                                     , 307-325. <a href="https://doi.org/10.1146/annurev-neuro-072116-031121" title="DOI URL">https://doi.org/10.1146/annurev-neuro-072116-031121</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-neuro-072116-031121&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-neuro-072116-031121%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Neuroscience%26atitle%3DNerve%252BGrowth%252BFactor%252Band%252BPain%252BMechanisms%26aulast%3DDenk%26aufirst%3DFranziska%26date%3D2017%26volume%3D40%26issue%3D1%26spage%3D307%26epage%3D325" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Kristen  Farrell</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –
              Part II. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (7)
                                     , 831-849. <a href="https://doi.org/10.1080/13543776.2017.1297797" title="DOI URL">https://doi.org/10.1080/13543776.2017.1297797</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1297797&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1297797%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252Bfor%252B2010-2016%252B%2525E2%252580%252593%252BPart%252BII%26aulast%3DBailey%26aufirst%3DJustin%2BJ.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D7%26spage%3D831%26epage%3D849" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>, <span class="hlFld-ContribAuthor ">Kristen  Farrell</span>, <span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>. </span><span class="cited-content_cbyCitation_article-title">Tropomyosin receptor kinase inhibitors: an updated patent review for 2010-2016 –
              Part I. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2017,</strong> <em>27 </em>
                                    (6)
                                     , 733-751. <a href="https://doi.org/10.1080/13543776.2017.1297796" title="DOI URL">https://doi.org/10.1080/13543776.2017.1297796</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/13543776.2017.1297796&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F13543776.2017.1297796%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DTropomyosin%252Breceptor%252Bkinase%252Binhibitors%25253A%252Ban%252Bupdated%252Bpatent%252Breview%252Bfor%252B2010-2016%252B%2525E2%252580%252593%252BPart%252BI%26aulast%3DBailey%26aufirst%3DJustin%2BJ.%26date%3D2017%26date%3D2017%26volume%3D27%26issue%3D6%26spage%3D733%26epage%3D751" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eric A.  Price</span>, <span class="hlFld-ContribAuthor ">Alicja  Krasowska-Zoladek</span>, <span class="hlFld-ContribAuthor ">Kausik K.  Nanda</span>, <span class="hlFld-ContribAuthor ">Shawn J.  Stachel</span>, <span class="hlFld-ContribAuthor ">Darrell A.  Henze</span>. </span><span class="cited-content_cbyCitation_article-title">Development of a pharmacodynamic biomarker to measure target engagement from inhibition of the NGF–TrkA pathway. </span><span class="cited-content_cbyCitation_journal-name">Journal of Neuroscience Methods</span><span> <strong>2017,</strong> <em>282 </em>, 34-42. <a href="https://doi.org/10.1016/j.jneumeth.2017.03.001" title="DOI URL">https://doi.org/10.1016/j.jneumeth.2017.03.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jneumeth.2017.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jneumeth.2017.03.001%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Neuroscience%2520Methods%26atitle%3DDevelopment%252Bof%252Ba%252Bpharmacodynamic%252Bbiomarker%252Bto%252Bmeasure%252Btarget%252Bengagement%252Bfrom%252Binhibition%252Bof%252Bthe%252BNGF%2525E2%252580%252593TrkA%252Bpathway%26aulast%3DPrice%26aufirst%3DEric%2BA.%26date%3D2017%26volume%3D282%26spage%3D34%26epage%3D42" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Noritaka  Furuya</span>, <span class="hlFld-ContribAuthor ">Takaki  Momose</span>, <span class="hlFld-ContribAuthor ">Kenji  Katsuno</span>, <span class="hlFld-ContribAuthor ">Nobuhiko  Fushimi</span>, <span class="hlFld-ContribAuthor ">Hideyuki  Muranaka</span>, <span class="hlFld-ContribAuthor ">Chiaki  Handa</span>, <span class="hlFld-ContribAuthor ">Tomonaga  Ozawa</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Kinoshita</span>. </span><span class="cited-content_cbyCitation_article-title">The juxtamembrane region of TrkA kinase is critical for inhibitor selectivity. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2017,</strong> <em>27 </em>
                                    (5)
                                     , 1233-1236. <a href="https://doi.org/10.1016/j.bmcl.2017.01.056" title="DOI URL">https://doi.org/10.1016/j.bmcl.2017.01.056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2017.01.056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2017.01.056%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DThe%252Bjuxtamembrane%252Bregion%252Bof%252BTrkA%252Bkinase%252Bis%252Bcritical%252Bfor%252Binhibitor%252Bselectivity%26aulast%3DFuruya%26aufirst%3DNoritaka%26date%3D2017%26volume%3D27%26issue%3D5%26spage%3D1233%26epage%3D1236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daehyun  Kim</span>, <span class="hlFld-ContribAuthor ">Jung Youl  Park</span>, <span class="hlFld-ContribAuthor ">Ji-Hyun  Kim</span>. </span><span class="cited-content_cbyCitation_article-title">Docking-based
              In Silico
              Screening for Identification of Micromolar Inhibitors of Tropomyosin-related Kinase A from Natural Origin. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2017,</strong> <em>38 </em>
                                    (2)
                                     , 205-210. <a href="https://doi.org/10.1002/bkcs.11064" title="DOI URL">https://doi.org/10.1002/bkcs.11064</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.11064&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.11064%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DDocking-based%252BIn%252BSilico%252BScreening%252Bfor%252BIdentification%252Bof%252BMicromolar%252BInhibitors%252Bof%252BTropomyosin-related%252BKinase%252BA%252Bfrom%252BNatural%252BOrigin%26aulast%3DKim%26aufirst%3DDaehyun%26date%3D2017%26date%3D2017%26volume%3D38%26issue%3D2%26spage%3D205%26epage%3D210" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hua-Poo  Su</span>, <span class="hlFld-ContribAuthor ">Keith  Rickert</span>, <span class="hlFld-ContribAuthor ">Christine  Burlein</span>, <span class="hlFld-ContribAuthor ">Kartik  Narayan</span>, <span class="hlFld-ContribAuthor ">Marina  Bukhtiyarova</span>, <span class="hlFld-ContribAuthor ">Danielle M.  Hurzy</span>, <span class="hlFld-ContribAuthor ">Craig A.  Stump</span>, <span class="hlFld-ContribAuthor ">Xufang  Zhang</span>, <span class="hlFld-ContribAuthor ">John  Reid</span>, <span class="hlFld-ContribAuthor ">Alicja  Krasowska-Zoladek</span>, <span class="hlFld-ContribAuthor ">Srivanya  Tummala</span>, <span class="hlFld-ContribAuthor ">Jennifer M.  Shipman</span>, <span class="hlFld-ContribAuthor ">Maria  Kornienko</span>, <span class="hlFld-ContribAuthor ">Peter A.  Lemaire</span>, <span class="hlFld-ContribAuthor ">Daniel  Krosky</span>, <span class="hlFld-ContribAuthor ">Amanda  Heller</span>, <span class="hlFld-ContribAuthor ">Abdelghani  Achab</span>, <span class="hlFld-ContribAuthor ">Chad  Chamberlin</span>, <span class="hlFld-ContribAuthor ">Peter  Saradjian</span>, <span class="hlFld-ContribAuthor ">Berengere  Sauvagnat</span>, <span class="hlFld-ContribAuthor ">Xianshu  Yang</span>, <span class="hlFld-ContribAuthor ">Michael R.  Ziebell</span>, <span class="hlFld-ContribAuthor ">Elliott  Nickbarg</span>, <span class="hlFld-ContribAuthor ">John M.  Sanders</span>, <span class="hlFld-ContribAuthor ">Mark T.  Bilodeau</span>, <span class="hlFld-ContribAuthor ">Steven S.  Carroll</span>, <span class="hlFld-ContribAuthor ">Kevin J.  Lumb</span>, <span class="hlFld-ContribAuthor ">Stephen M.  Soisson</span>, <span class="hlFld-ContribAuthor ">Darrell A.  Henze</span>, <span class="hlFld-ContribAuthor ">Andrew J.  Cooke</span>. </span><span class="cited-content_cbyCitation_article-title">Structural characterization of nonactive site, TrkA-selective kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Proceedings of the National Academy of Sciences</span><span> <strong>2017,</strong> <em>114 </em>
                                    (3)
                                     , E297-E306. <a href="https://doi.org/10.1073/pnas.1611577114" title="DOI URL">https://doi.org/10.1073/pnas.1611577114</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1073/pnas.1611577114&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1073%2Fpnas.1611577114%26sid%3Dliteratum%253Aachs%26jtitle%3DProceedings%2520of%2520the%2520National%2520Academy%2520of%2520Sciences%26atitle%3DStructural%252Bcharacterization%252Bof%252Bnonactive%252Bsite%25252C%252BTrkA-selective%252Bkinase%252Binhibitors%26aulast%3DSu%26aufirst%3DHua-Poo%26date%3D2017%26date%3D2016%26volume%3D114%26issue%3D3%26spage%3DE297%26epage%3DE306" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">T.  Bertrand</span>. </span><span class="cited-content_cbyCitation_article-title">Crystal Structures of Neurotrophin Receptors Kinase Domain. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2017,</strong>,, 1-18. <a href="https://doi.org/10.1016/bs.vh.2016.10.001" title="DOI URL">https://doi.org/10.1016/bs.vh.2016.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/bs.vh.2016.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fbs.vh.2016.10.001%26sid%3Dliteratum%253Aachs%26atitle%3DCrystal%252BStructures%252Bof%252BNeurotrophin%252BReceptors%252BKinase%252BDomain%26aulast%3DBertrand%26aufirst%3DT.%26date%3D2017%26spage%3D1%26epage%3D18%26pub%3DElsevier%26atitle%3DNeurotrophins%26date%3D2017%26volume%3D104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Ghilsoo  Nam</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Nanomolar Multikinase Inhibitor (KST016366): A New Benzothiazole Derivative with Remarkable Broad-Spectrum Antiproliferative Activity. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2016,</strong> <em>11 </em>
                                    (15)
                                     , 1587-1595. <a href="https://doi.org/10.1002/cmdc.201600224" title="DOI URL">https://doi.org/10.1002/cmdc.201600224</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201600224&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201600224%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDiscovery%252Bof%252Ba%252BNanomolar%252BMultikinase%252BInhibitor%252B%252528KST016366%252529%25253A%252BA%252BNew%252BBenzothiazole%252BDerivative%252Bwith%252BRemarkable%252BBroad-Spectrum%252BAntiproliferative%252BActivity%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2016%26date%3D2016%26volume%3D11%26issue%3D15%26spage%3D1587%26epage%3D1595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hyeonjeong  Choe</span>, <span class="hlFld-ContribAuthor ">You Hwa  Son</span>, <span class="hlFld-ContribAuthor ">Byung Jin  Byun</span>, <span class="hlFld-ContribAuthor ">Sang Un  Choi</span>, <span class="hlFld-ContribAuthor ">Kwangho  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Identification of Pyrrole[3,4-c]pyrazoles as Potent Tropomyosin Receptor Kinase A (TrkA) Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bulletin of the Korean Chemical Society</span><span> <strong>2016,</strong> <em>37 </em>
                                    (8)
                                     , 1378-1380. <a href="https://doi.org/10.1002/bkcs.10862" title="DOI URL">https://doi.org/10.1002/bkcs.10862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/bkcs.10862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fbkcs.10862%26sid%3Dliteratum%253Aachs%26jtitle%3DBulletin%2520of%2520the%2520Korean%2520Chemical%2520Society%26atitle%3DIdentification%252Bof%252BPyrrole%25255B3%25252C4-c%25255Dpyrazoles%252Bas%252BPotent%252BTropomyosin%252BReceptor%252BKinase%252BA%252B%252528TrkA%252529%252BInhibitors%26aulast%3DChoe%26aufirst%3DHyeonjeong%26date%3D2016%26date%3D2016%26volume%3D37%26issue%3D8%26spage%3D1378%26epage%3D1380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ashraf Kareem  El-Damasy</span>, <span class="hlFld-ContribAuthor ">Nam-Chul  Cho</span>, <span class="hlFld-ContribAuthor ">Ae Nim  Pae</span>, <span class="hlFld-ContribAuthor ">Eunice Eunkyeong  Kim</span>, <span class="hlFld-ContribAuthor ">Gyochang  Keum</span>. </span><span class="cited-content_cbyCitation_article-title">Novel 5-substituted-2-anilinoquinolines with 3-(morpholino or 4-methylpiperazin-1-yl)propoxy moiety as broad spectrum antiproliferative agents: Synthesis, cell based assays and kinase screening. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (14)
                                     , 3307-3312. <a href="https://doi.org/10.1016/j.bmcl.2016.05.047" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.05.047</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.05.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.05.047%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNovel%252B5-substituted-2-anilinoquinolines%252Bwith%252B3-%252528morpholino%252Bor%252B4-methylpiperazin-1-yl%252529propoxy%252Bmoiety%252Bas%252Bbroad%252Bspectrum%252Bantiproliferative%252Bagents%25253A%252BSynthesis%25252C%252Bcell%252Bbased%252Bassays%252Band%252Bkinase%252Bscreening%26aulast%3DEl-Damasy%26aufirst%3DAshraf%2BKareem%26date%3D2016%26volume%3D26%26issue%3D14%26spage%3D3307%26epage%3D3312" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Andrea  Wolkerstorfer</span>, <span class="hlFld-ContribAuthor ">Norbert  Handler</span>, <span class="hlFld-ContribAuthor ">Helmut  Buschmann</span>. </span><span class="cited-content_cbyCitation_article-title">New approaches to treating pain. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (4)
                                     , 1103-1119. <a href="https://doi.org/10.1016/j.bmcl.2015.12.103" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.12.103</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.12.103&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.12.103%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DNew%252Bapproaches%252Bto%252Btreating%252Bpain%26aulast%3DWolkerstorfer%26aufirst%3DAndrea%26date%3D2016%26volume%3D26%26issue%3D4%26spage%3D1103%26epage%3D1119" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Munetaka  Hirose</span>, <span class="hlFld-ContribAuthor ">Yoshihiro  Kuroda</span>, <span class="hlFld-ContribAuthor ">Eri  Murata</span>. </span><span class="cited-content_cbyCitation_article-title">NGF/TrkA Signaling as a Therapeutic Target for Pain. </span><span class="cited-content_cbyCitation_journal-name">Pain Practice</span><span> <strong>2016,</strong> <em>16 </em>
                                    (2)
                                     , 175-182. <a href="https://doi.org/10.1111/papr.12342" title="DOI URL">https://doi.org/10.1111/papr.12342</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/papr.12342&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fpapr.12342%26sid%3Dliteratum%253Aachs%26jtitle%3DPain%2520Practice%26atitle%3DNGF%25252FTrkA%252BSignaling%252Bas%252Ba%252BTherapeutic%252BTarget%252Bfor%252BPain%26aulast%3DHirose%26aufirst%3DMunetaka%26date%3D2016%26date%3D2015%26volume%3D16%26issue%3D2%26spage%3D175%26epage%3D182" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of WO2015042088 A1 - a novel urea-based scaffold for TrkA inhibition. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2016,</strong> <em>26 </em>
                                    (2)
                                     , 291-295. <a href="https://doi.org/10.1517/13543776.2016.1118062" title="DOI URL">https://doi.org/10.1517/13543776.2016.1118062</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2016.1118062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2016.1118062%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEvaluation%252Bof%252BWO2015042088%252BA1%252B-%252Ba%252Bnovel%252Burea-based%252Bscaffold%252Bfor%252BTrkA%252Binhibition%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2016%26date%3D2015%26volume%3D26%26issue%3D2%26spage%3D291%26epage%3D295" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin J.  Bailey</span>, <span class="hlFld-ContribAuthor ">Arturo  Aliaga</span>, <span class="hlFld-ContribAuthor ">Alexey  Kostikov</span>, <span class="hlFld-ContribAuthor ">Pedro  Rosa-Neto</span>, <span class="hlFld-ContribAuthor ">Melinda  Wuest</span>, <span class="hlFld-ContribAuthor ">Garrett M.  Brodeur</span>, <span class="hlFld-ContribAuthor ">Barry J.  Bedell</span>, <span class="hlFld-ContribAuthor ">Frank  Wuest</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Development of subnanomolar radiofluorinated (2-pyrrolidin-1-yl)imidazo[1,2-
              b
              ]pyridazine pan-Trk inhibitors as candidate PET imaging probes. </span><span class="cited-content_cbyCitation_journal-name">MedChemComm</span><span> <strong>2015,</strong> <em>6 </em>
                                    (12)
                                     , 2184-2193. <a href="https://doi.org/10.1039/C5MD00388A" title="DOI URL">https://doi.org/10.1039/C5MD00388A</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MD00388A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MD00388A%26sid%3Dliteratum%253Aachs%26jtitle%3DMedChemComm%26atitle%3DDevelopment%252Bof%252Bsubnanomolar%252Bradiofluorinated%252B%2525282-pyrrolidin-1-yl%252529imidazo%25255B1%25252C2-%252Bb%252B%25255Dpyridazine%252Bpan-Trk%252Binhibitors%252Bas%252Bcandidate%252BPET%252Bimaging%252Bprobes%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2015%26volume%3D6%26issue%3D12%26spage%3D2184%26epage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vadim  Bernard-Gauthier</span>, <span class="hlFld-ContribAuthor ">Justin  Bailey</span>, <span class="hlFld-ContribAuthor ">Sheldon  Berke</span>, <span class="hlFld-ContribAuthor ">Ralf  Schirrmacher</span>. </span><span class="cited-content_cbyCitation_article-title">Recent Advances in the Development and Application of Radiolabeled Kinase Inhibitors for PET Imaging. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (12)
                                     , 22000-22027. <a href="https://doi.org/10.3390/molecules201219816" title="DOI URL">https://doi.org/10.3390/molecules201219816</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201219816&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201219816%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DRecent%252BAdvances%252Bin%252Bthe%252BDevelopment%252Band%252BApplication%252Bof%252BRadiolabeled%252BKinase%252BInhibitors%252Bfor%252BPET%252BImaging%26aulast%3DBernard-Gauthier%26aufirst%3DVadim%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D12%26spage%3D22000%26epage%3D22027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yujeong  Jeong</span>, <span class="hlFld-ContribAuthor ">Sang Min  Lim</span>, <span class="hlFld-ContribAuthor ">Sungwoo  Hong</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of wrightiadione as a novel template for the TrkA kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (22)
                                     , 5186-5189. <a href="https://doi.org/10.1016/j.bmcl.2015.09.070" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.070</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.070&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.070%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Bwrightiadione%252Bas%252Ba%252Bnovel%252Btemplate%252Bfor%252Bthe%252BTrkA%252Bkinase%252Binhibitors%26aulast%3DJeong%26aufirst%3DYujeong%26date%3D2015%26volume%3D25%26issue%3D22%26spage%3D5186%26epage%3D5189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Doohyun  Lee</span>, <span class="hlFld-ContribAuthor ">Daehun  Kim</span>, <span class="hlFld-ContribAuthor ">Seungyeon  Lee</span>, <span class="hlFld-ContribAuthor ">Taegeum  Kim</span>, <span class="hlFld-ContribAuthor ">Joobin  Kim</span>, <span class="hlFld-ContribAuthor ">Sohee  Kim</span>, <span class="hlFld-ContribAuthor ">Kwang-Hyeon  Liu</span>, <span class="hlFld-ContribAuthor ">Sangkyu  Lee</span>, <span class="hlFld-ContribAuthor ">Jong-Sup  Bae</span>, <span class="hlFld-ContribAuthor ">Kyung-Sik  Song</span>, <span class="hlFld-ContribAuthor ">Chang-Woo  Cho</span>, <span class="hlFld-ContribAuthor ">Youn  Son</span>, <span class="hlFld-ContribAuthor ">Dong  Baek</span>, <span class="hlFld-ContribAuthor ">Taeho  Lee</span>. </span><span class="cited-content_cbyCitation_article-title">Efficient Syntheses of 1,2,3-Triazoloamide Derivatives Using Solid- and Solution-Phase Synthetic Approaches. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2015,</strong> <em>20 </em>
                                    (11)
                                     , 19984-20013. <a href="https://doi.org/10.3390/molecules201119673" title="DOI URL">https://doi.org/10.3390/molecules201119673</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules201119673&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules201119673%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DEfficient%252BSyntheses%252Bof%252B1%25252C2%25252C3-Triazoloamide%252BDerivatives%252BUsing%252BSolid-%252Band%252BSolution-Phase%252BSynthetic%252BApproaches%26aulast%3DLee%26aufirst%3DDoohyun%26date%3D2015%26date%3D2015%26volume%3D20%26issue%3D11%26spage%3D19984%26epage%3D20013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lei  Wang</span>, <span class="hlFld-ContribAuthor ">Ning  Liu</span>, <span class="hlFld-ContribAuthor ">Bin  Dai</span>. </span><span class="cited-content_cbyCitation_article-title">Metal-free site-selective C–N bond-forming reaction of polyhalogenated pyridines and pyrimidines. </span><span class="cited-content_cbyCitation_journal-name">RSC Advances</span><span> <strong>2015,</strong> <em>5 </em>
                                    (100)
                                     , 82097-82111. <a href="https://doi.org/10.1039/C5RA18653F" title="DOI URL">https://doi.org/10.1039/C5RA18653F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5RA18653F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5RA18653F%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Advances%26atitle%3DMetal-free%252Bsite-selective%252BC%2525E2%252580%252593N%252Bbond-forming%252Breaction%252Bof%252Bpolyhalogenated%252Bpyridines%252Band%252Bpyrimidines%26aulast%3DWang%26aufirst%3DLei%26date%3D2015%26date%3D2015%26volume%3D5%26issue%3D100%26spage%3D82097%26epage%3D82111" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0020.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0001.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. HTS leads.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0002.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Crystal structure of <b>1</b> with TrkA. The compound binds in a DFG-in conformation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0003.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Hydrogen bonding interactions of <b>1</b> within the active site of TrkA.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0011.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Evolution of Pyridopyrimidine HTS Lead <b>1</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0012.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Synthetic Route for Compound <b>6</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (<i>S</i>)-2-(2,5-difluorophenyl)pyrrolidine, EtOH, 69%; (b) POCl<sub>3</sub>, 70%; (c) 1-(1<i>H</i>-benzimidazol-2-yl)methanamine, EtOH, 58%.</p></p></figure><figure data-id="fig4" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0004.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Hinge-binding interactions of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0005.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. DFG-out binding of <b>2</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0013.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Evolution of Triazole HTS Lead <b>2</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0014.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Synthetic Route for Compound <b>11</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Imidazole, <span class="smallcaps smallerCapital">l</span>-proline, CuI, K<sub>2</sub>CO<sub>3</sub>, DMSO, 61%; (b) TMS–acetylene, PdCl<sub>2</sub>(PPh<sub>3</sub>)<sub>2</sub>, CuI, Et<sub>3</sub>N, DMF, 78%; (c) KF, MeOH, 100%; (d) 2-chloroacetyl chloride, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 72%; (e) NaN<sub>3</sub>, EtOH, 92%; (f) Cu powder, CH<sub>2</sub>Cl<sub>2</sub>–<i>t</i>-BuOH, H<sub>2</sub>O, aq CuSO<sub>4</sub>, 72%.</p></p></figure><figure data-id="fig6" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0006.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. (a) Crystal structure of <b>3</b> bound with TrkA. (b) Hinge-binding interactions of <b>3</b>. (c) View of <b>3</b> bound in the selectivity pocket.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch5" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0015.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 5. SAR Progression of HTS Lead <b>3</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch6" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Scheme 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0016.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0016.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 6. Synthetic Route for Compound <b>18</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch6"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) Isopropylamine, NaCNBH<sub>3</sub>, MeOH; (b) 1-isocyanato-4-(trifluoromethoxy)benzene, THF, 98% over two steps.</p></p></figure><figure data-id="fig7" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0007.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Binding pose of <b>4</b> in the TrkA active site.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0008.jpeg" id="rightTab-gr17" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. View of stabilizing interaction of inactive conformation.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch7" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Scheme 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0017.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 7. SAR Progression of HTS Lead <b>4</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch8" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Scheme 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0018.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 8. Optimization of Hinge Binding Interaction with Azaindole Series</div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch9" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Scheme 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0019.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 9. Synthetic Route for Compound <b>24</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=sch9"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) 3-Ethoxyphenylboronic acid, Pd(OAc)<sub>2</sub>, XPhos, KF, 1,4 dioxane 73%; (b) NaH, 2-bromophenyl ether, DMF, 1 N NaOH; (c) 2 N NaOH, 75% over two steps.</p></p></figure><figure data-id="fig9" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0009.jpeg" id="rightTab-gr18" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. CFA-induced mechanical hypersensitivity assay (inflammatory pain) with compound <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/medium/jm-2014-006429_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0010.jpeg" id="rightTab-gr19" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Spinal nerve ligation assay (neuropathic pain) after oral dosing of compound <b>11</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2014/jmcmar.2014.57.issue-13/jm5006429/production/images/large/jm-2014-006429_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm5006429&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i54">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_06404" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_06404" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group">Manning, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whyte, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martinez, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hunter, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sudarsanam, S.</span><span> </span><span class="NLM_article-title">The Protein Kinase Compliment of the Human Genome</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">298</span><span class="NLM_x">, </span> <span class="NLM_fpage">1912</span><span class="NLM_x">–</span> <span class="NLM_lpage">1934</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=298&publication_year=2002&pages=1912-1934&author=G.+Manningauthor=D.+B.+Whyteauthor=R.+Martinezauthor=T.+Hunterauthor=S.+Sudarsanam&title=The+Protein+Kinase+Compliment+of+the+Human+Genome"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DManning%26aufirst%3DG.%26aulast%3DWhyte%26aufirst%3DD.%2BB.%26aulast%3DMartinez%26aufirst%3DR.%26aulast%3DHunter%26aufirst%3DT.%26aulast%3DSudarsanam%26aufirst%3DS.%26atitle%3DThe%2520Protein%2520Kinase%2520Compliment%2520of%2520the%2520Human%2520Genome%26jtitle%3DScience%26date%3D2002%26volume%3D298%26spage%3D1912%26epage%3D1934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">Reichardt, L. F.</span><span> </span><span class="NLM_article-title">Neurotrophin-Regulated Signalling Pathways</span> <span class="citation_source-journal">Philos. Trans. R. Soc. B</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">361</span><span class="NLM_x">, </span> <span class="NLM_fpage">1545</span><span class="NLM_x">–</span> <span class="NLM_lpage">1564</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1098%2Frstb.2006.1894" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=16939974" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFakurfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=361&publication_year=2006&pages=1545-1564&author=L.+F.+Reichardt&title=Neurotrophin-Regulated+Signalling+Pathways"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Neurotrophin-regulated signalling pathways</span></div><div class="casAuthors">Reichardt, Louis F.</div><div class="citationInfo"><span class="NLM_cas:title">Philosophical Transactions of the Royal Society, B: Biological Sciences</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">361</span>
        (<span class="NLM_cas:issue">1473</span>),
    <span class="NLM_cas:pages">1545-1564</span>CODEN:
                <span class="NLM_cas:coden">PTRBAE</span>;
        ISSN:<span class="NLM_cas:issn">0962-8436</span>.
    
            (<span class="NLM_cas:orgname">Royal Society</span>)
        </div><div class="casAbstract">A review.  Neurotrophins are a family of closely related proteins that were identified initially as survival factors for sensory and sympathetic neurons, and have since been shown to control many aspects of survival, development and function of neurons in both the peripheral and the central nervous systems.  Each of the four mammalian neurotrophins has been shown to activate one or more of the three members of the tropomyosin-related kinase (Trk) family of receptor tyrosine kinases (TrkA, TrkB and TrkC).  In addn., each neurotrophin activates p75 neurotrophin receptor (p75NTR), a member of the tumor necrosis factor receptor superfamily.  Through Trk receptors, neurotrophins activate Ras, phosphatidyl inositol-3 (PI3)-kinase, phospholipase C-γ1 and signalling pathways controlled through these proteins, such as the MAP kinases.  Activation of p75NTR results in activation of the nuclear factor-κB (NF-κB) and Jun kinase as well as other signalling pathways.  Limiting quantities of neurotrophins during development control the no. of surviving neurons to ensure a match between neurons and the requirement for a suitable d. of target innervation.  The neurotrophins also regulate cell fate decisions, axon growth, dendrite growth and pruning and the expression of proteins, such as ion channels, transmitter biosynthetic enzymes and neuropeptide transmitters that are essential for normal neuronal function.  Continued presence of the neurotrophins is required in the adult nervous system, where they control synaptic function and plasticity, and sustain neuronal survival, morphol. and differentiation.  They also have addnl., subtler roles outside the nervous system.  In recent years, three rare human genetic disorders, which result in deleterious effects on sensory perception, cognition and a variety of behaviors, have been shown to be attributable to mutations in brain-derived neurotrophic factor and two of the Trk receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoX0o5HD04qQ7Vg90H21EOLACvtfcHk0lg46EKIDlJp2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFakurfF&md5=bfe4323cece6bc7e53fb1687917b86d7</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1098%2Frstb.2006.1894&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1098%252Frstb.2006.1894%26sid%3Dliteratum%253Aachs%26aulast%3DReichardt%26aufirst%3DL.%2BF.%26atitle%3DNeurotrophin-Regulated%2520Signalling%2520Pathways%26jtitle%3DPhilos.%2520Trans.%2520R.%2520Soc.%2520B%26date%3D2006%26volume%3D361%26spage%3D1545%26epage%3D1564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group">Watson, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dawbarn, D.</span><span> </span><span class="NLM_article-title">Targeting Nerve Growth Factor in Pain</span> <span class="citation_source-journal">BioDrugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">349</span><span class="NLM_x">–</span> <span class="NLM_lpage">359</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=349-359&author=J.+L.+Watsonauthor=S.+J.+Allenauthor=D.+Dawbarn&title=Targeting+Nerve+Growth+Factor+in+Pain"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWatson%26aufirst%3DJ.%2BL.%26aulast%3DAllen%26aufirst%3DS.%2BJ.%26aulast%3DDawbarn%26aufirst%3DD.%26atitle%3DTargeting%2520Nerve%2520Growth%2520Factor%2520in%2520Pain%26jtitle%3DBioDrugs%26date%3D2008%26volume%3D22%26spage%3D349%26epage%3D359" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span> </span><span class="NLM_article-title">Trk Kinase Inhibitors as New Treatments for Cancer Pain</span> <span class="citation_source-journal">Expert. Opin. Ther. Pat.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">305</span><span class="NLM_x">–</span> <span class="NLM_lpage">319</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1517%2F13543770902721261" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=305-319&author=T.+Wangauthor=D.+Yuauthor=M.+L.+Lamb&title=Trk+Kinase+Inhibitors+as+New+Treatments+for+Cancer+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Trk kinase inhibitors as new treatments for cancer and pain</span></div><div class="casAuthors">Wang, Tao; Yu, Dingwei; Lamb, Michelle L.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">305-319</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Background: Tropomyosin-related kinases (Trks) are a family of receptor tyrosine kinases activated by neurotrophins.  Trks play important roles in pain sensation as well as tumor cell growth and survival signaling.  Thus, inhibitors of Trk receptor kinases might provide targeted treatments for pain and cancer.  Objective: This paper reviews those patent applications since 2002 claiming small-mol. inhibitors of Trk receptor kinases.  Methods: Primary literature and patents were searched with SciFinder and Google Scholar.  Patents were selected based on their relevance to Trks and were evaluated and representative compds. were listed as examples.  Results/conclusion: Several series of Trk inhibitors with excellent in vitro potencies have been reported and a no. of compds. have gone into the clinic.  It should be noted that few of these inhibitors are Trk selective, demonstrating that targeting Trk kinases for treatment of pain and/or cancer offers a promising but also challenging approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvknvXUUz2DbVg90H21EOLACvtfcHk0lg46EKIDlJp2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXjslWlu7o%253D&md5=ffc2d3e33102631cac7b89dce7f96a5a</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1517%2F13543770902721261&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543770902721261%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DYu%26aufirst%3DD.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26atitle%3DTrk%2520Kinase%2520Inhibitors%2520as%2520New%2520Treatments%2520for%2520Cancer%2520Pain%26jtitle%3DExpert.%2520Opin.%2520Ther.%2520Pat.%26date%3D2009%26volume%3D19%26spage%3D305%26epage%3D319" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Lane, N. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schnitzer, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Birbara, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mokhtarani, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shelton, D. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. T.</span><span> </span><span class="NLM_article-title">Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee</span> <span class="citation_source-journal">N. Engl. J. Med.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">363</span><span class="NLM_x">, </span> <span class="NLM_fpage">1521</span><span class="NLM_x">–</span> <span class="NLM_lpage">1531</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1056%2FNEJMoa0901510" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=20942668" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC3cXht12ltrbI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=363&publication_year=2010&pages=1521-1531&author=N.+E.+Laneauthor=T.+J.+Schnitzerauthor=C.+A.+Birbaraauthor=M.+Mokhtaraniauthor=D.+L.+Sheltonauthor=M.+D.+Smithauthor=M.+T.+Brown&title=Tanezumab+for+the+Treatment+of+Pain+from+Osteoarthritis+of+the+Knee"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Tanezumab for the treatment of pain from osteoarthritis of the knee</span></div><div class="casAuthors">Lane, Nancy E.; Schnitzer, Thomas J.; Birbara, Charles A.; Mokhtarani, Masoud; Shelton, David L.; Smith, Mike D.; Brown, Mark T.</div><div class="citationInfo"><span class="NLM_cas:title">New England Journal of Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">363</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">1521</span>CODEN:
                <span class="NLM_cas:coden">NEJMAG</span>;
        ISSN:<span class="NLM_cas:issn">0028-4793</span>.
    
            (<span class="NLM_cas:orgname">Massachusetts Medical Society</span>)
        </div><div class="casAbstract">Background: Increased expression of nerve growth factor in injured or inflamed tissue is assocd. with increased pain.  This proof-of-concept study was designed to investigate the safety and analgesic efficacy of tanezumab, a humanized monoclonal antibody that binds and inhibits nerve growth factor.  Methods: We randomly assigned 450 patients with osteoarthritis of the knee to receive tanezumab (administered at a dose of 10, 25, 50, 100, or 200 Ag per kg of body wt.) or placebo on days 1 and 56.  The primary efficacy measures were knee pain while walking and the patient's global assessment of response to therapy.  We also assessed pain, stiffness, and phys. function using the Western Ontario and Mc-Master Universities Osteoarthritis Index (WOMAC); the rate of response using the criteria of the Outcome Measures for Rheumatol.  Committee and Osteoarthritis Research Society International Standing Committee for Clin. Trials Response Criteria Initiative (OMERACT-OARSI); and safety.  Results: When averaged over weeks 1 through 16, the mean redns. from baseline in knee pain while walking ranged from 45 to 62% with various doses of tanezumab, as compared with 22% with placebo (P < 0.001).  Tanezumab, as compared with placebo, was also assocd. with significantly greater improvements in the response to therapy as assessed with the use of the patients' global assessment measure (mean increases in score of 29 to 47% with various doses of tanezumab, as compared with 19% with placebo; P ≤ 0.001).  The rate of response according to the OMERACT-OARSI criteria ranged from 74 to 93% with tanezumab treatment, as compared with 44% with placebo (P < 0.001).  The rates of adverse events were 68% and 55% in the tanezumab and placebo groups, resp.  The most common adverse events among tanezumab-treated patients were headache (9% of the patients), upper respiratory tract infection (7%), and paresthesia (7%).  Conclusions: In this proof-of-concept study, treatment with tanezumab was assocd. with a redn. in joint pain and improvement in function, with mild and moderate adverse events, among patients with moderate-to-severe osteoarthritis of the knee.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoCmt4PNNZ44LVg90H21EOLACvtfcHk0li_k5tQs-bmMQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXht12ltrbI&md5=fe69490dfa3d47fe8a0c286d6b020d57</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1056%2FNEJMoa0901510&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1056%252FNEJMoa0901510%26sid%3Dliteratum%253Aachs%26aulast%3DLane%26aufirst%3DN.%2BE.%26aulast%3DSchnitzer%26aufirst%3DT.%2BJ.%26aulast%3DBirbara%26aufirst%3DC.%2BA.%26aulast%3DMokhtarani%26aufirst%3DM.%26aulast%3DShelton%26aufirst%3DD.%2BL.%26aulast%3DSmith%26aufirst%3DM.%2BD.%26aulast%3DBrown%26aufirst%3DM.%2BT.%26atitle%3DTanezumab%2520for%2520the%2520Treatment%2520of%2520Pain%2520from%2520Osteoarthritis%2520of%2520the%2520Knee%26jtitle%3DN.%2520Engl.%2520J.%2520Med.%26date%3D2010%26volume%3D363%26spage%3D1521%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="note"><p class="first last">Invitrogen 92 member kinase panel used as the general counterscreen at 1 μM to assess kinase selectivity.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="note"><p class="first last">Protein crystallography conditions and procedured are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited in the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT">4PMT</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="note"><p class="first last">Additional hinge binding TrkA inhibitors have also been previously reported in the literature; see the following:</p></div><div class="NLM_citation" id="rightTab-cit9a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lyne, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H.-J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Han, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mohr, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kaus, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Josey, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thress, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">MacIntyre, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Omer, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, D.</span><span> </span><span class="NLM_article-title">Identification of 4-Aminopyrazolylpyrimidines as Potent Inhibitors of Trk Kinases</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">4672</span><span class="NLM_x">–</span> <span class="NLM_lpage">4684</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800343j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=4672-4684&author=T.+Wangauthor=M.+L.+Lambauthor=D.+A.+Scottauthor=H.+Wangauthor=M.+H.+Blockauthor=P.+D.+Lyneauthor=J.+W.+Leeauthor=A.+M.+Daviesauthor=H.-J.+Zhangauthor=Y.+Zhuauthor=F.+Guauthor=Y.+Hanauthor=B.+Wangauthor=P.+J.+Mohrauthor=R.+J.+Kausauthor=J.+A.+Joseyauthor=E.+Hoffmannauthor=K.+Thressauthor=T.+MacIntyreauthor=H.+Wangauthor=C.+A.+Omerauthor=D.+Yu&title=Identification+of+4-Aminopyrazolylpyrimidines+as+Potent+Inhibitors+of+Trk+Kinases"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9a&amp;dbid=16384&amp;doi=10.1021%2Fjm800343j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800343j%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DT.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DScott%26aufirst%3DD.%2BA.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DLyne%26aufirst%3DP.%2BD.%26aulast%3DLee%26aufirst%3DJ.%2BW.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DZhang%26aufirst%3DH.-J.%26aulast%3DZhu%26aufirst%3DY.%26aulast%3DGu%26aufirst%3DF.%26aulast%3DHan%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DB.%26aulast%3DMohr%26aufirst%3DP.%2BJ.%26aulast%3DKaus%26aufirst%3DR.%2BJ.%26aulast%3DJosey%26aufirst%3DJ.%2BA.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DThress%26aufirst%3DK.%26aulast%3DMacIntyre%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DH.%26aulast%3DOmer%26aufirst%3DC.%2BA.%26aulast%3DYu%26aufirst%3DD.%26atitle%3DIdentification%2520of%25204-Aminopyrazolylpyrimidines%2520as%2520Potent%2520Inhibitors%2520of%2520Trk%2520Kinases%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D4672%26epage%3D4684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit9b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seo, J. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, K. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.-S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hong, S.</span><span> </span><span class="NLM_article-title">Design, Synthesis and Evaluation of 3,5-Disubstituted 7-Azaindoles as Trk Inhibitors with Anticancer and Antiangiogenic Activities</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5337</span><span class="NLM_x">–</span> <span class="NLM_lpage">5349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm3002982" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5337-5349&author=S.+Hongauthor=J.+Kimauthor=J.+H.+Seoauthor=K.+H.+Jungauthor=S.-S.+Hongauthor=S.+Hong&title=Design%2C+Synthesis+and+Evaluation+of+3%2C5-Disubstituted+7-Azaindoles+as+Trk+Inhibitors+with+Anticancer+and+Antiangiogenic+Activities"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9b&amp;dbid=16384&amp;doi=10.1021%2Fjm3002982&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm3002982%26sid%3Dliteratum%253Aachs%26aulast%3DHong%26aufirst%3DS.%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DSeo%26aufirst%3DJ.%2BH.%26aulast%3DJung%26aufirst%3DK.%2BH.%26aulast%3DHong%26aufirst%3DS.-S.%26aulast%3DHong%26aufirst%3DS.%26atitle%3DDesign%252C%2520Synthesis%2520and%2520Evaluation%2520of%25203%252C5-Disubstituted%25207-Azaindoles%2520as%2520Trk%2520Inhibitors%2520with%2520Anticancer%2520and%2520Antiangiogenic%2520Activities%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5337%26epage%3D5349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Van Linden, O. P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kooistra, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leurs, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Esch, I. J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Graff, C.</span><span> </span><span class="NLM_article-title">KLIFS: A Knowledge-Based Structural Database To Navigate Kinase–Ligand Interaction Space</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2014</span><span class="NLM_x">, </span> <span class="NLM_volume">57</span><span class="NLM_x">, </span> <span class="NLM_fpage">249</span><span class="NLM_x">–</span> <span class="NLM_lpage">277</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm400378w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=57&publication_year=2014&pages=249-277&author=O.+P.+J.+Van+Lindenauthor=A.+J.+Kooistraauthor=R.+Leursauthor=I.+J.+P.+de+Eschauthor=C.+de+Graff&title=KLIFS%3A+A+Knowledge-Based+Structural+Database+To+Navigate+Kinase%E2%80%93Ligand+Interaction+Space"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1021%2Fjm400378w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm400378w%26sid%3Dliteratum%253Aachs%26aulast%3DVan%2BLinden%26aufirst%3DO.%2BP.%2BJ.%26aulast%3DKooistra%26aufirst%3DA.%2BJ.%26aulast%3DLeurs%26aufirst%3DR.%26aulast%3Dde%2BEsch%26aufirst%3DI.%2BJ.%2BP.%26aulast%3Dde%2BGraff%26aufirst%3DC.%26atitle%3DKLIFS%253A%2520A%2520Knowledge-Based%2520Structural%2520Database%2520To%2520Navigate%2520Kinase%25E2%2580%2593Ligand%2520Interaction%2520Space%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2014%26volume%3D57%26spage%3D249%26epage%3D277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="note"><p class="first last">The cell-based assay is performed using the Discover X- Pathhunter assay platform. Experimental details are described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group">Bouhana, K. S.; Impastato, R.; Pheneger, J.; Jiang, Y.; Wallace, R. D.; Do, M. G.; Zaute, N. A.; Andrews, S. W.</span><span> </span><span class="NLM_article-title">Analgesic Effects of a Potent and Selective Kinase Inhibitor of Neurotrophin Receptors TRKA, TRKB and TRKC</span>. WO2010033941,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>WO2010048312,<span class="NLM_x"> </span><span class="NLM_year">2010</span><span class="NLM_x">; </span>WO2011006074,<span class="NLM_x"> </span><span class="NLM_year">2011</span><span class="NLM_x">; </span><a href="http://www.arraybiopharma.com" class="extLink">www.arraybiopharma.com</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2010&author=K.+S.+Bouhana&author=R.+Impastato&author=J.+Pheneger&author=Y.+Jiang&author=R.+D.+Wallace&author=M.+G.+Do&author=N.+A.+Zaute&author=S.+W.+Andrews&title=Analgesic+Effects+of+a+Potent+and+Selective+Kinase+Inhibitor+of+Neurotrophin+Receptors+TRKA%2C+TRKB+and+TRKC"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26atitle%3DAnalgesic%2520Effects%2520of%2520a%2520Potent%2520and%2520Selective%2520Kinase%2520Inhibitor%2520of%2520Neurotrophin%2520Receptors%2520TRKA%252C%2520TRKB%2520and%2520TRKC%26date%3D2010%26date%3D2010%26date%3D2011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Green, A.; Li, Y.; Stachel, S. J.</span><span> </span><span class="NLM_article-title">Preparation of Pyridotriazole and Benzotriazole Compounds as TrkA Kinase Inhibitors</span>. PCT Int. Appl. WO 2012125667 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Green&author=Y.+Li&author=S.+J.+Stachel&title=Preparation+of+Pyridotriazole+and+Benzotriazole+Compounds+as+TrkA+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%26atitle%3DPreparation%2520of%2520Pyridotriazole%2520and%2520Benzotriazole%2520Compounds%2520as%2520TrkA%2520Kinase%2520Inhibitors%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Green, A.; Li, Y.; Stachel, S. J.</span><span> </span><span class="NLM_article-title">TrkA kinase Inhibitors Compositions and Methods of Use</span> PCT Int. Appl. WO2012125668 A1,<span class="NLM_x"> </span><span class="NLM_year">2012</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=A.+Green&author=Y.+Li&author=S.+J.+Stachel&title=TrkA+kinase+Inhibitors+Compositions+and+Methods+of+Use"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DGreen%26aufirst%3DA.%26atitle%3DTrkA%2520kinase%2520Inhibitors%2520Compositions%2520and%2520Methods%2520of%2520Use%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited with the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><div class="note"><p class="first last">For an excellent review on type I and type II kinase inhibitors see the following:</p></div><span class="NLM_contrib-group">Zuccotto, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ardini, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casale, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angiolini, M.</span><span> </span><span class="NLM_article-title">Through the “Gatekeeper Door”: Exploiting the Active Kinase Conformation</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">2681</span><span class="NLM_x">–</span> <span class="NLM_lpage">2694</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm901443h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=2681-2694&author=F.+Zuccottoauthor=E.+Ardiniauthor=E.+Casaleauthor=M.+Angiolini&title=Through+the+%E2%80%9CGatekeeper+Door%E2%80%9D%3A+Exploiting+the+Active+Kinase+Conformation"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fjm901443h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901443h%26sid%3Dliteratum%253Aachs%26aulast%3DZuccotto%26aufirst%3DF.%26aulast%3DArdini%26aufirst%3DE.%26aulast%3DCasale%26aufirst%3DE.%26aulast%3DAngiolini%26aufirst%3DM.%26atitle%3DThrough%2520the%2520%25E2%2580%259CGatekeeper%2520Door%25E2%2580%259D%253A%2520Exploiting%2520the%2520Active%2520Kinase%2520Conformation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D2681%26epage%3D2694" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group">Huse, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">The Conformational Plasticity of Protein Kinases</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">109</span><span class="NLM_x">, </span> <span class="NLM_fpage">275</span><span class="NLM_x">–</span> <span class="NLM_lpage">282</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1016%2FS0092-8674%2802%2900741-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=12015977" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=109&publication_year=2002&pages=275-282&author=M.+Huseauthor=J.+Kuriyan&title=The+Conformational+Plasticity+of+Protein+Kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">The conformational plasticity of protein kinases</span></div><div class="casAuthors">Huse, Morgan; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Cell (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">109</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">275-282</span>CODEN:
                <span class="NLM_cas:coden">CELLB5</span>;
        ISSN:<span class="NLM_cas:issn">0092-8674</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">A review with 48 refs.  Protein kinases operate in a large no. of distinct signaling pathways, where the tight regulation of their catalytic activity is crucial to the development and maintenance of eukaryotic organisms.  The catalytic domains of different kinases adopt strikingly similar structures when they are active.  By contrast, crystal structures of inactive kinases have revealed a marked plasticity in the kinase domain that allows the adoption of distinct conformations in response to interactions with specific regulatory domains or proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpJrn7F3h4ej7Vg90H21EOLACvtfcHk0lh6KrY7D-DvTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjvV2lsLw%253D&md5=cd56edae94ad239f2ce7a5d6c8930cbb</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2FS0092-8674%2802%2900741-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0092-8674%252802%252900741-9%26sid%3Dliteratum%253Aachs%26aulast%3DHuse%26aufirst%3DM.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DThe%2520Conformational%2520Plasticity%2520of%2520Protein%2520Kinases%26jtitle%3DCell%26date%3D2002%26volume%3D109%26spage%3D275%26epage%3D282" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Albaugh, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mi, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Adrian, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jia, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sarkisova, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kreusch, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loren, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tuntland, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karanewsky, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seidel, H. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Molteni, V.</span><span> </span><span class="NLM_article-title">Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">140</span><span class="NLM_x">–</span> <span class="NLM_lpage">145</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml200261d" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC38XlvFCm" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2012&pages=140-145&author=P.+Albaughauthor=Y.+Fanauthor=Y.+Miauthor=F.+Sunauthor=F.+Adrianauthor=N.+Liauthor=Y.+Jiaauthor=Y.+Sarkisovaauthor=A.+Kreuschauthor=T.+Hoodauthor=M.+Luauthor=G.+Liuauthor=S.+Huangauthor=Z.+Liuauthor=J.+Lorenauthor=T.+Tuntlandauthor=D.+S.+Karanewskyauthor=H.+M.+Seidelauthor=V.+Molteni&title=Discovery+of+GNF-5837%2C+a+Selective+TRK+Inhibitor+with+Efficacy+in+Rodent+Cancer+Tumor+Models"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of GNF-5837, a Selective TRK Inhibitor with Efficacy in Rodent Cancer Tumor Models</span></div><div class="casAuthors">Albaugh, Pam; Fan, Yi; Mi, Yuan; Sun, Fangxian; Adrian, Francisco; Li, Nanxin; Jia, Yong; Sarkisova, Yelena; Kreusch, Andreas; Hood, Tami; Lu, Min; Liu, Guoxun; Huang, Shenlin; Liu, Zuosheng; Loren, Jon; Tuntland, Tove; Karanewsky, Donald S.; Seidel, H. Martin; Molteni, Valentina</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">140-145</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Neurotrophins and their receptors (TRKs) play key roles in the development of the nervous system and the maintenance of the neural network.  Accumulating evidence points to their role in malignant transformations, chemotaxis, metastasis, and survival signaling and may contribute to the pathogenesis of a variety of tumors of both neural and non-neural origin.  By screening the GNF kinase collection, a series of novel oxindole inhibitors of TRKs were identified.  Optimization led to the identification of GNF-5837 (I), a potent, selective, and orally bioavailable pan-TRK inhibitor that inhibited tumor growth in a mouse xenograft model derived from RIE cells expressing both TRKA and NGF.  The properties of I make it a good tool for the elucidation of TRK biol. in cancer and other nononcol. indications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqF4DjLhCqRFrVg90H21EOLACvtfcHk0lh6KrY7D-DvTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XlvFCm&md5=d355489fe9f791a8547699fa65ebba51</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fml200261d&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml200261d%26sid%3Dliteratum%253Aachs%26aulast%3DAlbaugh%26aufirst%3DP.%26aulast%3DFan%26aufirst%3DY.%26aulast%3DMi%26aufirst%3DY.%26aulast%3DSun%26aufirst%3DF.%26aulast%3DAdrian%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DJia%26aufirst%3DY.%26aulast%3DSarkisova%26aufirst%3DY.%26aulast%3DKreusch%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DT.%26aulast%3DLu%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DS.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLoren%26aufirst%3DJ.%26aulast%3DTuntland%26aufirst%3DT.%26aulast%3DKaranewsky%26aufirst%3DD.%2BS.%26aulast%3DSeidel%26aufirst%3DH.%2BM.%26aulast%3DMolteni%26aufirst%3DV.%26atitle%3DDiscovery%2520of%2520GNF-5837%252C%2520a%2520Selective%2520TRK%2520Inhibitor%2520with%2520Efficacy%2520in%2520Rodent%2520Cancer%2520Tumor%2520Models%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D3%26spage%3D140%26epage%3D145" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Schindler, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bornmann, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pellicena, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miller, W. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Clarkson, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuriyan, J.</span><span> </span><span class="NLM_article-title">Structural Mechanism for STI-571 Inhibition of Abelson Tyrosine Kinase</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">289</span><span class="NLM_x">, </span> <span class="NLM_fpage">1938</span><span class="NLM_x">–</span> <span class="NLM_lpage">1942</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1126%2Fscience.289.5486.1938" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=10988075" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2000&pages=1938-1942&author=T.+Schindlerauthor=W.+Bornmannauthor=P.+Pellicenaauthor=W.+T.+Millerauthor=B.+Clarksonauthor=J.+Kuriyan&title=Structural+Mechanism+for+STI-571+Inhibition+of+Abelson+Tyrosine+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural mechanism for STI-571 inhibition of Abelson tyrosine kinase</span></div><div class="casAuthors">Schindler, Thomas; Bornmann, William; Pellicena, Patricia; Miller, W. Todd; Clarkson, Bayard; Kuriyan, John</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, D. C.)</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">5486</span>),
    <span class="NLM_cas:pages">1938-1942</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">The inadvertent activation of the Abelson tyrosine kinase (Abl) causes chronic myelogenous leukemia (CML).  A small-mol. inhibitor of Abl (STI-571) is effective in the treatment of CML.  We report the crystal structure of the catalytic domain of Abl, complexed to a variant of STI-571.  Crit. to the binding of STI-571 is the adoption by the kinase of an inactive conformation, in which a centrally located "activation loop" is not phosphorylated.  The conformation of this loop is distinct from that in active protein kinases, as well as in the inactive form of the closely related Src kinases.  These results suggest that compds. that exploit the distinctive inactivation mechanisms of individual protein kinases can achieve both high affinity and high specificity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo9eAZqIQ1aebVg90H21EOLACvtfcHk0lh6KrY7D-DvTA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXms1altLc%253D&md5=56bb233f010f099d0073020ac6b9db59</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1126%2Fscience.289.5486.1938&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.289.5486.1938%26sid%3Dliteratum%253Aachs%26aulast%3DSchindler%26aufirst%3DT.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DPellicena%26aufirst%3DP.%26aulast%3DMiller%26aufirst%3DW.%2BT.%26aulast%3DClarkson%26aufirst%3DB.%26aulast%3DKuriyan%26aufirst%3DJ.%26atitle%3DStructural%2520Mechanism%2520for%2520STI-571%2520Inhibition%2520of%2520Abelson%2520Tyrosine%2520Kinase%26jtitle%3DScience%26date%3D2000%26volume%3D289%26spage%3D1938%26epage%3D1942" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Stachel, S. J.; Egbertson, M.; Brnardic, E.; Jones, K.; Sanders, J. M.; Henze, D. A.</span><span> </span><span class="NLM_article-title">TrkA Kinase Inhibitors, Composition and Methods Thereof</span>. PCT Int. Appl. WO 2013/176970, Nov<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=S.+J.+Stachel&author=M.+Egbertson&author=E.+Brnardic&author=K.+Jones&author=J.+M.+Sanders&author=D.+A.+Henze&title=TrkA+Kinase+Inhibitors%2C+Composition+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DStachel%26aufirst%3DS.%2BJ.%26atitle%3DTrkA%2520Kinase%2520Inhibitors%252C%2520Composition%2520and%2520Methods%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Herbertz, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pippin, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Salvino, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mallamo, J. P.</span><span> </span><span class="NLM_article-title">Knowledge Based Predictions of Ligand Binding Modes and Rational Inhibitor Design for Kinase Drug Discovery</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">5149</span><span class="NLM_x">–</span> <span class="NLM_lpage">5171</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm800475y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=5149-5171&author=A.+K.+Ghoseauthor=T.+Herbertzauthor=D.+A.+Pippinauthor=J.+M.+Salvinoauthor=J.+P.+Mallamo&title=Knowledge+Based+Predictions+of+Ligand+Binding+Modes+and+Rational+Inhibitor+Design+for+Kinase+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm800475y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm800475y%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DHerbertz%26aufirst%3DT.%26aulast%3DPippin%26aufirst%3DD.%2BA.%26aulast%3DSalvino%26aufirst%3DJ.%2BM.%26aulast%3DMallamo%26aufirst%3DJ.%2BP.%26atitle%3DKnowledge%2520Based%2520Predictions%2520of%2520Ligand%2520Binding%2520Modes%2520and%2520Rational%2520Inhibitor%2520Design%2520for%2520Kinase%2520Drug%2520Discovery%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D5149%26epage%3D5171" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Dar, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lopez, M. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shokat, K. M.</span><span> </span><span class="NLM_article-title">Small Molecule Recognition of c-Src via the Imantinib-Binding Conformation</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">1015</span><span class="NLM_x">–</span> <span class="NLM_lpage">1022</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1016%2Fj.chembiol.2008.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=18940662" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2008&pages=1015-1022&author=A.+C.+Darauthor=M.+S.+Lopezauthor=K.+M.+Shokat&title=Small+Molecule+Recognition+of+c-Src+via+the+Imantinib-Binding+Conformation"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Small Molecule Recognition of c-Src via the Imatinib-Binding Conformation</span></div><div class="casAuthors">Dar, Arvin C.; Lopez, Michael S.; Shokat, Kevan M.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology (Cambridge, MA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1015-1022</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Summary: The cancer drug, Imatinib, is a selective Abl kinase inhibitor that does not inhibit the closely related kinase c-Src.  This one drug and its ability to selectively inhibit Abl over c-Src has been a guiding principle in virtually all kinase drug discovery efforts in the last 15 years.  A prominent hypothesis explaining the selectivity of Imatinib is that Abl has an intrinsic ability to adopt an inactive conformation (termed DFG-out), whereas c-Src appears to pay a high intrinsic energetic penalty for adopting this conformation, effectively excluding Imatinib from its ATP pocket.  This explanation of the difference in binding affinity of Imatinib for Abl vs. c-Src makes the striking prediction that it would not be possible to design an inhibitor that binds to the DFG-out conformation of c-Src with high affinity.  The authors report the discovery of a series of such inhibitors.  The authors use structure-activity relationships and x-ray crystallog. to confirm the authors' findings.  These studies suggest that small mols. are capable of inducing the generally unfavorable DFG-out conformation in c-Src.  Structural comparison between c-Src in complex with these inhibitors allows the authors to speculate on the differential selectivity of Imatinib for c-Src and Abl.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpgbxnfmxtR-LVg90H21EOLACvtfcHk0ljfPdTJsn5Lgw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1KmsrfP&md5=f1047f4a56359511939164a3c2604cb6</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2008.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2008.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DDar%26aufirst%3DA.%2BC.%26aulast%3DLopez%26aufirst%3DM.%2BS.%26aulast%3DShokat%26aufirst%3DK.%2BM.%26atitle%3DSmall%2520Molecule%2520Recognition%2520of%2520c-Src%2520via%2520the%2520Imantinib-Binding%2520Conformation%26jtitle%3DChem.%2520Biol.%26date%3D2008%26volume%3D15%26spage%3D1015%26epage%3D1022" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group">Bhat, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xue, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Berg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hellberg, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ormo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nilsson, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Radesater, A.-C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jerning, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Markgren, P.-O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borgegard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nylof, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gimenez-Cassina, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hernandez, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucas, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Diaz-Nido, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Avila, J.</span><span> </span><span class="NLM_article-title">Structural Insights and Biological Effects of Glycogen Synthase Kinase 3-Specific Inhibitor AR-A014418</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">278</span><span class="NLM_x">, </span> <span class="NLM_fpage">45937</span><span class="NLM_x">–</span> <span class="NLM_lpage">45945</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=278&publication_year=2003&pages=45937-45945&author=R.+Bhatauthor=Y.+Xueauthor=S.+Bergauthor=S.+Hellbergauthor=M.+Ormoauthor=Y.+Nilssonauthor=A.-C.+Radesaterauthor=E.+Jerningauthor=P.-O.+Markgrenauthor=T.+Borgegardauthor=M.+Nylofauthor=A.+Gimenez-Cassinaauthor=F.+Hernandezauthor=J.+J.+Lucasauthor=J.+Diaz-Nidoauthor=J.+Avila&title=Structural+Insights+and+Biological+Effects+of+Glycogen+Synthase+Kinase+3-Specific+Inhibitor+AR-A014418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBhat%26aufirst%3DR.%26aulast%3DXue%26aufirst%3DY.%26aulast%3DBerg%26aufirst%3DS.%26aulast%3DHellberg%26aufirst%3DS.%26aulast%3DOrmo%26aufirst%3DM.%26aulast%3DNilsson%26aufirst%3DY.%26aulast%3DRadesater%26aufirst%3DA.-C.%26aulast%3DJerning%26aufirst%3DE.%26aulast%3DMarkgren%26aufirst%3DP.-O.%26aulast%3DBorgegard%26aufirst%3DT.%26aulast%3DNylof%26aufirst%3DM.%26aulast%3DGimenez-Cassina%26aufirst%3DA.%26aulast%3DHernandez%26aufirst%3DF.%26aulast%3DLucas%26aufirst%3DJ.%2BJ.%26aulast%3DDiaz-Nido%26aufirst%3DJ.%26aulast%3DAvila%26aufirst%3DJ.%26atitle%3DStructural%2520Insights%2520and%2520Biological%2520Effects%2520of%2520Glycogen%2520Synthase%2520Kinase%25203-Specific%2520Inhibitor%2520AR-A014418%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2003%26volume%3D278%26spage%3D45937%26epage%3D45945" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Boije af Gennas, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mologni, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ahmed, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rajaratnam, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marin, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lindholm, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viltadi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambacorti-Passerini, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scappozza, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yli-Kauhaluoma, J.</span><span> </span><span class="NLM_article-title">Design, Synthesis, and Biological Activity of Urea Derivatives as Anaplastic Lymphoma Kinase Inhibitors</span> <span class="citation_source-journal">ChemMedChem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">1680</span><span class="NLM_x">–</span> <span class="NLM_lpage">1692</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2011&pages=1680-1692&author=G.+Boije+af+Gennasauthor=L.+Mologniauthor=S.+Ahmedauthor=M.+Rajaratnamauthor=O.+Marinauthor=N.+Lindholmauthor=M.+Viltadiauthor=C.+Gambacorti-Passeriniauthor=L.+Scappozzaauthor=J.+Yli-Kauhaluoma&title=Design%2C+Synthesis%2C+and+Biological+Activity+of+Urea+Derivatives+as+Anaplastic+Lymphoma+Kinase+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoije%2Baf%2BGennas%26aufirst%3DG.%26aulast%3DMologni%26aufirst%3DL.%26aulast%3DAhmed%26aufirst%3DS.%26aulast%3DRajaratnam%26aufirst%3DM.%26aulast%3DMarin%26aufirst%3DO.%26aulast%3DLindholm%26aufirst%3DN.%26aulast%3DViltadi%26aufirst%3DM.%26aulast%3DGambacorti-Passerini%26aufirst%3DC.%26aulast%3DScappozza%26aufirst%3DL.%26aulast%3DYli-Kauhaluoma%26aufirst%3DJ.%26atitle%3DDesign%252C%2520Synthesis%252C%2520and%2520Biological%2520Activity%2520of%2520Urea%2520Derivatives%2520as%2520Anaplastic%2520Lymphoma%2520Kinase%2520Inhibitors%26jtitle%3DChemMedChem%26date%3D2011%26volume%3D6%26spage%3D1680%26epage%3D1692" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited in the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP">4PMP</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Behshad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klabe, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Margulis, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Becker-Pasha, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rupar, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collier, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hollis, G. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burn, T. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wynn, R.</span><span> </span><span class="NLM_article-title">Phosphorylation State-Dependent High Throughput Screening of the c-Met Kinase</span> <span class="citation_source-journal">Curr. Chem. Genomics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">4</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">33</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.2174%2F1875397301004010027" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref26/cit26a&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmtl2jtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2010&pages=27-33&author=E.+Behshadauthor=R.+M.+Klabeauthor=A.+Margulisauthor=M.+Becker-Pashaauthor=M.+J.+Ruparauthor=P.+Collierauthor=P.+C.+Liuauthor=G.+F.+Hollisauthor=T.+C.+Burnauthor=R.+Wynn&title=Phosphorylation+State-Dependent+High+Throughput+Screening+of+the+c-Met+Kinase"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26aR"><div class="casContent"><span class="casTitleNuber">26a</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphorylation state-dependent high throughput screening of the c-Met kinase</span></div><div class="casAuthors">Behshad, Elham; Klabe, Ronald M.; Margulis, Alexander; Becker-Pasha, Mary; Rupar, Mark J.; Collier, Paul; Liu, Phillip C.; Hollis, Gregory F.; Burn, Timothy C.; Wynn, Richard</div><div class="citationInfo"><span class="NLM_cas:title">Current Chemical Genomics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-33</span>CODEN:
                <span class="NLM_cas:coden">CCGUAQ</span>;
        ISSN:<span class="NLM_cas:issn">1875-3973</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">High-throughput screening (HTS) of ∼50,000 chem. compds. against phosphorylated and unphosphorylated c-Met, a tyrosine kinase receptor for hepatocyte growth factor (HGF), was carried out in order to compare hit rates, hit potencies and also to explore scaffolds that might serve as potential leads targeting only the unphosphorylated form of the enzyme.  The hit rate and potency for the confirmed hit mols. were higher for the unphosphoryalted form of c-Met.  While the target of small mol. inhibitor discovery efforts has traditionally been the phosphorylated form, there are now examples of small mols. that target unphosphorylated kinases.  Screening for inhibitors of unphosphorylated kinases may represent a complementary approach for prioritizing chem. scaffolds for hit-to-lead follow ups.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzBg5DtPZ3rbVg90H21EOLACvtfcHk0liZDOaHs9Z70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmtl2jtr0%253D&md5=02751141e17718e2febfa1ff552e55eb</span></div><a href="/servlet/linkout?suffix=cit26a&amp;dbid=16384&amp;doi=10.2174%2F1875397301004010027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1875397301004010027%26sid%3Dliteratum%253Aachs%26aulast%3DBehshad%26aufirst%3DE.%26aulast%3DKlabe%26aufirst%3DR.%2BM.%26aulast%3DMargulis%26aufirst%3DA.%26aulast%3DBecker-Pasha%26aufirst%3DM.%26aulast%3DRupar%26aufirst%3DM.%2BJ.%26aulast%3DCollier%26aufirst%3DP.%26aulast%3DLiu%26aufirst%3DP.%2BC.%26aulast%3DHollis%26aufirst%3DG.%2BF.%26aulast%3DBurn%26aufirst%3DT.%2BC.%26aulast%3DWynn%26aufirst%3DR.%26atitle%3DPhosphorylation%2520State-Dependent%2520High%2520Throughput%2520Screening%2520of%2520the%2520c-Met%2520Kinase%26jtitle%3DCurr.%2520Chem.%2520Genomics%26date%3D2010%26volume%3D4%26spage%3D27%26epage%3D33" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit26b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Wang, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marimuthi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tsai, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumar, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krupka, H. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Powell, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tabrizizad, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luu, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">West, B. L.</span><span> </span><span class="NLM_article-title">Structural Characterization of Autoinhibited c-Met Kinase Produced by Coexpression in Bacteria with Phosphatase</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci. U.S.A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2006</span><span class="NLM_x">, </span> <span class="NLM_volume">103</span><span class="NLM_x">, </span> <span class="NLM_fpage">3563</span><span class="NLM_x">–</span> <span class="NLM_lpage">3568</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=103&publication_year=2006&pages=3563-3568&author=W.+Wangauthor=A.+Marimuthiauthor=J.+Tsaiauthor=A.+Kumarauthor=H.+I.+Krupkaauthor=C.+Zhangauthor=B.+Powellauthor=Y.+Suzukiauthor=H.+Nguyenauthor=M.+Tabrizizadauthor=C.+Luuauthor=B.+L.+West&title=Structural+Characterization+of+Autoinhibited+c-Met+Kinase+Produced+by+Coexpression+in+Bacteria+with+Phosphatase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DW.%26aulast%3DMarimuthi%26aufirst%3DA.%26aulast%3DTsai%26aufirst%3DJ.%26aulast%3DKumar%26aufirst%3DA.%26aulast%3DKrupka%26aufirst%3DH.%2BI.%26aulast%3DZhang%26aufirst%3DC.%26aulast%3DPowell%26aufirst%3DB.%26aulast%3DSuzuki%26aufirst%3DY.%26aulast%3DNguyen%26aufirst%3DH.%26aulast%3DTabrizizad%26aufirst%3DM.%26aulast%3DLuu%26aufirst%3DC.%26aulast%3DWest%26aufirst%3DB.%2BL.%26atitle%3DStructural%2520Characterization%2520of%2520Autoinhibited%2520c-Met%2520Kinase%2520Produced%2520by%2520Coexpression%2520in%2520Bacteria%2520with%2520Phosphatase%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.S.A.%26date%3D2006%26volume%3D103%26spage%3D3563%26epage%3D3568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group">Whelligan, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Solanki, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thomson, D. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheung, K.-M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Boxall, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mas-Droux, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barillari, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Burns, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grummitt, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Collins, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Montfort, R. L. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aherne, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bayliss, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoelder, S.</span><span> </span><span class="NLM_article-title">Aminopyrazine Inhibitors Binding to Unusual Inactive Conformation of the Mitotic Kinase Nek2: SAR and Structural Characterization</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">7682</span><span class="NLM_x">–</span> <span class="NLM_lpage">7698</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1008727" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=7682-7698&author=D.+K.+Whelliganauthor=S.+Solankiauthor=D.+Taylorauthor=D.+W.+Thomsonauthor=K.-M.+J.+Cheungauthor=K.+Boxallauthor=C.+Mas-Drouxauthor=C.+Barillariauthor=S.+Burnsauthor=C.+G.+Grummittauthor=I.+Collinsauthor=R.+L.+M.+van+Montfortauthor=G.+W.+Aherneauthor=R.+Baylissauthor=S.+Hoelder&title=Aminopyrazine+Inhibitors+Binding+to+Unusual+Inactive+Conformation+of+the+Mitotic+Kinase+Nek2%3A+SAR+and+Structural+Characterization"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm1008727&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1008727%26sid%3Dliteratum%253Aachs%26aulast%3DWhelligan%26aufirst%3DD.%2BK.%26aulast%3DSolanki%26aufirst%3DS.%26aulast%3DTaylor%26aufirst%3DD.%26aulast%3DThomson%26aufirst%3DD.%2BW.%26aulast%3DCheung%26aufirst%3DK.-M.%2BJ.%26aulast%3DBoxall%26aufirst%3DK.%26aulast%3DMas-Droux%26aufirst%3DC.%26aulast%3DBarillari%26aufirst%3DC.%26aulast%3DBurns%26aufirst%3DS.%26aulast%3DGrummitt%26aufirst%3DC.%2BG.%26aulast%3DCollins%26aufirst%3DI.%26aulast%3Dvan%2BMontfort%26aufirst%3DR.%2BL.%2BM.%26aulast%3DAherne%26aufirst%3DG.%2BW.%26aulast%3DBayliss%26aufirst%3DR.%26aulast%3DHoelder%26aufirst%3DS.%26atitle%3DAminopyrazine%2520Inhibitors%2520Binding%2520to%2520Unusual%2520Inactive%2520Conformation%2520of%2520the%2520Mitotic%2520Kinase%2520Nek2%253A%2520SAR%2520and%2520Structural%2520Characterization%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D7682%26epage%3D7698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="note"><p class="first last">Structure coordinates have been deposited in the PDB: code <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS">4PMS</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Hanney, B.; Manley, P.; Rudd, M. T.; Sanders, J. M.; Stachel, S. J.; Henze, D.</span><span> </span><span class="NLM_article-title">TrkA Kinase Inhibitors, Compositions and Methods Thereof</span>. PCT. Int. Appl.  WO2013009582 A1,<span class="NLM_x"> </span><span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=B.+Hanney&author=P.+Manley&author=M.+T.+Rudd&author=J.+M.+Sanders&author=S.+J.+Stachel&author=D.+Henze&title=TrkA+Kinase+Inhibitors%2C+Compositions+and+Methods+Thereof"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHanney%26aufirst%3DB.%26atitle%3DTrkA%2520Kinase%2520Inhibitors%252C%2520Compositions%2520and%2520Methods%2520Thereof%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Regan, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pargellis, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peet, G. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proto, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swinamer, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span> </span><span class="NLM_article-title">The Kinetics of Binding to p38 MAP Kinase by Analogues of BIRB 796</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">3101</span><span class="NLM_x">–</span> <span class="NLM_lpage">3104</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1016%2FS0960-894X%2803%2900656-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=12941343" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2003&pages=3101-3104&author=J.+Reganauthor=C.+A.+Pargellisauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=E.+R.+Hickeyauthor=G.+W.+Peetauthor=A.+Protoauthor=A.+Swinamerauthor=N.+Moss&title=The+Kinetics+of+Binding+to+p38+MAP+Kinase+by+Analogues+of+BIRB+796"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">The kinetics of binding to p38 MAP kinase of analogues of BIRB 796</span></div><div class="casAuthors">Regan, John; Pargellis, Christopher A.; Cirillo, Pier F.; Gilmore, Thomas; Hickey, Eugene R.; Peet, Gregory W.; Proto, Alfred; Swinamer, Alan; Moss, Neil</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">3101-3104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science B.V.</span>)
        </div><div class="casAbstract">BIRB 796, a member of the N-pyrazole-N'-naphthyl urea class of p38 MAPK inhibitors, binds to the kinase with both slow assocn. and dissocn. rates.  Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a crit. binding domain.  We demonstrate that, independent of the loop movement, assocn. rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring.  As anticipated, the dissocn. rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions.  The value of structure-kinetic relationships (SKR) in drug design is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrr1jPKElIlvrVg90H21EOLACvtfcHk0liZDOaHs9Z70A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXms1Gmt7s%253D&md5=1ca2cb661cf037790ec1b0b43a105cf3</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2803%2900656-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252803%252900656-5%26sid%3Dliteratum%253Aachs%26aulast%3DRegan%26aufirst%3DJ.%26aulast%3DPargellis%26aufirst%3DC.%2BA.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DPeet%26aufirst%3DG.%2BW.%26aulast%3DProto%26aufirst%3DA.%26aulast%3DSwinamer%26aufirst%3DA.%26aulast%3DMoss%26aufirst%3DN.%26atitle%3DThe%2520Kinetics%2520of%2520Binding%2520to%2520p38%2520MAP%2520Kinase%2520by%2520Analogues%2520of%2520BIRB%2520796%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2003%26volume%3D13%26spage%3D3101%26epage%3D3104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Pargellis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tong, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Churchill, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cirillo, P. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilmore, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Graham, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grob, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hickey, E. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moss, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pav, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Regan, J.</span><span> </span><span class="NLM_article-title">Inhibition of p38 MAP Kinase by Utilizing a Novel Allosteric Binding Site</span> <span class="citation_source-journal">Nat. Struct. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">272</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1038%2Fnsb770" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=11896401" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2002&pages=268-272&author=C.+Pargellisauthor=L.+Tongauthor=L.+Churchillauthor=P.+F.+Cirilloauthor=T.+Gilmoreauthor=A.+G.+Grahamauthor=P.+M.+Grobauthor=E.+R.+Hickeyauthor=N.+Mossauthor=S.+Pavauthor=J.+Regan&title=Inhibition+of+p38+MAP+Kinase+by+Utilizing+a+Novel+Allosteric+Binding+Site"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of p38 MAP kinase by utilizing a novel allosteric binding site</span></div><div class="casAuthors">Pargellis, Christopher; Tong, Liang; Churchill, Laurie; Cirillo, Pier F.; Gilmore, Thomas; Graham, Anne G.; Grob, Peter M.; Hickey, Eugene R.; Moss, Neil; Pav, Susan; Regan, John</div><div class="citationInfo"><span class="NLM_cas:title">Nature Structural Biology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">268-272</span>CODEN:
                <span class="NLM_cas:coden">NSBIEW</span>;
        ISSN:<span class="NLM_cas:issn">1072-8368</span>.
    
            (<span class="NLM_cas:orgname">Nature America Inc.</span>)
        </div><div class="casAbstract">The p38 MAP kinase plays a crucial role in regulating the prodn. of proinflammatory cytokines, such as tumor necrosis factor and interleukin-1.  Blocking this kinase may offer an effective therapy for treating many inflammatory diseases.  Here we report a new allosteric binding site for a diaryl urea class of highly potent and selective inhibitors against human p38 MAP kinase.  The formation of this binding site requires a large conformational change not obsd. previously for any of the protein Ser/Thr kinases.  This change is in the highly conserved Asp-Phe-Gly motif within the active site of the kinase.  Soln. studies demonstrate that this class of compds. has slow binding kinetics, consistent with the requirement for conformational change.  Improving interactions in this allosteric pocket, as well as establishing binding interactions in the ATP pocket, enhanced the affinity of the inhibitors by 12,000-fold.  One of the most potent compds. in this series, BIRB 796, has picomolar affinity for the kinase and low nanomolar inhibitory activity in cell culture.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqT8_QT7_pbYrVg90H21EOLACvtfcHk0lhSKwbi-2MrzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xis1Kisbk%253D&md5=68850ecdbe08df4285ba38cfa2c93ea4</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1038%2Fnsb770&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnsb770%26sid%3Dliteratum%253Aachs%26aulast%3DPargellis%26aufirst%3DC.%26aulast%3DTong%26aufirst%3DL.%26aulast%3DChurchill%26aufirst%3DL.%26aulast%3DCirillo%26aufirst%3DP.%2BF.%26aulast%3DGilmore%26aufirst%3DT.%26aulast%3DGraham%26aufirst%3DA.%2BG.%26aulast%3DGrob%26aufirst%3DP.%2BM.%26aulast%3DHickey%26aufirst%3DE.%2BR.%26aulast%3DMoss%26aufirst%3DN.%26aulast%3DPav%26aufirst%3DS.%26aulast%3DRegan%26aufirst%3DJ.%26atitle%3DInhibition%2520of%2520p38%2520MAP%2520Kinase%2520by%2520Utilizing%2520a%2520Novel%2520Allosteric%2520Binding%2520Site%26jtitle%3DNat.%2520Struct.%2520Biol.%26date%3D2002%26volume%3D9%26spage%3D268%26epage%3D272" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="note"><p class="first last">Array BioPharma recently reported on the use of a small molecule pan-Trk inhibitor in models of bone cancer and skeletal fracture pain:</p></div><div class="NLM_citation" id="rightTab-cit32a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Ghilardi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Andrade, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuskowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, P. W.</span><span> </span><span class="NLM_article-title">Administration of a Tropomysin Receptor Kinase Inhibitor Attenuates Sarcoma-Induced Nerve Sprouting, Neuroma Formation and Bone Cancer Pain</span> <span class="citation_source-journal">Mol. Pain</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">87</span><span class="NLM_x">–</span> <span class="NLM_lpage">97</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1186%2F1744-8069-6-87" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=21138586" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32a&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2010&pages=87-97&author=J.+R.+Ghilardiauthor=K.+T.+Freemanauthor=J.+M.+Jimenez-Andradeauthor=W.+G.+Mantyhauthor=A.+P.+Bloomauthor=M.+A.+Kuskowskiauthor=P.+W.+Mantyh&title=Administration+of+a+Tropomysin+Receptor+Kinase+Inhibitor+Attenuates+Sarcoma-Induced+Nerve+Sprouting%2C+Neuroma+Formation+and+Bone+Cancer+Pain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32aR"><div class="casContent"><span class="casTitleNuber">32a</span><div class="casTitle"><span class="NLM_cas:atitle">Administration of a tropomyosin receptor kinase inhibitor attenuates sarcoma-induced nerve sprouting, neuroma formation and bone cancer pain</span></div><div class="casAuthors">Ghilardi, Joseph R.; Freeman, Katie T.; Jimenez-Andrade, Juan M.; Mantyh, William G.; Bloom, Aaron P.; Kuskowski, Michael A.; Mantyh, Patrick W.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pain</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">87</span>CODEN:
                <span class="NLM_cas:coden">MPOAC5</span>;
        ISSN:<span class="NLM_cas:issn">1744-8069</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Pain often accompanies cancer and most current therapies for treating cancer pain have significant unwanted side effects.  Targeting nerve growth factor (NGF) or its cognate receptor tropomyosin receptor kinase A (TrkA) has become an attractive target for attenuating chronic pain.  In the present report, we use a mouse model of bone cancer pain and examine whether oral administration of a selective small mol. Trk inhibitor (ARRY-470, which blocks TrkA, TrkB and TrkC kinase activity at low nm concns.) has a significant effect on cancer-induced pain behaviors, tumor-induced remodeling of sensory nerve fibers, tumor growth and tumor-induced bone remodeling.  Early/sustained (initiated day 6 post cancer cell injection), but not late/acute (initiated day 18 post cancer cell injection) administration of ARRY-470 markedly attenuated bone cancer pain and significantly blocked the ectopic sprouting of sensory nerve fibers and the formation of neuroma-like structures in the tumor bearing bone, but did not have a significant effect on tumor growth or bone remodeling.  These data suggest that, like therapies that target the cancer itself, the earlier that the blockade of TrkA occurs, the more effective the control of cancer pain and the tumor-induced remodeling of sensory nerve fibers.  Developing targeted therapies that relieve cancer pain without the side effects of current analgesics has the potential to significantly improve the quality of life and functional status of cancer patients.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoFTSrmfi4yxLVg90H21EOLACvtfcHk0lhSKwbi-2MrzQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFylsrrF&md5=67b3fe45cb035787f8822389107f8896</span></div><a href="/servlet/linkout?suffix=cit32a&amp;dbid=16384&amp;doi=10.1186%2F1744-8069-6-87&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1744-8069-6-87%26sid%3Dliteratum%253Aachs%26aulast%3DGhilardi%26aufirst%3DJ.%2BR.%26aulast%3DFreeman%26aufirst%3DK.%2BT.%26aulast%3DJimenez-Andrade%26aufirst%3DJ.%2BM.%26aulast%3DMantyh%26aufirst%3DW.%2BG.%26aulast%3DBloom%26aufirst%3DA.%2BP.%26aulast%3DKuskowski%26aufirst%3DM.%2BA.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DAdministration%2520of%2520a%2520Tropomysin%2520Receptor%2520Kinase%2520Inhibitor%2520Attenuates%2520Sarcoma-Induced%2520Nerve%2520Sprouting%252C%2520Neuroma%2520Formation%2520and%2520Bone%2520Cancer%2520Pain%26jtitle%3DMol.%2520Pain%26date%3D2010%26volume%3D6%26spage%3D87%26epage%3D97" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit32b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ghilardi, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, K. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jimenez-Andrade, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, W. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bloom, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouhana, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trollinger, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Winkler, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrews, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kuskowski, M. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mantyh, P. W.</span><span> </span><span class="NLM_article-title">Sustained Blockage of Neurotrophin Receptors TrkA, TrkB, and TrkC Reduces Non-Malignant Skeletal Pain but Not the Maintenance of Sensory and Sympathetic Nerve Fibers</span> <span class="citation_source-journal">Bone</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">28</span><span class="NLM_x">, </span> <span class="NLM_fpage">389</span><span class="NLM_x">–</span> <span class="NLM_lpage">398</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=28&publication_year=2011&pages=389-398&author=J.+R.+Ghilardiauthor=K.+T.+Freemanauthor=J.+M.+Jimenez-Andradeauthor=W.+G.+Mantyhauthor=A.+P.+Bloomauthor=K.+S.+Bouhanaauthor=D.+Trollingerauthor=J.+Winklerauthor=P.+Leeauthor=S.+W.+Andrewsauthor=M.+A.+Kuskowskiauthor=P.+W.+Mantyh&title=Sustained+Blockage+of+Neurotrophin+Receptors+TrkA%2C+TrkB%2C+and+TrkC+Reduces+Non-Malignant+Skeletal+Pain+but+Not+the+Maintenance+of+Sensory+and+Sympathetic+Nerve+Fibers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGhilardi%26aufirst%3DJ.%2BR.%26aulast%3DFreeman%26aufirst%3DK.%2BT.%26aulast%3DJimenez-Andrade%26aufirst%3DJ.%2BM.%26aulast%3DMantyh%26aufirst%3DW.%2BG.%26aulast%3DBloom%26aufirst%3DA.%2BP.%26aulast%3DBouhana%26aufirst%3DK.%2BS.%26aulast%3DTrollinger%26aufirst%3DD.%26aulast%3DWinkler%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DP.%26aulast%3DAndrews%26aufirst%3DS.%2BW.%26aulast%3DKuskowski%26aufirst%3DM.%2BA.%26aulast%3DMantyh%26aufirst%3DP.%2BW.%26atitle%3DSustained%2520Blockage%2520of%2520Neurotrophin%2520Receptors%2520TrkA%252C%2520TrkB%252C%2520and%2520TrkC%2520Reduces%2520Non-Malignant%2520Skeletal%2520Pain%2520but%2520Not%2520the%2520Maintenance%2520of%2520Sensory%2520and%2520Sympathetic%2520Nerve%2520Fibers%26jtitle%3DBone%26date%3D2011%26volume%3D28%26spage%3D389%26epage%3D398" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Wild, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bian, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davis, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bannon, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Louis, J.-C.</span><span> </span><span class="NLM_article-title">Antibodies to Nerve Growth Factor Reverse Established Tactile Allodynia in Rodent Models of Neuropathic Pain without Tolerance</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">322</span><span class="NLM_x">, </span> <span class="NLM_fpage">282</span><span class="NLM_x">–</span> <span class="NLM_lpage">287</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Fjm5006429&amp;key=10.1124%2Fjpet.106.116236" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Fjm5006429&amp;key=17431136" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Fjm5006429&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=322&publication_year=2007&pages=282-287&author=K.+D.+Wildauthor=D.+Bianauthor=D.+Zhuauthor=J.+Davisauthor=A.+W.+Bannonauthor=T.+J.+Zhangauthor=J.-C.+Louis&title=Antibodies+to+Nerve+Growth+Factor+Reverse+Established+Tactile+Allodynia+in+Rodent+Models+of+Neuropathic+Pain+without+Tolerance"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Antibodies to nerve growth factor reverse established tactile allodynia in rodent models of neuropathic pain without tolerance</span></div><div class="casAuthors">Wild, Kenneth D.; Bian, Di; Zhu, Dawn; Davis, James; Bannon, Anthony W.; Zhang, Tie J.; Louis, Jean-Claude</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">322</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">282-287</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">A considerable body of evidence implicates endogenous nerve growth factor (NGF) in conditions in which pain is a prominent feature, including neuropathic pain.  However, previous studies of NGF antagonism in animal models of neuropathic pain have examd. only the prevention of hyperalgesia and allodynia after injury, whereas the more relevant issue is whether treatment can provide relief of established pain, particularly without tolerance.  In the current work, we studied the effects of potent, neutralizing anti-NGF antibodies on the reversal of tactile allodynia and thermal hyperalgesia in established models of neuropathic and inflammatory pain in rats and mice.  In the complete Freund's adjuvant-induced hind-paw inflammation, spinal nerve ligation and streptozotocin-induced neuropathic pain models, a single i.p. injection of a polyclonal anti-NGF antibody reversed established tactile allodynia from approx. day 3 to day 7 after treatment.  Effects on thermal hyperalgesia were variable with a significant effect obsd. only in the spinal nerve ligation model.  In the mouse chronic constriction injury (CCI) model, a mouse monoclonal anti-NGF antibody reversed tactile allodynia when administered 2 wk after surgery.  Repeated administration of this antibody to CCI mice for 3 wk produced a sustained reversal (days 4 to 21) of tactile allodynia that returned 5 days after the end of dosing.  In conclusion, NGF seems to play a crit. role in models of established neuropathic and inflammatory pain in both rats and mice, with no development of tolerance to antagonism.  Antagonists of NGF, such as fully human monoclonal anti-NGF antibodies, may have therapeutic utility in analogous human pain conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplYoeF2Jtt_7Vg90H21EOLACvtfcHk0lh9PKyiXDc83A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntl2jtLs%253D&md5=0fc8d32552951e9e9543f1313df8da40</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1124%2Fjpet.106.116236&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.106.116236%26sid%3Dliteratum%253Aachs%26aulast%3DWild%26aufirst%3DK.%2BD.%26aulast%3DBian%26aufirst%3DD.%26aulast%3DZhu%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DJ.%26aulast%3DBannon%26aufirst%3DA.%2BW.%26aulast%3DZhang%26aufirst%3DT.%2BJ.%26aulast%3DLouis%26aufirst%3DJ.-C.%26atitle%3DAntibodies%2520to%2520Nerve%2520Growth%2520Factor%2520Reverse%2520Established%2520Tactile%2520Allodynia%2520in%2520Rodent%2520Models%2520of%2520Neuropathic%2520Pain%2520without%2520Tolerance%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2007%26volume%3D322%26spage%3D282%26epage%3D287" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT','PDB','4PMT'); return false;">PDB: 4PMT</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP','PDB','4PMP'); return false;">PDB: 4PMP</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS','PDB','4PMS'); return false;">PDB: 4PMS</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM','PDB','4PMM'); return false;">PDB: 4PMM</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i50"><a href="/doi/suppl/10.1021/jm5006429">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_31003"></div></div></div></div></div><hr /></hr><p class="last">Experimental procedures for protein crystallography, SPR, and details of in vitro and in vivo assays. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm5006429/suppl_file/jm5006429_si_001.pdf">jm5006429_si_001.pdf (178.53 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Structure coordinates have been deposited in the PDB: codes <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMT">4PMT</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMP">4PMP</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMS">4PMS</a>, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4PMM">4PMM</a>.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm5006429&amp;pbContext=%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2014.57.issue-13%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text%3Barticle%3Aarticle%3A10.1021%2Fjm5006429" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm5006429" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67993c576f7a3db2","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
